Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3019473	li-prot	mg/l (mg/l)	9912	13585	0.12%
3019473	li-prot	— (—)	620	706	100.00%	Distribution not available
3019473	li-prot	g/l (mg/l)	206	233	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Alzheimer’s disease (Late onset), excluding more controls

374

175

15.01

322.83

1.2

1.1

477.64

593.21

mg/l

2.11

329

168

Any mental disorder

2688

5680

2.42

320.92

1.4

505.79

544.81

mg/l

1.21

2534

5454

Focal epilepsy, strict definition

743

1653

4.82

311.16

1.5

1.6

531.54

512.26

mg/l

0.43

715

1570

Meningitis

362

395

11.04

309.86

2.0

1.3

1044.90

492.26

mg/l

13.64

350

372

Neurological diseases, wide definition

1204

546

11.60

307.65

1.6

1.5

468.32

424.79

mg/l

1.42

1145

519

Cerebrovascular diseases (FINNGEN)

1213

2067

4.43

307.65

1.6

1.2

674.75

505.10

mg/l

2.72

1162

1968

Demyelinating diseases of the central nervous system

770

731

13.08

307.65

1.2

1.3

426.91

503.83

mg/l

3.26

742

691

Other encephalitis

331

188

25.77

307.65

1.7

1.3

677.03

449.60

mg/l

8.09

324

177

Episodal and paroxysmal disorders

2989

5699

2.76

307.65

1.4

467.48

541.17

mg/l

5.42

2845

5435

MS-disease / Multiple Sclerosis

635

594

13.22

307.65

1.1

1.3

425.56

477.03

mg/l

1.68

609

564

Viral infections of the central nervous system

511

600

10.08

307.65

1.5

1.3

666.74

507.59

mg/l

6.90

488

567

Organic, including symptomatic, mental disorders

1543

2361

4.98

307.65

1.2

1.3

514.53

577.13

mg/l

1.85

1428

2259

Migraine

1464

3678

3.52

307.65

1.3

1.4

422.02

500.15

mg/l

3.44

1405

3511

Any dementia, excluding more controls

913

1336

4.97

307.65

1.2

1.3

506.41

580.71

mg/l

1.36

830

1282

Dizziness and giddiness

1812

4914

3.08

307.65

1.3

1.4

488.30

565.64

mg/l

3.94

1733

4707

Dementia, including avohilmo

1117

1958

4.11

307.65

1.2

1.3

509.14

579.84

mg/l

1.55

1021

1869

Symptoms and signs involving cognition, perception, emotional state and behaviour

3456

6030

4.21

307.65

1.3

1.4

491.28

556.08

mg/l

3.98

3281

5769

Headache

2786

4097

6.04

307.65

1.5

1.2

464.99

510.39

mg/l

2.05

2659

3898

Cerebrovascular diseases

1903

4599

3.07

307.65

1.5

1.3

644.16

548.76

mg/l

1.86

1818

4369

General symptoms and signs

3411

4665

3.79

307.65

1.4

1.2

542.70

532.96

mg/l

0.15

3253

4446

Other degenerative diseases of the nervous system

1545

619

21.12

307.65

1.2

447.54

528.54

mg/l

3.94

1452

585

Alzheimer’s disease, wide definition, excluding more controls

529

203

18.98

307.65

1.1

454.69

596.01

mg/l

3.48

477

195

Alzheimer disease, excluding more controls

588

235

17.90

307.65

1.2

1.1

461.80

592.02

mg/l

3.42

530

225

Other headache syndromes

1209

3479

3.61

307.65

1.3

476.82

521.39

mg/l

1.14

1159

3318

Implicit Sepsis

2117

5152

3.32

307.65

1.4

1.3

499.61

542.91

mg/l

2.00

2014

4917

Epilepsy

1127

2352

5.06

307.65

1.5

554.66

558.93

mg/l

0.05

1077

2244

Condition for Implicit Sepsis (Organ dysfunction codes)

2701

5528

3.70

307.65

1.3

487.88

555.69

mg/l

3.98

2564

5292

Mood disorders, excluding more controls

2299

5500

2.60

307.65

1.3

503.95

547.66

mg/l

1.15

2185

5281

Concussion

1114

1672

5.95

307.65

1.4

528.26

475.45

mg/l

0.46

1057

1594

Inflammatory diseases of the central nervous system

699

669

12.92

307.65

1.8

1.3

866.46

500.71

mg/l

17.21

680

632

Visual disturbances

1404

4385

3.34

307.65

1.3

1.4

505.92

508.92

mg/l

0.05

1335

4167

Hydrocephalus

907

443

29.05

307.65

2.1

1.4

469.17

542.27

mg/l

1.51

894

413

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

871

824

5.43

307.65

1.5

1.3

494.48

527.93

mg/l

0.81

822

791

Normal-pressure hydrocephalus

610

262

35.51

307.65

1.8

1.1

379.73

598.24

mg/l

6.95

604

240

Malaise and fatigue

1345

2714

4.29

307.65

1.3

542.59

520.96

mg/l

0.25

1280

2572

Psychiatric diseases

2774

5356

2.66

307.65

1.4

497.78

546.29

mg/l

2.04

2618

5142

Polyneuropathies and other disorders of the peripheral nervous system

791

1621

5.25

307.65

1.6

1.3

627.38

543.17

mg/l

1.36

766

1525

Disorders of optic nerve and visual pathways

533

813

7.44

307.65

1.3

1.5

487.11

495.51

mg/l

0.07

505

772

Other neurological diseases

2717

4736

4.89

307.65

1.6

1.2

521.73

561.02

mg/l

0.90

2605

4484

Postprocedural disorders of nervous system

572

553

12.46

307.65

1.3

1.2

383.63

486.09

mg/l

4.35

542

524

Neurological diseases

2977

2288

6.83

307.65

1.5

1.4

476.65

510.59

mg/l

0.89

2835

2182

Fever of other and unknown origin

1405

3551

3.79

307.65

1.7

1.2

576.04

510.13

mg/l

1.79

1356

3381

STROKE

1623

3796

3.07

307.65

1.5

1.3

636.00

529.40

mg/l

2.00

1556

3613

Encephalitis

345

205

24.27

307.65

1.7

1.2

673.45

440.70

mg/l

9.31

338

195

Visual disturbances and blindness

1482

4693

3.29

307.65

1.4

515.00

511.20

mg/l

0.07

1408

4465

Other demyelinating diseases of the central nervous system

390

292

17.87

307.65

1.2

1.4

416.50

499.07

mg/l

1.88

379

276

Disturbances of skin sensation

1051

2577

4.35

307.65

1.2

1.3

430.91

514.54

mg/l

6.49

1004

2446

Symptoms and signs involving the nervous and musculoskeletal systems

2342

5055

4.94

307.65

1.4

496.78

543.43

mg/l

1.34

2224

4828

Other symptoms and signs involving the nervous and musculoskeletal systems

1674

3574

5.00

307.65

1.4

486.85

522.92

mg/l

0.92

1586

3414

Intracranial trauma

1352

1728

6.03

307.65

1.4

552.98

475.47

mg/l

0.87

1282

1648

Dementia

1036

1714

4.36

307.65

1.2

1.3

505.61

586.50

mg/l

1.68

944

1640

Abnormal findings on diagnostic imaging of central nervous system

396

360

14.01

307.65

1.4

1.7

463.72

502.48

mg/l

0.69

378

339

Focal epilepsy

792

1793

4.72

307.65

1.5

1.6

537.19

509.87

mg/l

0.64

760

1703

Convulsions, not elsewhere classified

860

1468

6.14

307.65

1.7

1.3

501.73

504.09

mg/l

0.03

823

1399

Abnormalities of gait and mobility

518

742

7.74

307.65

1.5

1.4

523.76

548.03

mg/l

0.23

499

697

Other symptoms and signs involving cognitive functions and awareness

2089

2660

8.04

307.65

1.3

1.4

504.74

570.80

mg/l

2.13

1960

2538

Other mental disorders due to brain damage and dysfunction and to physical disease

445

628

7.77

303.11

1.3

486.85

553.58

mg/l

2.01

422

599

Cerebral cysts

353

382

10.78

302.39

1.5

1.2

444.21

507.99

mg/l

0.70

343

356

Alzheimer’s disease (Early onset), excluding more controls

195

39.41

301.54

1.1

415.25

562.54

mg/l

0.97

184

Any dementia

923

1599

4.24

300.65

1.2

1.3

507.32

569.96

mg/l

1.12

838

1521

Degenerative diseases of the nervous system

833

1464

4.48

296.49

1.2

1.3

474.29

590.78

mg/l

4.54

760

1390

Anxiety disorders, excluding more controls

1982

5184

2.60

296.00

1.3

508.65

542.75

mg/l

0.63

1876

4972

Viral encephalitis, not elsewhere classified/unspecified

231

136

24.39

293.22

1.7

1.4

712.77

450.54

mg/l

6.75

222

129

Other and unspecified polyneuropathies, also in other diseases

648

1373

5.06

288.08

1.3

614.05

552.14

mg/l

0.69

627

1290

Focal epilepsy, mode (most common among epilepsy diagnosis)

699

1581

4.74

286.77

1.5

1.6

542.39

505.69

mg/l

0.88

670

1501

Other antidepressants

2478

5664

2.33

276.31

1.3

501.17

549.99

mg/l

1.80

2347

5415

Stroke, including SAH

1471

3880

2.89

275.84

1.6

1.3

653.58

556.00

mg/l

1.47

1401

3670

Unspecific neurodegenerative disorder

920

1663

3.97

273.13

1.2

1.3

471.23

592.49

mg/l

5.80

837

1587

Mood [affective] disorders

2464

7486

2.21

258.90

1.3

498.98

545.81

mg/l

1.33

2338

7145

Mood disorders

2464

7490

2.21

257.57

1.3

498.32

545.97

mg/l

1.36

2339

7149

Depression

2318

7262

2.25

255.54

1.3

498.11

544.15

mg/l

1.20

2199

6931

Delirium, not induced by alcohol and other psychoactive substances

384

555

7.46

254.68

1.3

604.80

558.74

mg/l

0.27

362

529

Infections, IBD-co-morbidities

360

294

9.24

249.95

1.6

1.2

593.08

439.93

mg/l

1.26

341

274

Spirochaetal infections, other/unspecified

406

646

7.07

248.98

1.2

1.3

615.75

519.63

mg/l

2.91

390

607

Viral Sepsis

593

1341

4.68

242.48

1.6

1.3

530.59

547.94

mg/l

0.22

561

1263

Implicit viral Sepsis

589

1336

4.66

239.91

1.6

1.3

531.78

548.50

mg/l

0.21

557

1258

Depression or dysthymia

1542

3279

2.69

235.32

1.3

527.30

551.59

mg/l

0.35

1457

3154

N06DA Anticholinesterases

716

1470

4.10

234.68

1.2

1.3

469.92

594.65

mg/l

4.86

647

1393

Use of anticholinesterases

716

1470

4.10

234.68

1.2

1.3

469.92

594.65

mg/l

4.86

647

1393

Implicit bacterial Sepsis

906

2537

3.39

234.32

1.5

1.3

540.30

553.64

mg/l

0.22

854

2408

Dorsalgia

2332

5860

2.20

229.95

1.3

508.27

538.00

mg/l

0.63

2227

5582

Medical observation and evaluation for suspected diseases and conditions

1611

3202

2.63

229.62

1.4

1.3

485.08

570.30

mg/l

2.38

1542

3066

Pain, not elsewhere classified

653

1689

4.01

221.81

1.3

513.62

501.66

mg/l

0.10

615

1608

Alzheimer disease, including avohilmo

738

1411

3.92

219.56

1.2

1.3

513.44

577.08

mg/l

0.84

669

1336

Bacterial Sepsis

996

2967

3.08

219.05

1.5

1.3

566.80

547.11

mg/l

0.35

942

2823

Anxiety disorders

2135

7115

2.17

218.67

1.3

524.96

522.18

mg/l

0.03

2023

6796

Syncope and collapse

924

2620

3.21

218.67

1.4

1.2

465.49

525.75

mg/l

3.12

890

2485

General examination and investigation of persons without complaint and reported diagnosis

1536

3201

2.61

217.99

1.5

1.3

530.00

570.29

mg/l

0.49

1470

3065

Neurotic, stress-related and somatoform disorders

2115

7066

2.17

217.09

1.3

524.52

521.60

mg/l

0.03

2004

6747

Other soft tissue disorders, not elsewhere classified

2160

6244

2.18

216.40

1.4

499.25

544.59

mg/l

1.27

2069

5948

Symptoms and signs involving the skin and subcutaneous tissue

1623

7022

2.36

216.22

1.4

452.62

545.24

mg/l

8.73

1550

6694

Alzheimer’s disease, wide definition

544

1002

4.73

215.69

1.1

1.3

455.36

624.20

mg/l

5.09

487

948

Autoimmune diseases excluding thyroid diseases

2421

6546

2.09

212.62

1.3

1.4

539.09

537.67

mg/l

0.02

2318

6229

Stroke, excluding SAH

1276

3645

2.67

207.47

1.5

1.3

614.50

561.68

mg/l

0.70

1213

3444

Traumatic subdural haemorrhage

256

282

9.30

207.44

1.5

1.1

709.76

548.33

mg/l

0.71

240

264

Autoimmune diseases excluding thyroid diseases, strict definition

2343

6377

2.08

204.55

1.3

1.4

538.68

534.50

mg/l

0.06

2245

6063

Autoimmune diseases related-to ILD

1953

8151

2.15

204.49

1.2

1.3

504.09

541.67

mg/l

0.86

1861

7775

Other meningitis

173

118

20.44

203.16

2.2

1.2

908.39

441.43

mg/l

6.78

167

110

Other dorsopathies, not elsewhere classified

2301

5903

2.09

200.18

1.3

502.61

537.35

mg/l

0.91

2197

5623

Alzheimer disease

632

1222

4.04

199.23

1.1

1.3

468.82

600.80

mg/l

4.41

566

1155

Migraine without aura

593

1560

3.98

197.49

1.3

1.5

421.46

477.77

mg/l

0.88

573

1498

Certain infectious and parasitic diseases

2231

5389

2.11

195.18

1.5

1.3

534.65

499.56

mg/l

1.11

2136

5135

Low back pain

1632

5603

2.29

193.93

1.3

506.01

530.61

mg/l

0.51

1551

5336

Papilloedema, unspecified

193

173

14.25

191.22

1.4

468.68

442.70

mg/l

0.12

186

164

Migraine with aura

651

1870

3.62

190.08

1.3

1.4

447.57

485.35

mg/l

0.54

619

1796

Optic neuritis

259

342

8.78

189.39

1.2

1.3

406.00

467.28

mg/l

1.63

242

324

Diplopia

449

996

4.83

189.07

1.4

1.3

577.21

528.78

mg/l

0.58

434

945

Other disorders of optic [2nd] nerve and visual pathways

312

507

6.92

187.58

1.4

1.6

541.89

514.21

mg/l

0.16

298

481

Status epilepticus

206

207

11.48

185.93

1.5

1.7

636.67

520.01

mg/l

0.74

200

196

ILD medications

2536

7235

1.96

185.93

1.5

1.3

525.98

527.80

mg/l

0.03

2424

6894

Recurrent or chronic depression

937

2340

2.97

184.03

1.3

453.86

537.39

mg/l

3.11

893

2244

Aneurysms, operations, SAH

486

1171

4.38

183.26

1.9

1.2

758.92

537.19

mg/l

1.64

466

1101

Anxiety (asthma-related co-morbidities)

1432

4920

2.35

180.79

1.3

1.4

478.23

530.12

mg/l

0.65

1355

4709

Bacterial infection, other or unspecified

1145

4131

2.57

179.95

1.7

1.3

633.68

527.70

mg/l

2.02

1081

3928

Alzheimer’s disease (Early onset)

195

188

11.46

179.77

1.1

1.3

415.25

590.70

mg/l

4.33

184

179

Lower back pain or/and sciatica

2231

7944

1.98

179.41

1.3

516.67

537.96

mg/l

0.44

2127

7567

Cerebral palsy and other paralytic syndromes

418

919

4.88

178.08

1.7

1.5

570.85

526.08

mg/l

0.59

390

872

Nerve, nerve root and plexus disorders

2267

7333

1.98

176.68

1.3

545.57

532.71

mg/l

0.23

2161

6988

Pain (limb, back, neck, head abdominally)

1577

3464

2.32

173.19

1.5

1.4

494.32

561.11

mg/l

3.07

1497

3302

Parkinson's disease, excluding more controls

224

259

8.72

172.62

1.4

1.1

475.30

579.76

mg/l

2.10

210

248

Viral meningitis

228

292

9.09

171.23

1.4

1.3

673.73

469.90

mg/l

4.85

218

278

Pain in limb

1726

5958

2.14

170.93

1.4

509.99

536.40

mg/l

0.52

1654

5677

Depression medications

802

1243

3.33

168.16

1.3

1.1

435.92

428.44

mg/l

0.19

751

1187

ILD medications: immunosuppressive drugs

1403

6170

2.23

163.23

1.8

1.3

540.35

526.89

mg/l

0.15

1353

5884

Ischaemic Stroke, excluding all haemorrhages

1123

3456

2.52

163.22

1.4

1.3

583.86

567.26

mg/l

0.16

1068

3267

Nontraumatic intracranial haemmorrhage

483

1269

3.97

160.97

2.0

1.3

820.13

562.43

mg/l

1.91

459

1192

All anxiety disorders

1447

5373

2.22

160.25

1.3

477.20

509.58

mg/l

0.36

1370

5142

Pain in joint

1193

3281

2.45

160.00

1.2

1.3

518.48

562.07

mg/l

0.66

1125

3129

Examination and observation for other reasons

1243

3169

2.43

159.65

1.4

1.3

465.80

570.81

mg/l

3.63

1199

3037

Dorsopathies

2237

5955

1.95

159.19

1.3

1.4

509.01

535.32

mg/l

0.61

2132

5675

Sequelae of cerebrovascular disease

712

2074

3.10

158.65

1.6

1.3

641.54

556.69

mg/l

0.65

681

1959

Used for control exclusion in common control thyroid runs

2291

6117

1.93

158.20

1.3

1.4

514.88

536.74

mg/l

0.44

2191

5820

Parkinson's disease, strict definition, excluding more controls

200

229

8.85

156.54

1.4

1.1

472.66

574.89

mg/l

2.14

188

219

Disorders of thyroid, IBD co-morbidities

297

345

6.42

155.59

1.5

1.2

604.09

431.98

mg/l

1.33

280

322

Anaemias

575

1081

3.64

151.64

1.7

1.2

502.03

436.00

mg/l

1.84

543

1036

Opioids

2172

6013

1.93

150.98

1.3

503.00

514.94

mg/l

0.25

2061

5735

Other special examinations and investigations of persons without complaint or reported diagnosis

1418

3202

2.28

150.27

1.4

1.3

503.82

570.30

mg/l

1.65

1332

3066

Subjective visual disturbances

630

2074

3.16

147.88

1.3

1.4

464.38

519.13

mg/l

1.15

600

1968

Use of donepezil

401

940

4.27

146.49

1.2

1.3

465.71

625.00

mg/l

3.96

356

887

ILD medications: prednisolone, methylprednisolone, prednisone

2291

7085

1.85

144.85

1.4

1.3

549.76

531.50

mg/l

0.29

2188

6747

Autoimmune diseases

2355

6589

1.85

144.60

1.3

1.4

518.39

536.44

mg/l

0.35

2254

6270

First line medication for Crohn's disease

2371

7153

1.83

143.72

1.6

1.3

548.87

513.28

mg/l

0.78

2270

6813

Diseases of the eye and adnexa

1862

4719

2.01

143.71

1.5

1.4

481.12

538.13

mg/l

1.99

1770

4509

Other anxiety disorders

1090

4211

2.35

141.57

1.3

490.82

486.93

mg/l

0.03

1034

4032

Extrapyramidal and movement disorders

785

2979

2.72

140.92

1.3

540.25

541.32

mg/l

0.01

737

2827

GASTRO-related operations

1788

4508

2.02

140.63

1.7

1.2

492.33

515.98

mg/l

0.57

1712

4286

Any gastric operation

1788

4508

2.02

140.63

1.7

1.2

492.33

515.98

mg/l

0.57

1712

4286

Speech disturbances, not elsewhere classified

295

597

5.32

138.95

1.4

1.2

529.44

545.58

mg/l

0.19

281

558

Selective serotonin reuptake inhibitors

2037

5700

1.91

138.26

1.3

493.23

548.41

mg/l

2.26

1930

5451

Care involving use of rehabilitation procedures

1363

6264

2.11

137.68

1.4

541.34

529.82

mg/l

0.15

1283

6000

Other bacterial diseases

1891

6950

1.91

137.18

1.6

1.3

615.35

524.36

mg/l

2.72

1791

6639

Parasetamol

1737

4470

2.01

136.03

1.4

1.3

493.91

513.03

mg/l

0.49

1646

4267

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

279

550

5.51

135.75

1.8

1.3

1013.26

504.99

mg/l

1.89

273

521

Intracranial injury

1223

5529

2.18

135.47

1.4

507.12

519.84

mg/l

0.16

1156

5269

Subarachnoid haemorrhage

317

698

4.82

134.50

2.1

1.3

868.27

537.03

mg/l

1.60

302

656

Abnormal involuntary movements

364

909

4.22

130.93

1.5

1.3

577.58

548.73

mg/l

0.12

344

860

Primary_lymphoid and hematopoietic malignant neoplasms

568

1890

3.12

130.80

3.0

1.3

612.71

539.35

mg/l

1.53

552

1783

Persons encountering health services for specific procedures and health care

2223

7815

1.79

127.63

1.4

543.83

525.62

mg/l

0.38

2098

7480

Primary_lymphoid and hematopoietic malignant neoplasms

568

1917

3.08

127.47

3.0

1.3

612.71

543.24

mg/l

1.22

552

1808

Tramadol

1602

5296

1.98

126.15

1.3

540.85

518.22

mg/l

0.43

1524

5048

Dementia in Alzheimer disease

319

606

4.65

125.99

1.2

1.3

483.01

601.58

mg/l

4.03

285

579

Sciatica+with lumbago

1034

4423

2.27

125.46

1.3

545.93

547.44

mg/l

0.01

992

4210

Nausea and vomiting

615

2146

2.90

125.21

1.7

1.5

608.02

518.34

mg/l

0.76

592

2036

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

630

2272

2.85

124.70

1.3

464.23

493.94

mg/l

0.78

595

2181

Bell's palsy

360

926

4.11

124.59

1.5

1.3

567.75

511.45

mg/l

1.03

347

870

Cardiovascular diseases

1463

3927

2.07

124.51

1.5

1.4

472.24

467.91

mg/l

0.07

1402

3754

Other spirochaetal diseases

621

2256

2.86

122.00

1.2

1.4

579.10

536.37

mg/l

1.10

600

2136

Codeine

1953

5897

1.85

121.22

1.3

537.19

516.91

mg/l

0.30

1862

5625

Lyme disease

615

2234

2.86

120.87

1.2

1.4

578.75

535.37

mg/l

1.12

594

2115

Alzheimer’s disease (Late onset)

387

887

3.85

120.01

1.2

1.3

476.65

630.83

mg/l

3.43

337

840

Other intervertebral disc disorders

1620

5197

1.94

119.31

1.3

554.18

553.75

mg/l

0.00

1543

4947

Cardiovascular diseases (excluding rheumatic etc)

1497

4421

1.99

116.92

1.5

1.4

486.48

469.79

mg/l

0.37

1432

4216

Benzodiazepine use

1993

8110

1.77

114.89

1.3

491.09

546.85

mg/l

2.31

1887

7741

Substance abuse, excluding more controls

1033

4191

2.20

114.74

1.3

526.44

561.53

mg/l

0.74

977

4026

Use of rivastigmine

295

692

4.44

114.55

1.2

1.3

475.04

615.80

mg/l

2.41

271

654

Other reaction to severe stress, and adjustment disorders

850

3697

2.36

113.73

1.4

1.3

522.99

485.06

mg/l

0.36

805

3538

Oral corticosteroids

2132

7475

1.75

113.42

1.4

1.3

543.89

527.53

mg/l

0.26

2029

7124

Injuries to the head

2178

8327

1.73

112.40

1.4

537.24

527.07

mg/l

0.15

2072

7945

Soft tissue disorders

2129

6366

1.76

111.74

1.4

486.17

543.12

mg/l

2.70

2025

6065

Migraine without aura and triptan purchases

463

1506

3.21

111.28

1.4

1.3

430.24

469.17

mg/l

0.41

447

1449

Inflammatory bowel disease treatment related agents

2308

7791

1.70

110.57

1.5

1.3

534.98

528.31

mg/l

0.10

2201

7426

Memory loss

252

542

4.93

110.11

1.3

449.56

589.66

mg/l

6.21

226

520

Pain in throat and chest

1729

5814

1.84

109.73

1.3

517.16

555.93

mg/l

0.83

1633

5545

Disorders of ocular muscles, binocular movement, accommodation and refraction

1035

4902

2.14

109.62

1.5

1.4

470.13

500.34

mg/l

0.84

980

4686

Other disorders of fluid, electrolyte and acid-base balance

607

2208

2.73

109.46

1.5

1.4

596.56

555.47

mg/l

0.35

576

2091

Persons encountering health services for examination and investigation

1301

3202

2.07

108.92

1.4

1.3

505.86

570.30

mg/l

1.60

1229

3066

Any reimbursement code in KELA

1337

3330

2.04

108.57

1.6

1.3

473.73

500.57

mg/l

0.67

1272

3177

Paralytic strabismus

241

510

5.09

107.94

1.5

1.4

573.51

545.55

mg/l

0.17

235

481

Symptoms and signs involving the circulatory and respiratory systems

2122

6192

1.74

106.25

1.4

478.12

546.32

mg/l

3.17

2018

5908

Explicit Sepsis

774

3195

2.37

104.84

2.0

1.4

652.20

532.88

mg/l

1.67

727

3044

Other disorders of urethra and urinary system

1347

5299

1.94

103.39

1.4

1.3

522.03

514.53

mg/l

0.10

1282

5051

Other diseases of urinary system

2005

6588

1.73

102.14

1.4

1.3

532.87

527.40

mg/l

0.08

1899

6294

Alzheimer’s disease (Atypical or mixed), excluding more controls

117

11.24

101.93

1.2

1.1

523.99

611.79

mg/l

0.69

103

Personality disorders, excluding more controls

562

2124

2.72

101.73

1.2

1.3

433.52

495.84

mg/l

2.37

533

2042

Spondylopathies

1450

4692

1.90

101.56

1.3

619.80

554.11

mg/l

1.09

1386

4472

Bacterial meningitis

167

269

6.97

101.46

2.0

1.2

1309.58

487.47

mg/l

9.16

161

253

Hypothyroidism (congenital or acquired)

574

1168

2.88

100.90

1.3

1.2

462.34

427.38

mg/l

1.05

551

1117

Metabolic disorders

1807

6432

1.77

100.66

1.4

556.47

543.26

mg/l

0.24

1720

6138

Migraine with aura and triptan purchases

422

1390

3.17

99.32

1.3

438.20

476.62

mg/l

0.35

401

1332

Hypothyroidism and >3 levothyroxin purchases

567

1163

2.86

98.53

1.3

1.2

461.61

427.30

mg/l

1.01

546

1112

Hypothyroidism, levothyroxine purchases

567

1163

2.86

98.53

1.3

1.2

461.61

427.30

mg/l

1.01

546

1112

Oedema, not elsewhere classified

504

1822

2.81

98.01

1.3

1.2

544.21

512.46

mg/l

0.21

486

1723

Symptoms and signs involving speech and voice

680

2882

2.42

96.79

1.3

496.56

525.51

mg/l

0.78

653

2733

Hard cardiovascular diseases

1446

5045

1.87

96.66

1.5

1.3

602.93

555.77

mg/l

0.66

1380

4807

Persons encountering health services in other circumstances, wide

2341

7471

1.64

96.40

1.4

534.94

536.58

mg/l

0.02

2243

7113

Abnormalities of breathing

1786

6152

1.75

94.59

1.3

1.4

501.57

547.03

mg/l

1.19

1711

5870

Bleeding

1514

6164

1.81

94.49

1.6

1.3

644.12

541.54

mg/l

1.74

1426

5885

Symptoms and signs involving the digestive system and abdomen

1997

5919

1.71

94.44

1.5

1.4

510.79

534.84

mg/l

0.74

1900

5636

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1711

6170

1.76

94.08

1.4

1.3

587.22

516.55

mg/l

1.65

1617

5904

1711

6170

1.76

94.08

1.4

1.3

587.22

516.55

mg/l

1.65

1617

5904

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1161

5654

1.94

92.62

1.3

512.73

566.59

mg/l

1.20

1103

5379

Hypo-osmolality and hyponatraemia

364

1152

3.26

90.83

1.4

640.74

543.73

mg/l

0.59

342

1095

Strabismus

628

2642

2.44

90.74

1.5

487.85

499.50

mg/l

0.16

600

2513

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

334

1010

3.46

90.73

1.8

1.2

685.56

531.58

mg/l

2.62

323

943

Influenza and pneumonia

2037

8191

1.66

90.41

1.5

1.4

561.97

520.46

mg/l

0.94

1932

7832

Lumbar disc prolapse

1174

4928

1.92

89.59

1.3

563.60

546.79

mg/l

0.17

1123

4695

Codeine or tramadol medication

2200

7574

1.63

88.26

1.3

538.53

530.07

mg/l

0.12

2096

7214

Use of other anti-dementia drugs

392

1127

3.11

88.06

1.2

1.3

471.44

600.60

mg/l

3.71

342

1061

Use of memantine

392

1127

3.11

88.06

1.2

1.3

471.44

600.60

mg/l

3.71

342

1061

Myalgia

510

1985

2.64

87.31

1.3

471.14

498.68

mg/l

0.55

486

1888

Nonorganic sleeping disorders, excluding more controls

400

1377

3.00

86.70

1.4

1.3

403.17

520.40

mg/l

8.60

386

1323

Other extrapyramidal and movement disorders in other diseases

474

1790

2.73

86.40

1.2

1.3

589.49

532.91

mg/l

0.35

442

1700

Non-follicular lymphoma

260

691

3.98

86.16

1.9

1.3

626.02

544.32

mg/l

1.48

252

650

Unspecified dementia

195

363

4.99

85.71

1.2

622.68

585.62

mg/l

0.10

179

347

Fall on same level

2248

7908

1.61

85.69

1.3

1.4

548.05

522.02

mg/l

0.52

2144

7552

Non-follicular lymphoma, hilmo, excluding all cancers

260

698

3.94

84.94

1.9

1.2

626.02

499.31

mg/l

3.32

252

647

Schizophrenia or delusion, excluding more controls

582

2420

2.44

84.55

1.2

1.3

478.35

552.30

mg/l

1.90

551

2320

Other/unspecified dorsalgia

707

3209

2.24

84.17

1.3

552.77

538.34

mg/l

0.10

676

3059

Viral hepatitis, IBD co-morbidity

105

123

8.85

82.89

1.3

1.2

553.79

449.60

mg/l

0.77

118

Cervicalgia

424

1552

2.81

81.95

1.3

472.19

493.28

mg/l

0.34

402

1478

Transient ischemic attack

851

3455

2.08

81.36

1.3

532.68

559.87

mg/l

0.72

814

3266

Septicaemia

724

3243

2.19

81.33

2.0

1.4

623.96

515.97

mg/l

2.20

681

3081

Hemiplegia

175

361

5.20

80.75

1.6

1.3

463.70

496.98

mg/l

0.59

164

338

Complications of medical and surgical care

1323

7210

1.77

79.51

1.5

1.3

565.03

529.83

mg/l

0.54

1259

6870

Enlarged lymph nodes

305

943

3.33

79.40

1.5

1.3

598.32

517.85

mg/l

0.50

287

896

Asthma (mode)

1455

4572

1.77

79.27

1.3

530.78

534.10

mg/l

0.04

1381

4374

Diseases of the musculoskeletal system and connective tissue

1143

3018

1.92

79.23

1.5

1.4

471.05

529.45

mg/l

1.41

1080

2882

Other septicaemia

652

2894

2.26

79.17

2.1

1.4

599.14

516.52

mg/l

1.33

612

2751

Hypertensive diseases (excluding secondary)

1089

3324

1.93

79.15

1.3

554.81

495.41

mg/l

1.05

1034

3168

Complications of surgical and medical care, not elsewhere classified

1791

7920

1.64

78.35

1.5

1.3

553.76

529.49

mg/l

0.45

1719

7541

COPD/asthma/ILD related infections

1988

6180

1.63

78.34

1.4

1.3

548.04

516.39

mg/l

0.61

1875

5914

COPD/asthma related infections

1988

6180

1.63

78.34

1.4

1.3

548.04

516.39

mg/l

0.61

1875

5914

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2068

7449

1.60

78.15

1.4

545.10

536.58

mg/l

0.11

1983

7092

Cerebral aneurysm, nonruptured

235

623

3.98

78.14

1.6

1.3

556.05

524.58

mg/l

0.35

225

591

Other and unspecified visual disturbances

258

730

3.72

78.00

1.2

1.4

453.33

512.67

mg/l

1.23

242

691

Antihypertensive medication - note that there are other indications

1343

4130

1.80

77.77

1.4

453.34

498.04

mg/l

1.21

1278

3936

Asthma, excluding more controls

1445

4417

1.77

77.58

1.3

522.44

535.73

mg/l

0.17

1373

4225

Cystitis

1573

5700

1.71

77.56

1.3

527.58

511.56

mg/l

0.25

1492

5436

Asthma

1467

4541

1.75

77.16

1.3

521.60

534.87

mg/l

0.18

1393

4343

Spondylosis

912

4022

1.98

76.60

1.4

1.3

596.96

569.08

mg/l

0.25

881

3834

Dysphagia

473

1891

2.57

76.55

1.3

549.59

549.27

mg/l

0.00

448

1789

Abdominal and pelvic pain

1901

5916

1.63

75.82

1.4

497.28

534.69

mg/l

1.71

1814

5633

Sleep disorders (combined)

1834

7486

1.62

75.81

1.3

530.46

544.60

mg/l

0.16

1744

7148

Symptoms and signs involving the urinary system

1365

6141

1.74

75.46

1.4

1.3

610.54

538.47

mg/l

0.84

1296

5854

Systemic atrophies primarily affecting the central nervous system

153

300

5.57

75.28

1.6

1.4

590.09

525.39

mg/l

0.22

147

278

Second line medication for Crohn's disease

1089

6032

1.84

74.71

1.9

1.3

541.63

523.25

mg/l

0.17

1050

5741

Non-invasive ventilation

437

1590

2.65

74.44

1.5

1.3

544.15

505.54

mg/l

0.68

387

1524

Neuromuscular dysfunction of bladder

238

659

3.79

74.22

1.4

1.3

611.83

546.18

mg/l

0.31

221

618

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1770

7917

1.62

73.78

1.7

1.3

548.89

528.24

mg/l

0.37

1684

7557

Benign neoplasm of meninges

253

733

3.62

73.73

1.4

1.2

706.42

531.87

mg/l

2.49

239

692

Triptan medication for migraine, single purchase ok

1514

6150

1.69

73.04

1.3

454.56

531.78

mg/l

3.45

1441

5879

Migraine, single triptan purchase ok & required. ICD-code if available is included

1514

6150

1.69

73.04

1.3

454.56

531.78

mg/l

3.45

1441

5879

L04AX Other immunosuppressants

1059

5859

1.84

72.96

1.9

1.3

539.44

525.00

mg/l

0.12

1021

5582

All pneumoniae

1863

8164

1.59

71.73

1.4

580.25

523.33

mg/l

1.34

1764

7807

Benign neoplasm of meninges

253

747

3.56

71.63

1.4

1.3

706.42

537.94

mg/l

2.77

239

706

Provisional assignment of new diseases of uncertain etiology

881

4630

1.94

71.50

1.5

1.4

550.29

488.04

mg/l

0.95

849

4412

Codes for special purposes

881

4637

1.94

71.17

1.5

1.4

550.29

487.99

mg/l

0.95

849

4419

Benign neoplasm: Cerebral meninges

236

673

3.69

70.55

1.3

1.2

705.60

516.08

mg/l

2.62

223

635

Somatoform disorder

373

1387

2.78

70.25

1.3

523.99

512.97

mg/l

0.05

349

1318

Pneumonias (Asthma/COPD co-morbidities)

1845

8141

1.59

70.17

1.4

580.51

523.65

mg/l

1.32

1747

7784

COPD differential diagnosis

1528

4573

1.69

69.84

1.4

1.3

516.71

534.13

mg/l

0.35

1449

4375

Other specific joint derangements/joint disorders

1436

5764

1.69

69.72

1.2

1.4

513.21

510.60

mg/l

0.03

1357

5504

ILD differential diagnosis

1525

4572

1.69

69.24

1.4

1.3

516.22

534.10

mg/l

0.36

1446

4374

Acute upper respiratory infections of multiple and unspecified sites

1393

6245

1.69

69.16

1.5

1.3

519.30

515.16

mg/l

0.04

1326

5955

Other pulmonary diagnosis

1529

4591

1.69

69.06

1.4

1.3

516.67

534.49

mg/l

0.36

1448

4391

Pneumonia, organism unspecified

1631

7343

1.63

68.87

1.4

591.06

531.55

mg/l

1.20

1544

7020

Hypertension, essential

1469

5022

1.69

68.73

1.3

564.55

514.76

mg/l

1.25

1395

4793

Excluding asthma or asthma-COPD overlap

1526

4591

1.68

68.43

1.4

1.3

516.85

534.49

mg/l

0.35

1447

4391

Systemic connective tissue disorders

653

3139

2.12

68.37

1.3

581.41

528.36

mg/l

0.33

615

2970

Benign neoplasm: Cerebral meninges

236

690

3.60

67.94

1.3

1.2

705.60

527.33

mg/l

2.81

223

650

Other disorders of eye and adnexa

337

1216

2.88

67.45

1.4

1.5

464.68

508.93

mg/l

1.15

324

1153

Follow-up examination after treatment for conditions other than malignant neoplasms

761

2475

2.04

66.63

1.2

1.3

483.98

542.10

mg/l

1.09

719

2371

Other disorders of lacrimal gland

642

3100

2.12

66.51

1.4

1.3

534.64

518.74

mg/l

0.14

601

2928

Undefined dementia

195

456

4.04

66.44

1.2

1.3

622.68

559.01

mg/l

0.19

179

424

Diseases of the myoneural junction and muscle

281

932

3.14

65.57

1.5

1.4

535.28

542.22

mg/l

0.07

269

877

Bipolar affective disorders

422

1724

2.52

65.44

1.3

445.38

496.38

mg/l

1.47

407

1654

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1782

8056

1.57

65.09

1.4

583.56

524.80

mg/l

1.33

1685

7707

Bronchitis

1923

8237

1.55

64.77

1.5

1.3

515.85

534.78

mg/l

0.29

1828

7853

Acute upper respiratory infections

1870

7603

1.56

64.26

1.4

1.3

552.04

526.17

mg/l

0.37

1772

7249

Factors influencing health status and contact with health services

592

1316

2.29

63.97

1.4

1.2

546.85

582.39

mg/l

0.30

556

1251

2047

7114

1.53

63.69

1.4

1.3

544.25

529.06

mg/l

0.21

1942

6790

L04AA Selective immunosuppressants

469

2040

2.37

63.33

1.6

1.4

566.52

510.98

mg/l

0.42

449

1937

Covid-19 confirmed case

555

2589

2.19

62.96

1.6

1.4

608.85

503.86

mg/l

1.11

530

2458

Viral infections characterized by skin and mucous membrane lesions

787

4170

1.92

62.29

1.6

1.4

563.50

524.89

mg/l

0.66

759

3977

Somnolence, stupor and coma

126

245

5.46

62.14

1.5

421.82

514.62

mg/l

2.04

120

232

Cervicobrachial syndrome

429

1809

2.43

61.93

1.4

1.3

492.51

491.85

mg/l

0.01

414

1725

Traumatic subarachnoid haemorrhage

10.48

61.48

1.3

1.1

656.92

504.21

mg/l

0.38

Asthma (only as main-diagnosis), excluding more controls

1251

4417

1.71

61.46

1.3

480.05

535.73

mg/l

1.77

1188

4225

Falls/tendency to fall

2074

6896

1.52

61.22

1.4

528.27

525.78

mg/l

0.04

1977

6583

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

630

3118

2.07

61.15

1.3

464.23

483.14

mg/l

0.44

595

2981

Asthma (only as main-diagnosis)

1262

4541

1.70

60.75

1.3

478.95

534.87

mg/l

1.84

1199

4343

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

160

384

4.35

60.67

1.5

1.3

514.85

568.89

mg/l

0.82

152

358

Behavioural syndromes associated with physiological disturbances and physical factors

660

3346

2.01

59.71

1.5

1.4

417.46

478.87

mg/l

3.25

633

3189

Intestinal infectious diseases

1678

8504

1.55

59.17

1.4

533.58

521.37

mg/l

0.18

1599

8105

Temporomandibular joint disorders

289

1032

2.87

58.56

1.3

506.43

500.79

mg/l

0.03

273

979

Diarrhoea and gastroenteritis of presumed infectious origin

1269

7107

1.64

58.09

1.4

577.00

505.92

mg/l

0.71

1206

6761

Dental caries

521

2424

2.18

57.99

2.4

1.3

607.35

524.11

mg/l

0.70

501

2321

Non-selective monoamine reuptake inhibitors

622

3020

2.03

57.86

1.3

520.93

561.92

mg/l

0.49

584

2897

Disorders of lipoprotein metabolism and other lipidaemias

1338

5176

1.64

57.71

1.3

568.13

567.85

mg/l

0.00

1275

4937

Sleep disorders

468

2115

2.27

57.70

1.3

400.75

502.56

mg/l

9.55

452

2008

Intracerebral haemorrhage

228

721

3.26

57.41

2.2

1.3

829.84

588.24

mg/l

1.47

215

670

Endocrine, nutritional and metabolic diseases

1600

5186

1.59

57.14

1.4

497.75

518.28

mg/l

0.49

1525

4950

Symptoms and signs concerning food and fluid intake

186

518

3.70

57.09

1.6

1.3

483.35

531.03

mg/l

0.56

177

486

Asthma, unspecified (mode), excluding more controls

896

3938

1.81

56.98

1.4

1.3

523.30

523.93

mg/l

0.01

854

3768

Paraplegia, diplegia of upper limbs

149

6.93

56.79

1.6

1.4

902.77

455.02

mg/l

2.76

139

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1039

6122

1.71

56.70

1.6

1.3

590.11

530.96

mg/l

0.83

992

5824

Other diseases of intestines

1952

7620

1.50

56.46

1.3

1.4

508.31

533.28

mg/l

0.55

1861

7276

All influenza

478

2201

2.22

56.07

1.5

1.4

555.73

538.22

mg/l

0.10

452

2103

Other diseases of spinal cord

102

181

6.10

55.86

1.9

1.2

968.45

514.72

mg/l

0.94

168

Persons encountering health services in other circumstances

698

3686

1.92

55.80

1.4

520.83

511.41

mg/l

0.08

660

3506

Exclusions for E4_PCOS_BROAD

385

1627

2.44

55.61

1.4

1.7

513.46

500.09

mg/l

0.21

364

1548

Unspecified mental disorder

792

4366

1.84

55.43

1.2

1.3

490.33

521.27

mg/l

0.69

748

4174

Asthma, unspecified (mode)

901

4043

1.79

55.27

1.4

1.3

523.85

523.40

mg/l

0.01

857

3868

Diagnoses used for exclusion with ILD

462

2118

2.23

54.81

1.5

1.3

658.27

537.09

mg/l

0.82

436

2005

Acute sinusitis

955

5183

1.74

54.70

1.4

1.3

566.54

514.21

mg/l

0.48

904

4954

Shoulder lesions

1310

4979

1.63

54.33

1.3

504.29

568.42

mg/l

3.08

1267

4738

Visual field defects

200

608

3.44

54.12

1.6

1.3

627.69

542.93

mg/l

0.66

191

576

Mental and behavioural disorders due to psychoactive substance use

1059

6011

1.68

53.80

1.3

523.55

551.41

mg/l

0.55

1001

5735

Substance abuse

1033

5905

1.69

53.74

1.3

526.44

553.38

mg/l

0.51

977

5630

Disorders of lacrimal system

725

3931

1.88

53.61

1.5

1.3

537.77

530.77

mg/l

0.06

682

3727

Poisoning by drugs, medicaments and biological substances

510

2457

2.12

53.40

1.2

1.4

431.48

497.79

mg/l

4.08

479

2344

Other functional intestinal disorders

784

4141

1.83

53.30

1.4

1.5

587.44

523.50

mg/l

0.64

734

3940

Diseases of the ear and mastoid process

2149

7490

1.46

53.21

1.4

1.3

538.56

529.19

mg/l

0.15

2054

7138

Exposure to unspecified factor

1705

8847

1.51

53.12

1.3

1.4

548.16

525.75

mg/l

0.39

1630

8432

Hypertensive diseases

1453

5242

1.59

53.11

1.3

1.4

551.99

520.01

mg/l

0.62

1378

5004

Hypertension

1451

5235

1.59

52.98

1.3

1.4

550.21

520.37

mg/l

0.56

1377

4997

Gastrointestinal diseases

1225

3728

1.66

52.89

1.6

1.3

465.25

522.28

mg/l

1.84

1162

3566

Other general symptoms and signs

121

257

4.88

52.83

1.8

1.7

413.23

524.31

mg/l

1.98

115

245

Oxycodone

583

2862

2.00

52.25

1.5

1.3

635.82

539.54

mg/l

0.78

557

2726

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

121

175

5.18

52.06

1.2

1.3

772.17

462.04

mg/l

0.72

109

161

Other external causes of accidental injury

1542

4987

1.56

51.80

1.4

495.09

527.05

mg/l

0.90

1462

4755

Poisoning by medicine

470

2222

2.17

51.77

1.2

1.4

432.01

492.29

mg/l

3.32

441

2117

Use of hypnotics and sedatives

1885

7401

1.49

51.68

1.3

523.10

548.88

mg/l

0.58

1797

7068

Disorders of eyelid, lacrimal system and orbit

1418

7203

1.56

51.47

1.4

1.3

534.75

539.39

mg/l

0.07

1345

6866

Fibromyalgia

204

648

3.27

51.31

1.2

1.4

394.24

488.69

mg/l

3.75

191

618

Pain in thoracic spine

295

1149

2.64

50.69

1.4

441.87

494.46

mg/l

1.93

284

1088

Disorders of adult personality and behaviour

595

3086

1.97

50.62

1.2

1.3

434.27

485.49

mg/l

2.17

564

2945

Disorders of vestibular function (Vertigo)

755

4188

1.82

50.60

1.3

481.33

534.79

mg/l

2.34

728

3961

Herpesviral [herpes simplex] infections

263

971

2.81

50.52

1.5

1.4

568.12

504.86

mg/l

1.18

254

916

Renal tubulo-interstitial diseases

1461

7333

1.54

50.32

1.4

620.69

513.08

mg/l

1.90

1378

7004

Pure hypercholesterolaemia

1143

4715

1.64

50.23

1.3

568.17

573.49

mg/l

0.09

1088

4499

External causes of morbidity and mortality

1270

3957

1.62

49.99

1.4

517.93

504.15

mg/l

0.30

1192

3775

Radiculopathy

295

1158

2.61

49.82

1.2

1.3

497.00

531.30

mg/l

0.55

286

1094

Benign neoplasm of brain and other parts of central nervous system

171

499

3.61

49.56

1.8

1.2

644.42

482.91

mg/l

2.41

164

465

Generalized anxiety disorder

331

1383

2.46

49.05

1.2

1.3

414.79

494.22

mg/l

2.77

317

1325

Accidents

1526

4987

1.55

48.98

1.4

503.75

527.05

mg/l

0.56

1442

4755

Cervical disc disorders

597

3130

1.94

48.96

1.4

1.3

500.06

565.81

mg/l

1.47

572

2978

Unspecified fall

817

4691

1.75

48.37

1.3

1.5

528.03

524.25

mg/l

0.05

775

4467

Post-traumatic stress disorder

204

672

3.15

48.29

1.3

382.79

482.44

mg/l

2.68

189

644

Other joint disorders

1662

5920

1.51

48.29

1.2

1.4

479.64

509.80

mg/l

1.11

1584

5650

Personality disorders

562

2910

1.97

48.10

1.2

1.3

433.52

485.74

mg/l

1.87

533

2777

291

1158

2.59

48.00

1.6

1.3

507.29

504.24

mg/l

0.03

277

1090

Complications of procedures, not elsewhere classified

1341

7563

1.55

47.76

1.5

1.3

539.75

529.17

mg/l

0.14

1285

7203

Certain disorders involving the immune mechanism

386

1745

2.27

47.69

2.3

1.4

579.21

513.94

mg/l

0.44

367

1662

Acute tubulo-interstitial nephritis

1034

5658

1.64

47.16

1.4

640.13

498.79

mg/l

1.78

974

5394

Spinal stenosis

745

3276

1.80

47.12

1.4

1.3

718.15

582.87

mg/l

1.34

707

3114

Diseases of oesophagus, stomach and duodenum

1840

7710

1.46

47.05

1.3

1.4

511.80

537.72

mg/l

0.63

1726

7384

Dentinal caries

446

2132

2.13

47.00

1.7

1.3

647.23

519.96

mg/l

1.04

429

2039

Dissociative [conversion] disorders

121

289

4.45

46.70

1.2

1.3

474.34

498.31

mg/l

0.11

115

270

Invasive ventilation

185

590

3.29

46.50

1.5

1.7

1245.52

536.18

mg/l

1.23

174

557

Benign neoplasm of brain and other parts of central nervous system

171

520

3.46

46.50

1.8

1.4

644.42

531.75

mg/l

1.32

164

489

Zoster [herpes zoster]

316

1325

2.45

46.45

1.7

1.3

575.35

531.02

mg/l

0.86

305

1249

Mental and behavioural disorders due to alcohol, excluding acute intoxication

774

4461

1.76

46.45

1.3

536.75

550.88

mg/l

0.20

730

4254

Mental and behavioural disorders due to alcohol

885

5150

1.69

46.36

1.3

522.74

550.30

mg/l

0.54

837

4906

Nonorganic sleeping disorders

400

1857

2.21

46.28

1.4

403.17

492.09

mg/l

7.19

386

1763

Other systemic involvement of connective tissue (FG)

451

2173

2.10

46.24

1.2

1.3

615.70

505.16

mg/l

0.54

424

2057

Neoplasms

1513

5376

1.52

45.95

1.9

1.3

546.87

498.78

mg/l

0.59

1437

5131

Triptan medication for migraine, min. 3 purchases

1044

5108

1.63

45.94

1.3

435.81

498.33

mg/l

1.78

995

4883

Kela-code for severe mental illness

689

3862

1.81

45.80

1.2

1.3

485.25

517.31

mg/l

0.84

651

3687

Dementia in other diseases classified elsewhere

104

223

4.91

45.79

1.2

1.3

502.06

542.91

mg/l

0.37

213

Asthma-related infections

989

6009

1.64

45.64

1.4

541.35

523.50

mg/l

0.19

943

5727

Asthma, hospital admission 2, infections

989

6009

1.64

45.64

1.4

541.35

523.50

mg/l

0.19

943

5727

Alcohol use disorder, Swedish definition

937

5294

1.66

45.49

1.3

532.11

554.96

mg/l

0.41

885

5040

Other necrotizing vasculopathies (FG)

146

407

3.76

45.30

1.3

468.71

527.61

mg/l

1.20

137

379

Constipation

1430

6820

1.52

45.00

1.3

1.4

536.52

545.41

mg/l

0.14

1336

6528

Retention of urine

527

2286

1.98

44.81

1.4

1.3

609.14

543.24

mg/l

0.60

496

2169

Specific personality disorders

487

2467

2.02

44.50

1.2

1.3

429.66

482.73

mg/l

1.94

461

2352

982

5589

1.63

44.25

1.3

527.33

549.35

mg/l

0.42

929

5321

Other sleep disorders

206

718

2.95

43.97

1.2

1.3

422.51

545.76

mg/l

5.37

192

685

1031

5799

1.61

43.84

1.3

521.52

553.93

mg/l

0.67

975

5526

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

933

5754

1.64

43.41

1.6

1.3

598.50

528.02

mg/l

0.93

890

5472

Dyspnoea

1459

7555

1.49

43.14

1.3

1.4

520.08

537.49

mg/l

0.32

1405

7196

Psychotic depression

122

309

4.08

43.14

1.3

1.4

464.74

545.90

mg/l

0.98

113

297

779

4567

1.72

42.85

1.4

1.5

552.03

503.32

mg/l

0.53

746

4358

Disorders of other endocrine glands

751

4323

1.73

42.83

1.4

1.5

497.38

499.97

mg/l

0.04

707

4125

Diseases of inner ear

847

5009

1.68

42.76

1.3

481.44

551.54

mg/l

3.63

817

4749

Other and unspecified nerve root and plexus disorders, also in other diseases

346

1564

2.26

42.74

1.3

514.88

513.46

mg/l

0.02

326

1484

Ocular pain

197

686

2.99

42.46

1.5

431.20

499.74

mg/l

1.95

191

651

severe traumatic brain injury, does not include concussion

358

1649

2.22

42.10

1.5

1.3

689.50

548.23

mg/l

0.77

335

1552

Other and unspecified nonorganic psychotic disorders

406

1971

2.11

41.82

1.2

1.3

454.26

500.05

mg/l

1.16

385

1877

Insomnia

334

1508

2.27

41.51

1.4

404.78

498.95

mg/l

6.48

319

1435

Coxibs

503

1337

2.03

41.50

1.3

479.26

541.26

mg/l

1.44

472

1267

Suicide or other Intentional self-harm

486

2523

1.97

41.38

1.3

474.40

505.55

mg/l

0.72

453

2407

Arthropathies

1689

5955

1.46

40.81

1.3

1.4

512.56

508.38

mg/l

0.06

1599

5684

Use of levodopa decarboxylase inhibitor

224

850

2.71

40.74

1.3

1.2

518.66

568.31

mg/l

0.74

215

793

Genitourinary diseases

1133

3621

1.58

40.45

1.4

1.5

504.47

524.94

mg/l

0.49

1071

3464

Other viral diseases

571

3135

1.85

40.44

1.7

1.5

514.51

484.26

mg/l

0.26

548

2993

Hypothyroidism, strict autoimmune

1166

5026

1.55

40.21

1.3

474.89

523.98

mg/l

2.05

1114

4768

Diseases of the respiratory system

1157

3723

1.57

39.98

1.4

1.3

520.91

510.33

mg/l

0.24

1089

3570

Other systemic involvement of connective tissue

460

2372

1.97

39.89

1.2

1.3

611.33

526.47

mg/l

0.39

433

2246

Alcohol use disorder, ICD-based

701

4112

1.73

39.77

1.2

1.3

538.80

549.11

mg/l

0.13

659

3920

Other necrotizing vasculopathies

161

523

3.21

39.24

1.3

471.68

532.31

mg/l

1.33

151

494

Other diseases of blood and blood-forming organs, wide

392

1926

2.08

39.10

2.1

1.4

606.33

516.66

mg/l

0.67

375

1832

Alcohol abuse, main dg, excluding more controls

258

1070

2.47

38.89

1.2

1.3

560.04

542.12

mg/l

0.14

247

1029

Other strabismus

429

2176

2.01

38.82

1.4

1.6

437.37

491.17

mg/l

2.18

406

2071

Other and unspecified myopathies

176

606

3.01

38.66

1.5

1.4

531.12

553.91

mg/l

0.19

168

568

Gastro-oesophageal reflux disease

1107

6443

1.54

38.54

1.3

1.4

491.50

548.82

mg/l

2.88

1035

6177

Schizophrenia, schizotypal and delusional disorders

587

3309

1.80

38.43

1.2

1.3

479.72

513.22

mg/l

0.82

556

3148

Injuries to the abdomen, lower back, lumbar spine and pelvis

630

3597

1.76

38.39

1.3

1.4

534.73

526.99

mg/l

0.09

592

3419

Schizophrenia or delusion

582

3298

1.79

37.44

1.2

1.3

478.35

512.52

mg/l

0.84

551

3139

Finngen Rheumatological endpoints

1714

6931

1.42

37.36

1.3

543.95

520.92

mg/l

0.32

1633

6611

Panic disorder

297

1338

2.27

37.08

1.3

605.98

487.80

mg/l

0.28

285

1284

Unknown and unspecified causes of morbidity

130

383

3.49

36.88

1.3

888.58

528.13

mg/l

0.92

120

363

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

546

3019

1.82

36.75

2.4

1.3

395.01

462.48

mg/l

5.07

520

2889

Abnormalities of heart beat

571

3214

1.78

36.30

1.3

438.23

527.34

mg/l

5.01

536

3053

Osteopathies and chondropathies

861

5172

1.60

35.78

1.5

1.3

600.50

529.70

mg/l

0.79

818

4918

Asthma (diagnoses ohter than nonallergic)

1428

8563

1.44

35.60

1.4

523.54

520.60

mg/l

0.04

1357

8172

Hypothyroidism, drug reimbursement

242

700

2.51

35.57

1.3

1.2

471.26

439.06

mg/l

0.63

231

670

Injury, poisoning and certain other consequences of external causes

982

3137

1.58

35.13

1.5

1.4

492.13

506.94

mg/l

0.35

928

2983

Other CVD (FINNGEN)

202

605

2.69

34.64

1.5

1.2

545.84

510.99

mg/l

0.39

190

563

ILD medications: azathioprine

286

1306

2.24

34.59

1.4

1.3

504.83

493.73

mg/l

0.16

277

1239

Dermatitis and eczema

1817

8687

1.38

34.55

1.4

514.73

533.11

mg/l

0.40

1728

8287

Cervicocranial syndrome

203

797

2.62

34.55

1.2

1.3

597.39

491.66

mg/l

0.38

196

765

Sarcoidosis

263

1163

2.32

34.50

1.5

1.3

642.28

532.98

mg/l

0.54

251

1096

Hypopituitarism

173

631

2.86

34.33

1.4

2.1

483.45

495.33

mg/l

0.14

165

598

Other acute lower respiratory infections

843

5123

1.59

34.25

1.4

528.31

525.84

mg/l

0.02

802

4878

Polyuria

356

1776

2.04

34.06

1.3

486.17

528.65

mg/l

1.05

336

1681

Transport accidents

761

4194

1.63

33.86

1.3

504.68

519.45

mg/l

0.17

726

4003

Asthma, including avohilmo

1983

8521

1.36

33.78

1.3

1.4

506.28

535.95

mg/l

0.70

1890

8125

Rotator cuff syndrome

935

4502

1.56

33.74

1.3

531.65

576.97

mg/l

1.25

905

4291

Focal brain injury

169

4.71

33.66

1.5

1.2

928.17

518.80

mg/l

0.75

157

Fungal Sepsis

238

4.17

33.65

1.6

1.3

786.51

491.66

mg/l

0.52

225

Sleep apnoea

1459

7000

1.43

33.47

1.3

571.82

552.44

mg/l

0.18

1381

6680

Other symptoms and signs involving general sensations and perceptions

211

4.32

32.88

1.2

1.4

473.74

487.72

mg/l

0.11

201

Other disorders of nervous system

134

434

3.21

32.84

1.8

1.2

658.36

544.47

mg/l

0.76

127

404

Cough

652

3784

1.67

32.81

1.7

1.4

470.04

548.98

mg/l

2.37

616

3604

Other heart diseases

816

3395

1.60

32.70

1.4

498.96

476.10

mg/l

0.67

780

3242

Optic atrophy

119

5.75

32.46

1.5

1.7

636.69

421.27

mg/l

0.77

110

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

340

1702

2.04

32.39

1.2

1.3

421.15

487.52

mg/l

3.76

319

1625

Parkinson's disease, including avohilmo

246

1085

2.32

32.38

1.4

1.2

472.91

595.66

mg/l

3.77

231

1015

Other problems related to primary support group, including family circumstances

258

1132

2.28

32.34

3.8

1.4

368.57

464.47

mg/l

5.25

250

1084

Implicit fungal Sepsis

210

4.33

32.34

1.6

1.3

482.77

480.89

mg/l

0.01

200

Alzheimer’s disease (Atypical or mixed)

118

355

3.40

32.23

1.2

1.3

522.92

647.77

mg/l

0.81

104

337

Open wound of head

777

4862

1.59

32.07

1.4

535.29

542.02

mg/l

0.10

743

4638

Sleep apnoea, including avohilmo

1555

7282

1.40

31.56

1.3

567.51

548.29

mg/l

0.19

1470

6949

Brain meningioma, excluding all cancers (controls excluding all cancers)

125

400

3.28

31.44

1.5

1.2

811.22

494.04

mg/l

3.55

120

376

Injuries to the thorax

671

4143

1.64

31.33

1.3

515.76

556.91

mg/l

0.86

627

3949

Brain meningioma

120

376

3.35

31.25

1.4

1.2

765.10

532.75

mg/l

2.24

115

357

Diseases of pulp and periapical tissues

583

3486

1.69

30.96

1.5

1.3

585.06

535.14

mg/l

0.33

561

3326

Emotionally unstable personality disorder

264

1227

2.21

30.72

1.2

1.3

420.75

475.59

mg/l

1.26

249

1168

Hypotension

232

1026

2.31

30.30

1.5

1.3

537.24

583.70

mg/l

0.53

217

959

Benign neoplasm: Pituitary gland, craniopharyngeal duct

122

394

3.24

30.19

1.3

1.2

530.37

471.64

mg/l

0.75

116

368

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

547

3240

1.71

30.18

1.4

1.5

550.45

501.32

mg/l

0.52

520

3089

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

182

728

2.58

30.00

1.4

1.3

423.94

521.13

mg/l

2.99

171

689

Other medical care

584

3444

1.68

29.71

1.6

1.4

625.59

518.39

mg/l

2.84

559

3269

Brachial plexus disorders

192

791

2.50

29.68

1.3

530.96

491.10

mg/l

0.48

185

754

Internuclear ophthalmoplegia

17.84

29.65

1.1

1.3

713.58

506.89

mg/l

0.33

Azathioprine

286

1389

2.10

29.62

1.4

504.83

492.47

mg/l

0.18

277

1320

Benign neoplasms

1372

5521

1.42

29.59

1.4

1.3

504.51

499.26

mg/l

0.10

1298

5271

Visual impairment including blindness (binocular or monocular)

131

445

3.04

29.56

1.5

589.37

511.76

mg/l

0.54

122

423

Phobic anxiety disorders

254

1180

2.20

29.48

1.4

429.65

494.07

mg/l

1.88

243

1132

Use of glatiramer acetate

131

5.23

29.19

1.1

1.5

435.25

421.95

mg/l

0.14

121

Neuralgia and neuritis, unspecified

115

367

3.26

28.99

1.4

1.3

488.15

507.30

mg/l

0.16

110

346

Agranulocytosis

213

929

2.36

28.99

2.3

1.4

662.30

521.03

mg/l

0.56

204

874

Diffuse brain injury

6.02

28.80

1.3

1.2

494.83

477.37

mg/l

0.12

Pneumonitis due to solids and liquids

142

512

2.85

28.70

1.6

1.3

735.07

545.88

mg/l

0.46

130

479

Rheumatism, unspecified

242

1117

2.21

28.60

1.3

454.71

529.36

mg/l

1.68

231

1060

Other and unspecified effects of external causes

486

2832

1.74

28.54

1.3

1.5

488.73

490.90

mg/l

0.02

468

2695

Dermatitis

939

6378

1.49

28.52

1.5

1.4

529.21

534.34

mg/l

0.06

895

6084

Asthma, hospital admissions 3, pneumonia

526

3125

1.70

28.48

1.5

573.64

526.27

mg/l

0.35

494

2969

Asthma-related pneumonia or sepsis

526

3125

1.70

28.48

1.5

573.64

526.27

mg/l

0.35

494

2969

Cramp and spasm

117

383

3.20

28.39

1.4

1.3

829.86

532.69

mg/l

0.53

111

361

Inflammatory diseases of female pelvic organs

984

5053

1.48

28.25

1.3

436.15

497.51

mg/l

2.83

928

4827

Other disorders of ear

1435

6947

1.39

28.14

1.4

561.41

544.60

mg/l

0.24

1368

6627

Asthma-related pneumonia

523

3118

1.70

27.97

1.5

564.48

524.70

mg/l

0.28

491

2963

Congenital malformations of the nervous system

199

4.21

27.89

1.8

3.3

646.49

403.86

mg/l

1.30

190

Hyperkinetic disorders, excluding more controls

189

771

2.44

27.87

1.3

1.8

458.06

442.23

mg/l

0.12

183

739

Disorders of sclera, cornea, iris and ciliary body

850

5689

1.51

27.85

1.3

557.28

525.10

mg/l

0.62

815

5415

Vocal cord dysfunction

218

900

2.29

27.76

1.3

1.4

519.06

525.56

mg/l

0.05

208

851

Persistent mood disorders

317

1634

1.97

27.72

1.2

1.3

487.95

514.52

mg/l

0.45

296

1560

Other and unspecified mood [affective] disorders

151

573

2.72

27.71

1.2

1.4

503.85

490.65

mg/l

0.07

138

549

Functional dyspepsia

427

2420

1.79

27.64

1.3

481.02

529.07

mg/l

1.28

408

2309

Special screening examination for infectious and parasitic diseases

402

1645

1.85

27.62

1.3

509.42

538.77

mg/l

0.23

380

1577

Injuries to the neck

405

2262

1.82

27.61

1.3

1.4

440.76

502.59

mg/l

2.85

386

2149

Benign neoplasm: Pituitary gland, craniopharyngeal duct

122

416

3.06

27.54

1.3

530.37

503.75

mg/l

0.26

116

390

Disorders of refraction and accommodation

456

2630

1.75

27.41

1.6

1.5

419.92

492.71

mg/l

4.74

429

2513

Diseases of the skin and subcutaneous tissue

1749

6546

1.35

27.40

1.4

1.3

529.71

524.89

mg/l

0.06

1666

6245

Exposure to other specified factors

1197

8023

1.41

27.33

1.4

510.15

531.49

mg/l

0.35

1151

7649

Irritable bowel syndrome

460

2674

1.75

27.24

1.3

439.69

503.17

mg/l

3.09

437

2542

Chronic sinusitis

690

4440

1.57

27.11

1.3

470.24

533.56

mg/l

2.29

649

4241

Disorders of the thyroid gland

1530

7382

1.36

27.10

1.3

506.91

531.16

mg/l

0.56

1460

7034

Infections of the skin and subcutaneous tissue

922

6281

1.48

27.03

1.7

1.4

528.36

536.81

mg/l

0.09

885

5991

Other and unspecified dermatitis

788

5225

1.52

27.02

1.5

1.4

533.77

533.21

mg/l

0.00

751

4980

Hypothyroidism, other/unspecified

1433

6918

1.38

26.99

1.3

502.83

526.42

mg/l

0.51

1369

6582

Pain and other conditions associated with female genital organs and menstrual cycle

377

1986

1.85

26.96

1.3

404.34

490.40

mg/l

2.49

358

1908

Parkinson's disease

224

1028

2.22

26.87

1.4

1.2

475.30

592.63

mg/l

3.24

210

962

Benign paroxysmal vertigo

420

2401

1.78

26.42

1.3

507.02

536.97

mg/l

0.55

402

2268

Other viral diseases, not elsewhere classified

342

1835

1.89

26.37

1.9

1.6

466.73

479.65

mg/l

0.19

332

1757

Type 2 diabetes, wide definition

1200

5575

1.41

26.33

1.3

641.73

548.74

mg/l

2.12

1134

5322

Abnormal findings on examination of blood, without diagnosis

667

4007

1.57

26.29

1.4

592.05

563.46

mg/l

0.25

636

3810

Other bacterial intestinal infections

281

1416

2.02

26.29

1.6

1.3

550.67

528.05

mg/l

0.29

265

1334

Acute bronchitis

610

3767

1.60

26.20

1.4

1.5

502.69

526.26

mg/l

0.37

578

3577

Obesity related asthma

525

3203

1.66

25.95

1.3

550.68

526.03

mg/l

0.17

498

3056

Other CVD

258

1267

2.07

25.88

1.4

1.3

539.22

567.85

mg/l

0.33

241

1188

Hypothyreosis and Thyroxine purchase for inclusion criteria

1466

7150

1.36

25.88

1.3

500.44

526.38

mg/l

0.60

1400

6806

Injuries to the ankle and foot

1138

7412

1.41

25.88

1.4

483.39

518.76

mg/l

1.12

1085

7075

Benign neoplasm of other and unspecified endocrine glands

222

1034

2.20

25.77

1.3

522.72

489.64

mg/l

0.54

209

974

Enthesopathies of lower limb, excluding foot

335

1811

1.88

25.37

1.3

493.44

500.73

mg/l

0.12

314

1730

Substance use, excluding alcohol

344

1878

1.86

25.33

1.3

537.82

499.98

mg/l

0.45

325

1789

Injuries to the wrist and hand

1596

8706

1.34

25.31

1.3

1.4

543.08

525.53

mg/l

0.22

1528

8297

Aplastic and other anaemias

596

3568

1.60

25.29

1.6

1.4

538.31

548.44

mg/l

0.15

558

3383

Cardiac arrhythmias

985

4517

1.45

25.18

1.2

1.3

498.56

483.08

mg/l

0.33

925

4322

Other and unspecified anaemias

547

3280

1.63

25.16

1.7

1.3

535.24

554.50

mg/l

0.30

512

3107

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

733

3036

1.55

25.06

1.4

1.3

503.00

477.74

mg/l

0.68

706

2889

Other disorders of bladder

188

829

2.32

24.91

1.3

1.2

540.79

554.27

mg/l

0.09

178

777

Chronic lower respiratory diseases

2004

8381

1.30

24.87

1.3

1.4

500.99

535.57

mg/l

0.90

1902

8002

Asthma, hospital admissions , main diagnosis only

1306

8605

1.37

24.85

1.4

474.17

525.54

mg/l

2.38

1241

8205

Viral pneumonia

219

1029

2.18

24.85

1.5

723.04

536.68

mg/l

0.76

205

975

Irregular menses

791

4311

1.50

24.79

1.4

1.3

488.81

477.45

mg/l

0.08

754

4126

Sequelae of external causes of morbidity and mortality

379

2145

1.79

24.74

1.5

1.3

613.15

531.90

mg/l

0.93

357

2032

Propionic acid derivatives

493

1452

1.72

24.71

1.5

479.61

528.87

mg/l

1.07

459

1381

Hypokalaemia

184

807

2.33

24.70

1.8

1.3

568.20

541.06

mg/l

0.17

176

759

Supplementary factors related to causes of morbidity and mortality classified elsewhere

487

2953

1.67

24.69

1.5

1.4

643.66

509.14

mg/l

0.82

455

2809

Other anaemias

550

3310

1.62

24.65

1.7

1.3

535.38

553.73

mg/l

0.28

515

3137

Vascular dementia

300

3.21

24.59

1.4

1.3

840.52

573.79

mg/l

0.48

284

Use of galantamine

102

334

3.14

24.54

1.2

1.3

485.43

572.46

mg/l

1.03

317

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

374

1918

1.80

24.46

1.7

1.6

465.99

422.49

mg/l

0.44

357

1832

Restless leg syndrome

209

973

2.20

24.34

1.2

1.3

562.27

522.24

mg/l

0.17

199

916

Trigeminal neuralgia

117

418

2.89

24.22

1.4

1.3

476.18

501.70

mg/l

0.28

110

392

Other and unspecified drugs and medicaments

164

693

2.44

24.13

1.4

420.65

518.55

mg/l

2.93

155

653

Injuries to the shoulder and upper arm

1261

7767

1.37

24.04

1.4

1.3

532.45

552.24

mg/l

0.40

1210

7392

Urticaria and erythema

598

3836

1.58

24.00

1.5

1.4

499.34

495.41

mg/l

0.05

561

3666

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

810

5416

1.48

23.99

1.3

518.21

538.09

mg/l

0.40

772

5171

Superficial injury of head

352

1967

1.82

23.96

1.3

1.5

573.50

506.97

mg/l

0.28

341

1880

Cluster headache, wide,, including avohilmo

119

434

2.85

23.79

1.4

1.3

435.16

513.64

mg/l

1.74

114

406

Parkinson's disease, strict definition

200

923

2.21

23.73

1.4

1.2

472.66

599.71

mg/l

3.15

188

862

Hypersomnia

106

5.23

23.70

1.1

1.2

415.29

454.69

mg/l

0.34

Temporomandibular joint disorders, including avohilmo

692

4590

1.52

23.66

1.3

537.77

473.10

mg/l

0.56

656

4375

Paracetamol of NSAID medication

312

808

1.96

23.65

1.8

1.6

462.36

489.38

mg/l

0.47

292

773

Deposits [accretions] on teeth

152

603

2.51

23.65

5.2

1.4

468.37

509.64

mg/l

0.26

145

572

Benign neoplasms

1644

6963

1.33

23.64

1.4

512.66

525.71

mg/l

0.31

1555

6655

Giant cell arteritis

277

3.36

23.53

1.2

1.3

457.98

510.47

mg/l

0.64

260

Fracture of rib(s), sternum and thoracic spine

416

2451

1.72

23.52

1.4

1.3

494.30

546.79

mg/l

1.53

394

2333

Other enthesopathies

451

2720

1.68

23.34

1.3

549.41

564.67

mg/l

0.09

432

2594

Benign neoplasm of other and unspecified endocrine glands

222

1076

2.11

23.30

1.3

522.72

524.30

mg/l

0.02

209

1013

Voice disturbances

400

2340

1.73

23.27

1.3

469.69

525.91

mg/l

2.00

387

2226

Type of accident

449

2710

1.68

23.23

1.6

1.4

638.25

505.42

mg/l

0.74

419

2579

Dislocation, sprain and strain of joints and ligaments at neck level

285

1509

1.93

23.22

1.3

1.4

410.08

484.64

mg/l

4.35

273

1435

Heterophoria

166

720

2.37

23.04

1.6

1.7

425.70

486.86

mg/l

1.33

155

686

Cerebral amyloid angiopathy

14.64

22.70

1.4

1.2

714.68

626.89

mg/l

0.17

Polyarthropathies

1051

5016

1.41

22.64

1.3

1.4

618.96

516.88

mg/l

1.49

1008

4787

Sequelae of injuries, of poisoning and of other consequences of external causes

384

2240

1.74

22.61

1.3

518.74

522.52

mg/l

0.04

363

2128

Other specified/unspecified arthritis

413

2456

1.70

22.59

1.2

1.4

509.31

492.95

mg/l

0.27

402

2335

Other and unspecified paralytic syndromes

5.46

22.57

1.3

1.2

464.38

415.80

mg/l

0.57

Other nutritional deficiencies

1010

7096

1.40

22.56

1.3

1.4

529.44

512.28

mg/l

0.22

950

6774

Other infectious diseases

144

592

2.50

22.50

1.4

456.29

525.98

mg/l

1.83

135

557

Lesion of lateral popliteal nerve

105

369

2.95

22.49

1.3

470.99

521.39

mg/l

0.51

342

Acetic acid derivatives and related substances

433

1318

1.73

22.19

1.2

1.3

503.55

543.47

mg/l

0.65

408

1249

Giant cell arteritis with polymyalgia rheumatica

247

3.44

22.17

1.2

1.3

469.30

516.19

mg/l

0.49

234

Emotional disorders starting during childhood or adolecense, excluding more controls

100

336

3.01

22.16

3.1

1.9

427.97

381.54

mg/l

0.31

317

Other arthritis (FG)

471

2919

1.63

21.93

1.3

1.4

519.51

494.23

mg/l

0.51

459

2772

Temporal arteritis

249

3.41

21.90

1.2

1.3

469.30

515.14

mg/l

0.48

235

Sequelae of injuries of head

115

431

2.77

21.84

1.4

464.41

534.54

mg/l

1.42

102

404

Bacterial intestinal infections, IBD co-morbidities

272

1446

1.91

21.83

1.6

1.3

543.38

541.07

mg/l

0.02

256

1364

Drug-induced neutropenia

141

584

2.49

21.78

1.9

1.3

741.79

510.54

mg/l

0.63

134

550

Fasciculation

5.67

21.76

1.3

397.71

441.43

mg/l

0.41

Undetermined asthma, excluding more controls

202

974

2.11

21.39

1.5

1.3

470.26

500.98

mg/l

0.47

188

928

Other diseases of upper respiratory tract

1771

7164

1.30

21.38

1.3

1.4

511.70

535.86

mg/l

0.62

1668

6836

Fracture of lumbar spine and pelvis

294

1614

1.85

21.21

1.3

557.33

537.98

mg/l

0.13

271

1520

Brain glioblastoma, excluding all cancers (controls excluding all cancers)

5.50

21.18

1.6

1.2

966.51

447.25

mg/l

1.95

Brain glioblastoma

5.50

21.18

1.6

1.2

966.51

480.82

mg/l

1.74

Continuous positive airway pressure

279

1292

1.89

21.15

1.5

653.33

518.27

mg/l

0.72

259

1248

Other disorders of teeth and supporting structures

330

1884

1.78

21.00

1.3

676.25

544.45

mg/l

0.55

312

1795

Disorders of conjunctiva

1282

8090

1.34

20.74

1.4

483.23

525.81

mg/l

0.94

1229

7707

Other and unspecified tonsillitis

570

3156

1.55

20.73

1.4

1.3

481.00

497.35

mg/l

0.23

540

3023

Secondary and unspecified malignant neoplasm of lymph nodes

148

640

2.38

20.71

1.8

1.3

520.77

547.37

mg/l

0.32

139

599

Undetermined asthma

202

988

2.08

20.61

1.5

1.3

470.26

496.94

mg/l

0.39

188

941

Mycoses

396

2389

1.68

20.60

1.5

1.3

567.50

514.66

mg/l

0.34

378

2266

Iridocyclitis

352

2061

1.73

20.50

1.3

1.4

520.39

512.72

mg/l

0.09

335

1954

Deforming dorsopathies

390

2349

1.68

20.36

1.3

1.4

477.06

495.16

mg/l

0.40

369

2234

Superficial injury of lower leg

387

2332

1.68

20.23

1.2

1.4

525.47

502.84

mg/l

0.19

367

2220

Statin medication

1132

4667

1.37

20.22

1.4

1.3

559.96

542.09

mg/l

0.24

1079

4441

Problems related to lifestyle

188

906

2.12

20.10

1.4

472.36

501.07

mg/l

0.38

180

858

Allergic asthma (mode), excluding more controls

372

2178

1.69

20.08

1.3

531.26

467.23

mg/l

0.40

357

2081

Chronic periapical parodontitis

321

1844

1.77

20.03

1.5

1.3

666.85

544.98

mg/l

0.49

308

1756

Carpal tunnel syndrome

844

5416

1.42

19.98

1.3

585.77

542.28

mg/l

0.46

813

5160

Allergic asthma (mode)

372

2183

1.69

19.93

1.3

531.26

466.83

mg/l

0.40

357

2088

Lung diseases due to external agents

192

935

2.09

19.88

1.5

1.3

673.98

575.35

mg/l

0.30

179

877

Exclusions for E4_PCOS_CONSORTIUM

1168

5448

1.35

19.74

1.3

1.4

514.06

493.25

mg/l

0.34

1117

5197

All influenza (not pneumonia)

251

1345

1.90

19.74

1.5

565.85

513.73

mg/l

0.19

235

1283

Injuries to the knee and lower leg

1878

8511

1.27

19.66

1.3

1.4

538.28

525.15

mg/l

0.21

1800

8108

Dentofacial anomalies [including malocclusion]

459

2873

1.60

19.65

2.2

1.3

481.83

496.91

mg/l

0.13

439

2756

Osteoporosis

324

1790

1.75

19.44

1.7

1.3

622.88

548.61

mg/l

0.38

301

1694

Volume depletion

136

582

2.39

19.42

1.3

1.5

544.99

572.68

mg/l

0.14

125

549

Inflammatory disease of uterus

254

1380

1.88

19.20

1.2

1.3

385.05

467.41

mg/l

4.24

236

1316

Conjunctivitis

1167

7656

1.34

19.19

1.4

451.44

511.51

mg/l

3.65

1120

7297

Other symptoms and signs involving the urinary system

169

797

2.17

19.15

1.4

526.20

542.60

mg/l

0.10

160

749

Urticaria

488

3154

1.57

19.12

1.5

476.33

500.70

mg/l

0.42

456

3012

Dystonia

109

426

2.64

19.08

1.3

408.51

498.96

mg/l

3.03

103

404

Myasthenia gravis

115

4.46

18.72

1.4

504.60

463.17

mg/l

0.39

106

Disorders of muscles

161

753

2.18

18.61

1.2

1.3

575.91

517.49

mg/l

0.19

151

714

Persons with potential health hazards related to communicable diseases

636

4330

1.47

18.59

1.6

1.4

480.44

463.02

mg/l

0.25

603

4136

Diseases of male genital organs

797

2823

1.44

18.59

1.3

1.5

582.71

597.08

mg/l

0.10

756

2695

Other symptoms and signs involving the circulatory and respiratory systems

119

492

2.48

18.45

1.3

1.4

486.44

545.04

mg/l

0.87

110

461

Monoamine oxidase A inhibitors

175

849

2.10

18.36

1.2

1.3

418.77

547.89

mg/l

7.14

168

814

Diseases of oral cavity, salivary glands and jaws

1444

5710

1.30

18.35

1.7

1.3

500.48

532.86

mg/l

1.05

1371

5452

Superficial injury of abdomen, lower back and pelvis

249

1364

1.86

18.33

1.3

1.4

470.81

501.62

mg/l

0.60

237

1288

Acute alcohol intoxication

375

2304

1.65

18.21

1.2

1.3

527.80

557.80

mg/l

0.32

352

2192

Dental caries 1

1199

4610

1.34

18.15

1.6

1.3

519.97

554.77

mg/l

0.88

1131

4413

Diaphragmatic hernia

486

3174

1.55

18.14

1.3

556.18

539.27

mg/l

0.11

455

3008

Mixed and other personality disorders

156

733

2.18

17.93

1.2

1.3

391.95

498.44

mg/l

5.15

150

693

Dental caries, including avohilmo

1196

4607

1.33

17.91

1.6

1.3

520.17

554.64

mg/l

0.87

1128

4410

Alcohol dependence

396

2477

1.62

17.89

1.2

1.3

544.40

566.53

mg/l

0.21

373

2367

Diseases of pulp and periapical tissues, including avohilmo

1730

7115

1.27

17.86

1.3

1.4

505.20

525.74

mg/l

0.47

1627

6804

Excessive, frequent and irregular menstruation

655

2494

1.47

17.67

1.4

1.3

452.92

497.62

mg/l

1.03

620

2390

Anti-inflammatory and antirheumatic products, non-steroids

459

1453

1.60

17.65

1.5

486.61

528.61

mg/l

0.82

428

1382

Use of pramipexole

300

1755

1.73

17.62

1.3

571.30

557.92

mg/l

0.06

284

1663

Polycystic ovarian syndrome, consortium definition

1097

4963

1.34

17.57

1.4

1.3

491.11

486.20

mg/l

0.05

1041

4740

Dental pulpitis 1

1729

7127

1.27

17.54

1.3

1.4

505.32

525.78

mg/l

0.47

1626

6816

Dental pulpitis 4

1729

7126

1.27

17.53

1.3

1.4

505.32

525.85

mg/l

0.47

1626

6814

Hypoglycaemia, other or unspecified

127

555

2.35

17.44

1.7

443.38

512.69

mg/l

1.79

120

525

Disorders of synovium and tendon

754

4853

1.41

17.40

1.4

1.3

546.60

550.89

mg/l

0.04

719

4621

Diseases of liver

472

3095

1.54

17.34

1.3

565.04

550.93

mg/l

0.13

450

2950

Secondary uncertain malignant neoplasm

185

939

2.01

17.20

1.7

1.3

537.69

536.25

mg/l

0.01

175

879

Vitamin deficiency, wide

366

2.68

17.16

1.3

1.5

462.92

498.87

mg/l

0.43

346

Vitamin deficiency

366

2.68

17.16

1.3

1.5

462.92

498.87

mg/l

0.43

346

Alcohol abuse, main dg

258

1459

1.80

17.14

1.2

1.4

560.04

515.31

mg/l

0.42

247

1387

Other metabolic disorders

208

1101

1.92

17.09

1.5

1.3

489.80

492.21

mg/l

0.03

196

1049

Social phobias

148

696

2.17

16.94

1.5

1.3

403.01

475.82

mg/l

2.25

142

665

Fall on and from stairs and steps

368

2294

1.62

16.92

1.3

1.4

498.47

528.94

mg/l

0.44

348

2185

Other disorders of glucose regulation and pancreatic internal secretion

148

697

2.17

16.92

1.6

1.7

469.36

518.85

mg/l

0.92

140

662

Acute alcohol intoxication, ICD10

314

1883

1.69

16.87

1.2

1.4

511.99

523.91

mg/l

0.11

297

1788

Other disorders of bone

317

1907

1.69

16.82

1.4

1.3

536.59

498.27

mg/l

0.43

306

1818

Anterior Iridocyclitis

312

1870

1.69

16.79

1.3

516.27

514.42

mg/l

0.02

297

1776

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

1390

6404

1.29

16.76

2.0

1.3

623.82

527.77

mg/l

1.32

1333

6099

Internal derangement of knee

563

3844

1.47

16.74

1.3

506.58

526.90

mg/l

0.22

540

3670

Malignant neoplasm, wide definition for exclusion

1390

6405

1.29

16.74

2.0

1.3

623.82

527.74

mg/l

1.32

1333

6100

Hyperlipidaemia, other/unspecified

480

3007

1.52

16.72

1.2

1.3

563.08

573.99

mg/l

0.14

454

2847

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

1389

6404

1.29

16.66

2.0

1.3

623.74

527.70

mg/l

1.32

1332

6099

Hypermobility syndrome

114

487

2.41

16.56

1.2

1.4

401.97

461.75

mg/l

1.03

109

465

Conductive and sensorineural hearing loss

1093

5744

1.33

16.52

1.4

1.3

598.12

552.81

mg/l

0.65

1035

5479

Acute and subacute iridocyclitis

294

1743

1.71

16.50

1.3

522.86

511.60

mg/l

0.12

280

1655

Other disorders of skin and subcutaneous tissue

937

6415

1.35

16.41

1.4

1.3

594.14

542.41

mg/l

0.57

883

6112

KRA_PSY_EATING, excluding more controls

136

624

2.21

16.40

1.2

1.4

357.87

460.65

mg/l

2.50

129

600

Erysipelas

700

4555

1.41

16.40

1.3

560.77

535.21

mg/l

0.52

660

4344

Soft tissue disorders related to use, overuse and pressure

356

2224

1.62

16.21

1.3

490.83

558.01

mg/l

1.44

340

2110

Disorders of lens

942

4417

1.35

16.17

1.3

578.32

580.46

mg/l

0.02

903

4208

Other heart diseases, wide

1501

7374

1.27

16.06

1.3

1.4

495.16

537.27

mg/l

1.53

1425

7041

Other and unspecified iron deficiency

427

2787

1.55

16.03

1.3

1.4

497.55

533.77

mg/l

0.71

409

2635

Leisure time condition

274

1613

1.72

15.82

1.5

599.05

507.86

mg/l

0.29

255

1525

Adverse effects, not elsewhere classified

318

1948

1.66

15.78

1.3

1.5

496.89

484.47

mg/l

0.07

307

1845

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

586

4088

1.44

15.70

1.3

1.4

461.98

483.77

mg/l

0.49

557

3913

Dental pulpitis 2, only avohilmo

1093

4244

1.33

15.70

1.5

1.4

523.23

551.18

mg/l

0.62

1030

4062

Other diseases of hard tissues of teeth

976

5486

1.33

15.68

1.8

1.3

480.31

529.34

mg/l

1.13

929

5245

Conjunctivitis (acute, non atopic)

430

2820

1.54

15.63

1.5

482.57

492.90

mg/l

0.15

413

2685

Sequelae with surgical and medical care as external cause

278

1654

1.70

15.43

1.6

1.3

624.82

530.97

mg/l

0.93

262

1568

Disorders of mineral metabolism

130

607

2.19

15.24

1.3

1.4

464.76

546.48

mg/l

1.72

121

572

Sensorineural hearing loss

1006

5347

1.32

15.21

1.3

603.18

554.86

mg/l

0.65

952

5094

Disorders of choroid and retina

1089

6095

1.31

15.17

1.4

1.3

544.63

565.52

mg/l

0.50

1034

5805

Hypothyroidism, strict autoimmune, 3 medication purchases required

1249

6657

1.29

15.16

1.3

475.15

524.37

mg/l

2.21

1194

6340

Acute pharyngitis

247

1420

1.75

15.14

1.4

464.10

487.22

mg/l

0.32

240

1359

Covid-19 suspected case

339

2132

1.61

15.11

1.3

1.4

442.50

479.41

mg/l

0.80

331

2021

Disorders of skin appendages

710

5163

1.39

15.05

1.3

543.48

499.56

mg/l

0.42

677

4930

Fracture of skull and facial bones

313

1933

1.64

15.02

1.3

1.4

533.13

517.46

mg/l

0.24

291

1840

195

3.21

14.92

1.3

434.06

503.04

mg/l

0.97

185

Vascular syndromes of brain in cerebrovascular disorders

242

2.93

14.92

1.3

552.78

565.78

mg/l

0.09

230

Chronic diseases of tonsils and adenoids

1259

6240

1.28

14.89

1.3

1.4

495.05

524.58

mg/l

0.55

1193

5962

Congenital malformations, deformations and chromosomal abnormalities

914

6626

1.33

14.85

1.4

487.80

499.25

mg/l

0.22

873

6327

Degeneration of the brain due to alcohol

146

3.59

14.78

1.2

1.3

442.93

565.64

mg/l

1.94

132

Dental pulpitis 2

1062

4147

1.32

14.75

1.5

1.4

517.65

542.85

mg/l

0.59

999

3969

Oter anti-inflammatory and antirheumatic agents, non-steroids

307

1022

1.68

14.74

1.2

1.3

623.64

575.07

mg/l

0.20

281

971

Persons encountering health services for specific procedures, not carried out

129

610

2.16

14.66

1.3

1.4

453.07

498.92

mg/l

0.56

120

579

Dental caries 3

1250

4984

1.29

14.65

1.4

532.67

552.78

mg/l

0.32

1174

4778

Noninfective enteritis and colitis

679

4924

1.39

14.59

1.3

1.5

506.43

512.69

mg/l

0.12

641

4702

Other obstetric conditions, not elsewhere classified

541

2426

1.46

14.56

1.3

412.15

414.28

mg/l

0.04

522

2312

Other noninfective gastroenteritis and colitis

358

2299

1.57

14.52

1.4

1.6

485.84

500.49

mg/l

0.26

334

2188

Any event in cancer register

1435

6784

1.26

14.49

1.9

1.3

636.96

516.51

mg/l

1.89

1377

6467

Ovarian cyst

589

2383

1.44

14.42

1.3

430.97

502.78

mg/l

2.12

558

2283

Bacterial pneumonia, not elsewhere classified

505

3079

1.46

14.37

1.5

1.4

597.01

530.63

mg/l

0.58

476

2939

Hernia of abdominal wall, postoperative

219

1246

1.78

14.26

1.3

1.2

496.12

516.02

mg/l

0.23

209

1184

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1444

7863

1.25

14.25

1.7

1.3

547.55

526.41

mg/l

0.39

1381

7501

Bacterial pneumoniae

535

3304

1.44

14.24

1.5

1.4

595.10

528.38

mg/l

0.63

503

3156

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

529

2372

1.46

14.21

1.3

401.23

413.22

mg/l

0.27

511

2261

Infections with a predominantly sexual mode of transmission

494

3409

1.46

14.18

1.4

1.3

483.49

459.13

mg/l

0.36

474

3247

Fenamates

225

856

1.79

14.07

1.4

1.3

481.69

547.95

mg/l

1.53

215

814

Trochanteric bursitis

186

1014

1.86

14.02

1.3

473.13

541.41

mg/l

1.41

180

963

Convergent concomitant strabismus

115

530

2.23

14.01

1.2

1.8

449.81

485.50

mg/l

0.51

108

505

Iron deficiency anaemia

527

3653

1.44

14.00

1.4

512.15

532.46

mg/l

0.36

502

3463

Insulin, intermediate and long-acting

742

5396

1.36

13.93

1.3

1.4

669.51

533.96

mg/l

2.22

706

5145

Lesion of ulnar nerve

199

1111

1.82

13.90

1.3

493.27

529.36

mg/l

0.56

190

1054

Pain associated with micturition

179

969

1.88

13.85

1.4

506.55

516.13

mg/l

0.11

164

910

Nutritional anaemias

615

4309

1.40

13.84

1.3

1.4

506.08

530.54

mg/l

0.55

584

4087

Fitting and adjustment of other devices

412

2560

1.51

13.82

1.3

572.38

540.40

mg/l

0.40

383

2421

Diseases of the digestive system

590

4215

1.41

13.79

1.4

501.22

535.77

mg/l

0.60

553

3999

Bacterial pneumonia (organism specified)

576

3734

1.41

13.77

1.5

1.4

592.03

542.87

mg/l

0.45

544

3549

Dental caries 1, only avohilmo

1196

4784

1.28

13.76

1.3

1.4

521.27

553.72

mg/l

0.81

1128

4578

Unspecified/other endometriosis

166

880

1.92

13.72

1.3

368.88

446.39

mg/l

3.42

154

849

Alcohol withdrawal state with delirium

118

554

2.18

13.72

1.2

1.3

566.48

548.71

mg/l

0.06

113

522

Appendectomy

979

7285

1.30

13.72

1.3

510.99

530.22

mg/l

0.26

935

6946

Agoraphobia

227

2.91

13.63

1.2

1.3

428.17

506.07

mg/l

0.95

212

Non-allergic asthma (mode)

263

1579

1.67

13.60

1.3

1.4

481.81

495.87

mg/l

0.16

243

1506

Obesity and other hyperalimentation

907

6878

1.31

13.59

1.3

533.36

512.85

mg/l

0.24

862

6561

Other disorders of adrenal gland

367

2.47

13.59

1.5

1.6

602.79

518.65

mg/l

0.56

348

Non-allergic asthma (mode), excluding more controls

263

1580

1.67

13.57

1.3

1.4

481.81

496.60

mg/l

0.17

243

1506

Assault

224

1306

1.74

13.51

1.2

1.4

476.98

492.11

mg/l

0.21

213

1241

Other disorders of eyelid

535

3651

1.43

13.49

1.3

543.04

545.40

mg/l

0.03

511

3456

Spondyloarthritis

254

1530

1.68

13.49

1.2

1.3

696.56

518.66

mg/l

0.74

241

1448

Oxicams

324

1150

1.62

13.48

1.2

1.3

499.85

557.67

mg/l

0.95

310

1092

Mental disorders, not otherwise specified

154

803

1.96

13.43

1.1

1.4

524.13

481.20

mg/l

0.25

147

764

Degeneration of nervous system due to alcohol

156

3.36

13.36

1.2

442.93

533.75

mg/l

1.39

144

Pulmonary heart disease

356

2330

1.54

13.31

1.5

1.3

609.08

560.40

mg/l

0.69

341

2196

Pulmonary embolism

356

2330

1.54

13.31

1.5

1.3

609.08

559.47

mg/l

0.71

341

2196

Obesity

900

6847

1.31

13.26

1.3

532.48

513.55

mg/l

0.22

855

6531

Venous thromboembolism

679

4861

1.36

13.22

1.4

1.3

600.14

545.67

mg/l

0.93

654

4608

Dental pulpitis 4, only avohilmo

1714

7335

1.23

13.12

1.3

1.4

504.96

531.52

mg/l

0.64

1610

7014

Tinnitus

325

2094

1.57

13.12

1.2

1.3

521.46

524.84

mg/l

0.04

312

1995

Hyperplasia of prostate

466

1811

1.48

13.09

1.3

570.59

605.58

mg/l

0.72

440

1727

Malignant neoplasm

1345

6395

1.25

13.01

2.0

1.3

626.41

531.84

mg/l

1.23

1289

6094

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

128

633

2.07

12.99

1.4

665.21

477.23

mg/l

1.17

121

603

Dental pulpitis 1, only avohilmo

1717

7358

1.22

12.99

1.3

1.4

503.08

531.81

mg/l

0.72

1613

7036

Menorrhagia

548

2132

1.43

12.97

1.3

491.57

520.65

mg/l

0.40

516

2045

Asthma and allergy, excluding more controls

202

1143

1.77

12.90

1.3

1.4

456.84

458.77

mg/l

0.02

196

1089

Enterocolitis due to Clostridium difficile

147

765

1.95

12.84

1.7

1.4

506.65

537.06

mg/l

0.34

139

720

Asthma and allergy

202

1147

1.76

12.75

1.3

1.4

456.84

460.55

mg/l

0.04

196

1095

Hypermetropia

127

631

2.06

12.74

1.7

1.9

379.26

504.60

mg/l

3.99

119

598

Gingivitis and periodontal diseases

1366

5661

1.25

12.72

1.4

1.3

518.15

533.61

mg/l

0.26

1290

5405

Fall on same level involving ice and snow

787

5973

1.33

12.71

1.3

526.91

537.58

mg/l

0.16

743

5691

Other and unspecified urticaria

304

1947

1.58

12.65

1.5

486.52

495.34

mg/l

0.09

285

1847

Dental caries 1 and operation codes

1289

5279

1.26

12.58

1.5

1.3

530.12

547.15

mg/l

0.29

1219

5044

Other respiratory disorders and diseases

245

1491

1.66

12.55

1.7

1.4

497.78

556.22

mg/l

1.34

231

1398

Other diseases of the respiratory system

245

1491

1.66

12.55

1.7

1.4

497.78

556.22

mg/l

1.34

231

1398

Chronic rhinitis, nasopharyngitis and pharyngitis

453

3153

1.45

12.53

1.3

1.4

483.81

505.89

mg/l

0.46

429

3015

Dental operations

958

3785

1.31

12.52

1.4

1.3

502.94

560.63

mg/l

1.75

901

3612

Immunodeficiencies

419

2.31

12.51

2.1

1.7

462.89

483.79

mg/l

0.23

396

Abnormal blood-pressure reading, without diagnosis

345

2.44

12.42

1.3

1.4

562.86

539.14

mg/l

0.11

327

Keratitis

488

3450

1.43

12.39

1.2

1.3

582.47

525.38

mg/l

0.83

466

3286

Coagulation defects, purpura and other haemorrhagic conditions

272

1707

1.61

12.35

2.0

1.5

541.00

512.38

mg/l

0.30

261

1617

Myeloid leukaemia

164

3.17

12.29

2.6

1.3

497.94

512.83

mg/l

0.09

156

Diseases of middle ear and mastoid

877

5540

1.30

12.28

1.5

1.3

558.71

492.02

mg/l

1.00

840

5277

Obesity due to excess calories

665

4954

1.35

12.26

1.2

1.4

557.85

508.08

mg/l

0.52

627

4742

Paralytic ileus and intestinal obstruction

317

2064

1.55

12.18

1.3

1.4

513.21

552.86

mg/l

0.65

298

1952

Dental caries 3 and operation codes

1355

5603

1.25

12.18

1.4

531.23

546.91

mg/l

0.26

1279

5362

Pulmonary heart disease, diseases of pulmonary circulation

375

2530

1.49

12.17

1.5

1.3

609.60

553.53

mg/l

0.87

359

2389

Diverticular disease of intestine

919

4729

1.30

12.03

1.3

531.66

573.56

mg/l

1.33

880

4515

Unspecified acute lower respiratory infection

216

1289

1.70

11.99

1.3

1.4

610.68

517.20

mg/l

0.34

207

1233

Dental caries 3, only avohilmo

1254

5134

1.25

11.98

1.4

524.24

553.05

mg/l

0.54

1179

4920

Metatarsalgia

139

728

1.94

11.97

1.2

1.4

697.40

508.28

mg/l

0.48

132

690

Excessive vomiting in pregnancy

146

780

1.91

11.89

1.3

1.2

357.01

451.84

mg/l

5.33

135

735

DVT of lower extremities and pulmonary embolism

497

3539

1.41

11.87

1.5

1.3

578.65

543.64

mg/l

0.65

478

3354

Insulin, combination of fast acting with intermediate-acting or long-acting

824

5850

1.31

11.85

1.3

1.4

664.35

529.76

mg/l

2.54

784

5571

Mental and behavioural disorders due to sedatives or hypnotics

122

615

2.03

11.81

1.2

1.3

476.44

522.40

mg/l

0.46

113

584

Postprocedural endocrine and metabolic disorders, not elsewhere classified

179

1019

1.78

11.80

1.5

1.3

472.43

492.69

mg/l

0.31

168

972

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

203

1199

1.72

11.74

1.6

1.2

522.86

523.94

mg/l

0.01

191

1119

Insulin medication

823

5425

1.30

11.65

1.3

1.4

664.57

521.35

mg/l

2.79

783

5170

Striking against or struck by other objects

477

3401

1.41

11.56

1.3

1.5

483.85

522.40

mg/l

0.91

450

3250

Spondylolisthesis/Spondylolysis

225

1370

1.66

11.55

1.2

1.3

505.56

497.40

mg/l

0.12

210

1307

Acute appendicitis, no complications

833

6443

1.30

11.51

1.3

502.90

531.02

mg/l

0.39

792

6157

Cellulitis

301

1968

1.55

11.45

1.7

1.4

569.97

518.56

mg/l

0.73

292

1865

Unspecified haematuria

501

3083

1.40

11.38

1.4

695.57

557.20

mg/l

0.66

483

2933

Emotional disorders starting during childhood or adolescence

101

478

2.15

11.36

3.0

1.9

426.35

377.58

mg/l

0.33

448

Other enthesopathy of foot (+metatarsalgia)

145

784

1.88

11.34

1.2

1.4

683.61

503.79

mg/l

0.48

138

743

Diabetic neuropathy

140

747

1.89

11.22

1.4

1.3

884.27

598.29

mg/l

0.64

130

701

Other symptoms and signs involving the digestive system and abdomen

215

1305

1.67

11.20

1.5

1.4

513.89

538.25

mg/l

0.24

196

1235

Cutaneous abscess, furuncle and carbuncle

361

2465

1.48

11.14

1.3

567.99

511.30

mg/l

0.34

348

2338

Candidiasis

196

1165

1.71

11.11

1.4

1.3

617.52

504.17

mg/l

0.38

184

1101

Acute renal failure

241

1509

1.61

11.08

1.4

1.3

594.23

563.02

mg/l

0.29

222

1420

Abnormal weight loss

129

678

1.94

11.06

1.2

1.5

513.83

550.02

mg/l

0.29

120

640

Secondary hypertension

109

535

2.05

11.00

1.3

1.4

534.59

508.08

mg/l

0.15

100

500

Superficial injury of hip and thigh

187

1100

1.72

10.96

1.2

1.3

528.84

522.81

mg/l

0.04

178

1031

Senile cataract

810

3873

1.30

10.95

1.3

552.14

592.17

mg/l

0.89

774

3689

Emotional disorders and disorders of social functioning with onset specific to childhood

107

522

2.07

10.95

2.9

1.9

426.18

384.10

mg/l

0.29

491

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

116

591

2.00

10.92

1.2

1.5

439.62

515.04

mg/l

0.82

108

560

Diseases of arteries, arterioles and capillaries (FINNGEN)

314

1446

1.53

10.88

1.4

1.2

551.59

532.96

mg/l

0.24

302

1366

Weight loss

140

761

1.87

10.83

1.6

1.5

508.31

541.20

mg/l

0.28

131

720

Abnormal findings on diagnostic imaging of other body structures

176

1024

1.74

10.80

1.3

489.52

534.43

mg/l

1.06

165

968

Maternal care for other conditions predominantly related to pregnancy

323

2143

1.50

10.78

1.2

1.3

433.68

431.76

mg/l

0.03

306

2037

Assault by bodily force

133

713

1.90

10.76

1.2

1.4

480.16

493.35

mg/l

0.17

127

679

Chronic gastritis

330

2232

1.49

10.67

1.2

1.3

575.20

557.73

mg/l

0.08

308

2126

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

396

2776

1.44

10.64

1.4

1.3

485.61

518.27

mg/l

0.83

379

2645

Hyperkinetic disorders

189

1112

1.70

10.62

1.3

2.0

458.06

411.93

mg/l

0.44

183

1061

Fracture of foot, except ankle

348

2384

1.47

10.59

1.4

512.26

493.37

mg/l

0.25

330

2270

Myeloid leukaemia

179

2.90

10.59

2.6

1.3

497.94

505.31

mg/l

0.05

169

Noninfectious colitis NAS

197

1190

1.68

10.53

1.3

1.5

508.93

514.37

mg/l

0.06

184

1127

Diabetic retinopathy, excluding more controls

315

1172

1.53

10.42

1.4

1.3

587.87

558.84

mg/l

0.42

298

1109

Other female pelvic inflammatory diseases

237

1505

1.59

10.35

1.3

435.87

504.94

mg/l

1.81

221

1436

Other gastritis (incl. Duodenitis)

281

1853

1.53

10.31

1.3

619.81

572.93

mg/l

0.18

270

1770

Lateral epicondylitis

182

1083

1.70

10.29

1.3

485.33

519.05

mg/l

0.39

177

1026

Impingement syndrome of shoulder

315

2132

1.49

10.20

1.4

1.3

576.31

568.80

mg/l

0.06

301

2029

Cerebral oedema

11.09

10.20

2.9

1.5

642.75

409.31

mg/l

1.03

Fracture at wrist and hand level

474

3451

1.38

10.19

1.3

1.4

495.09

519.73

mg/l

0.69

453

3293

Intestinal stricture

364

2534

1.45

10.17

1.4

510.32

564.30

mg/l

1.15

343

2400

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

252

1630

1.56

10.16

1.3

396.82

458.54

mg/l

2.61

238

1559

Disorders of calcium metabolism

443

2.12

10.13

1.3

1.4

472.99

525.62

mg/l

0.70

418

Other specified and unspecified personality disorders

152

866

1.79

10.11

1.3

1.4

412.19

510.35

mg/l

3.46

146

824

Misadventures to patients during surgical and medical care

190

1153

1.67

10.00

1.5

1.3

531.15

523.43

mg/l

0.08

183

1088

Superficial injury of wrist and hand

294

1975

1.50

9.93

1.4

534.57

494.20

mg/l

0.13

284

1882

Other hearing loss

299

1978

1.50

9.91

1.3

558.10

535.64

mg/l

0.11

291

1859

Haemorrhage from respiratory passages

415

2755

1.41

9.84

1.5

1.4

508.86

574.15

mg/l

1.48

391

2619

Early lumbar disc prolapse operation

175

1045

1.70

9.83

1.2

1.3

520.36

500.12

mg/l

0.13

170

1006

Dialysis, with operation codes

180

1083

1.69

9.82

1.6

1.5

554.12

540.21

mg/l

0.18

171

1028

Tonsillectomy and adenotomy

909

5039

1.26

9.80

1.4

488.27

478.08

mg/l

0.06

856

4831

Schizoaffective disorder

130

714

1.86

9.80

1.2

1.3

460.21

506.83

mg/l

0.48

121

676

Arthrosis

1021

4506

1.25

9.77

1.3

546.30

529.69

mg/l

0.33

975

4296

Inflammatory diseases of prostate (prostatitis)

163

956

1.73

9.75

1.3

530.51

566.92

mg/l

0.73

158

906

Benign neoplasm of colon, rectum, anus and anal canal

697

3842

1.30

9.67

1.3

565.51

560.40

mg/l

0.04

655

3653

Obsessive-compulsive disorder

106

547

1.97

9.65

1.2

1.4

368.06

466.37

mg/l

2.74

100

520

False labour

476

2179

1.38

9.59

1.3

400.12

449.89

mg/l

0.88

456

2080

Disorders of vitreous body and globe

608

4524

1.32

9.58

1.3

593.60

561.94

mg/l

0.20

579

4293

Secondary thrombocytopenia

3.77

9.56

1.7

1.2

509.90

462.28

mg/l

0.20

Speech therapy

344

2400

1.45

9.56

1.4

580.47

516.44

mg/l

0.55

335

2278

Nephropathy related operations

173

1038

1.69

9.56

1.7

1.5

554.06

543.29

mg/l

0.14

165

984

Renal failure

490

3311

1.36

9.50

1.4

630.98

559.23

mg/l

0.60

460

3136

Acute and transient psychotic disorders

182

1109

1.66

9.47

1.2

1.3

474.68

503.71

mg/l

0.36

172

1054

Other diseases of jaws

109

572

1.94

9.46

1.4

1.3

455.60

522.79

mg/l

1.24

102

537

Other and unspecified injuries of head

462

2.05

9.45

1.3

1.5

511.14

543.23

mg/l

0.31

440

Amblyopia ex anopsia

344

2.24

9.41

1.5

2.4

508.29

458.54

mg/l

0.29

327

Amenorrhoea

120

651

1.88

9.41

1.3

412.65

447.61

mg/l

0.57

113

631

Beningn neoplasm: Meninges, unspecified

115

3.28

9.36

1.6

1.2

1058.81

475.10

mg/l

1.70

108

Other retinal disorders

765

4830

1.28

9.35

1.4

1.3

549.18

560.44

mg/l

0.19

723

4588

Endometriosis

520

2292

1.36

9.34

1.3

441.75

509.66

mg/l

2.01

488

2201

Asthma/COPD (KELA code 203)

1413

8343

1.20

9.25

1.3

1.4

477.36

536.43

mg/l

2.80

1341

7965

Heartburn

141

807

1.77

9.24

1.3

468.38

525.45

mg/l

0.82

134

760

Viral and other specified intestinal infections

314

2116

1.46

9.24

1.5

1.6

464.57

461.21

mg/l

0.03

303

2016

Faecal incontinence

115

619

1.89

9.22

1.5

1.2

453.47

519.29

mg/l

1.13

109

589

Familial hypercholesterolemia

181

1110

1.65

9.16

1.3

628.12

582.96

mg/l

0.34

172

1051

Injuries to the elbow and forearm

955

6993

1.24

9.11

1.3

1.4

523.76

527.06

mg/l

0.04

901

6675

Meniscus derangement

766

4126

1.28

9.06

1.3

513.43

537.41

mg/l

0.62

723

3938

Superficial injury of thorax

200

1262

1.60

9.03

1.3

561.03

524.19

mg/l

0.25

184

1193

Unspecified privation

152

895

1.72

9.03

1.5

1.4

508.68

523.71

mg/l

0.18

145

847

Other diseases of the digestive system

364

2592

1.41

9.02

1.4

521.15

555.53

mg/l

0.39

336

2455

Reimbursement for rheumatic diseases

778

6164

1.27

9.01

1.3

1.4

588.97

530.88

mg/l

0.46

743

5866

Diseases of appendix

1081

8100

1.22

8.94

1.3

517.29

538.24

mg/l

0.33

1029

7737

Other/unspecified enthesopathies of lower limb, excluding foot

102

534

1.94

8.93

1.3

1.4

486.76

495.53

mg/l

0.09

512

Appendicitis, broad definition

1072

8056

1.22

8.92

1.3

517.18

538.34

mg/l

0.33

1020

7694

Generalized epilepsy

353

2.17

8.84

1.3

1.8

543.71

489.14

mg/l

0.20

337

Benign neoplasm: Colon

598

3516

1.31

8.80

1.3

571.34

562.23

mg/l

0.06

564

3337

Injuries to the hip and thigh

551

3840

1.32

8.77

1.3

1.4

574.76

536.02

mg/l

0.49

518

3640

Complications of genitourinary prosthetic devices, implants and grafts

169

2.75

8.76

1.4

1.3

685.00

452.64

mg/l

0.58

156

Contact with and exposure to communicable diseases

484

3614

1.34

8.74

1.4

463.56

446.46

mg/l

0.20

457

3457

Other disorders of patella

250

1670

1.51

8.74

1.3

448.61

480.21

mg/l

0.75

241

1595

Other maternal disorders predominantly related to pregnancy

832

4174

1.26

8.70

1.3

450.99

499.39

mg/l

1.30

798

3975

Heart failure, not strict

976

5471

1.24

8.70

1.4

583.83

564.03

mg/l

0.24

926

5220

Acute appendicitis

1009

7805

1.23

8.66

1.3

517.90

539.91

mg/l

0.33

961

7454

Failure and rejection of transplanted organs and tissues

100

3.36

8.66

3.3

1.2

578.72

470.16

mg/l

0.53

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

400

2917

1.38

8.65

1.3

1.4

585.89

498.51

mg/l

0.60

384

2777

Other diseases of liver

237

1570

1.53

8.64

1.2

1.3

596.46

524.77

mg/l

0.56

228

1489

Abnormal findings on diagnostic imaging of lung

543

4033

1.32

8.62

1.3

567.02

568.10

mg/l

0.01

520

3820

Benign neoplasm: Colon

605

4588

1.30

8.60

1.3

573.79

564.85

mg/l

0.07

569

4352

Suppurative and unspecified otitis media

551

3730

1.32

8.60

1.8

1.4

559.57

478.40

mg/l

0.76

528

3559

Tubulo-interstitial nephritis, not specified as acute or chronic

492

1.96

8.60

1.4

1.3

581.11

507.00

mg/l

0.74

469

Disorders of vitreous body

586

4427

1.30

8.55

1.3

590.40

564.25

mg/l

0.16

560

4198

Hernia

1321

7521

1.20

8.48

1.3

1.4

574.21

544.74

mg/l

0.35

1260

7174

Other fall from one level to another

314

2207

1.44

8.44

1.9

1.5

536.13

497.50

mg/l

0.48

300

2095

Sicca syndrome [Sjögren]

123

697

1.79

8.41

1.4

1.2

407.32

505.07

mg/l

3.60

118

658

Viral pneumonia (unknown virus, not influenza)

105

568

1.88

8.38

1.5

1.4

832.80

529.18

mg/l

0.59

536

Adhesive capsulitis of shoulder

205

1325

1.56

8.36

1.4

1.3

467.75

546.75

mg/l

1.86

199

1255

TMD related operations

239

1599

1.51

8.34

1.3

1.4

525.84

496.06

mg/l

0.14

226

1521

Childhood asthma (age<16), excluding more controls

192

963

1.60

8.30

1.4

455.63

420.41

mg/l

0.38

182

917

Retinal detachments and breaks

402

2954

1.37

8.30

1.3

532.60

554.21

mg/l

0.38

384

2800

Atopic dermatitis

817

5610

1.25

8.29

1.3

1.4

466.14

489.49

mg/l

0.54

781

5368

Beningn neoplasm: Meninges, unspecified

124

3.03

8.28

1.6

1.3

1058.81

510.50

mg/l

1.54

116

Panniculitis affecting regions of neck and back

265

2.32

8.27

1.4

1.3

517.47

503.69

mg/l

0.10

254

Acute suppurative otitis media

412

2839

1.37

8.22

2.0

1.4

508.07

455.94

mg/l

0.89

397

2709

Benign neoplasm of colon, rectum, anus and anal canal

731

5253

1.26

8.22

1.3

564.96

576.69

mg/l

0.10

686

4995

Unspecified visual impairment (binocular)

3.30

8.21

1.2

1.9

433.16

441.60

mg/l

0.05

Insulin, fast-acting

473

3566

1.33

8.20

1.3

1.4

701.67

515.81

mg/l

1.85

447

3396

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

768

6055

1.25

8.20

1.4

433.48

503.46

mg/l

4.35

736

5772

GI-bleeding

358

2586

1.39

8.20

1.4

514.57

553.92

mg/l

0.46

330

2449

Fissure and fistula of anal and rectal regions

319

2261

1.42

8.20

1.4

1.3

570.05

531.32

mg/l

0.25

299

2158

Car occupant injured in other and unspecified transport accidents

272

1874

1.47

8.18

1.3

476.45

498.94

mg/l

0.35

259

1773

Childhood asthma (age<16)

192

967

1.59

8.18

1.4

455.63

422.06

mg/l

0.36

182

921

Unspecified urinary incontinence

117

660

1.80

8.13

1.3

639.04

513.78

mg/l

0.42

111

628

Other or unspecified ileus, impaction or obstruction

210

1374

1.54

8.09

1.3

534.36

570.94

mg/l

0.40

200

1299

Acute lymphadenitis

520

1.90

7.98

2.1

1.5

433.14

514.33

mg/l

1.53

492

Gonarthrosis [arthrosis of knee](FG)

1014

4908

1.22

7.95

1.3

575.38

545.31

mg/l

0.42

969

4677

Other cataract

523

3098

1.31

7.94

1.4

1.3

577.91

563.99

mg/l

0.10

508

2934

Other abnormal immunological findings in serum

138

2.85

7.93

1.3

1.6

791.33

462.65

mg/l

0.61

132

Other viral hepatitis

104

572

1.85

7.90

1.3

547.06

493.27

mg/l

0.33

542

Glomerular diseases

232

1561

1.50

7.89

1.4

553.30

531.13

mg/l

0.20

225

1472

Injury of muscle and tendon at shoulder and upper arm level

434

3256

1.34

7.86

1.2

1.3

547.67

577.38

mg/l

0.47

418

3098

Other disorders of the musculoskeletal system and connective tissue

187

1203

1.57

7.85

1.4

1.3

549.03

532.67

mg/l

0.12

182

1135

Gout

290

1854

1.44

7.81

1.5

1.3

660.36

545.36

mg/l

2.29

278

1754

Fentanyl

110

616

1.80

7.80

1.3

838.28

547.12

mg/l

0.57

102

579

Astigmatism

531

1.88

7.79

2.4

2.1

359.61

490.54

mg/l

4.58

505

Direct fill therapy

198

1294

1.55

7.75

1.9

1.6

553.78

502.72

mg/l

0.41

188

1226

Budesonide

183

1178

1.57

7.67

1.3

502.46

504.17

mg/l

0.02

175

1121

Other arrhythmias

902

5663

1.22

7.61

1.3

516.34

543.62

mg/l

0.41

846

5404

Crohn disease

193

1260

1.55

7.61

1.3

1.5

475.48

496.21

mg/l

0.29

184

1197

Dislocation, sprain and strain of joints and ligaments of knee

871

6633

1.23

7.55

1.3

500.63

527.41

mg/l

0.45

834

6327

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

279

3068

0.71

7.54

1.3

563.54

553.40

mg/l

0.11

273

2901

Other arthrosis

671

3812

1.27

7.52

1.3

571.39

541.60

mg/l

0.31

650

3640

Spondylopathies (FG)

196

1287

1.54

7.52

1.3

590.97

487.64

mg/l

0.48

184

1223

Mouth breathing

539

4191

1.29

7.49

1.3

1.5

492.65

543.79

mg/l

1.87

513

4002

Open wound of wrist and hand

594

4632

1.28

7.48

1.3

532.83

528.31

mg/l

0.05

569

4415

Gonarthrosis

860

4016

1.23

7.45

1.3

552.68

537.03

mg/l

0.20

821

3832

Care involving dialysis

103

576

1.82

7.42

1.4

1.5

587.29

539.90

mg/l

0.56

544

Haemorrhage, not elsewhere classified

149

2.66

7.34

2.7

1.3

501.50

486.07

mg/l

0.10

137

Thyroiditis, ILD-related definition

154

963

1.62

7.33

1.4

1.3

597.60

496.48

mg/l

0.30

146

911

Calculus of kidney and ureter

361

2664

1.36

7.33

1.4

1.3

744.16

556.90

mg/l

0.62

347

2528

Urolithiasis

387

2886

1.35

7.33

1.3

733.01

553.71

mg/l

0.64

371

2740

Fibroblastic disorders

262

1831

1.44

7.33

1.2

1.3

539.71

566.16

mg/l

0.29

250

1740

Insulin, fast-acting or short human

475

3647

1.31

7.29

1.3

1.4

701.20

520.81

mg/l

1.78

449

3474

Collagenous colitis

123

729

1.71

7.25

1.3

1.4

469.98

518.81

mg/l

0.59

115

689

Polymyalgia rheumatica

145

896

1.64

7.24

1.2

1.3

1035.24

554.72

mg/l

0.83

131

844

Chronic viral hepatitis

473

1.90

7.24

1.3

1.4

572.05

484.26

mg/l

0.50

449

Dental pulpitis 3

217

1047

1.51

7.22

1.8

353.71

398.95

mg/l

1.12

204

1003

Allergic conjunctivitis

797

6415

1.23

7.17

1.4

435.09

504.90

mg/l

4.40

764

6116

Sequelae of other external causes

411

1.96

7.16

1.5

1.3

675.92

527.75

mg/l

0.59

387

Dental operations, only avohilmo

982

4163

1.21

7.11

1.3

1.4

507.79

561.78

mg/l

1.66

926

3976

Other condition

190

1257

1.53

7.08

1.7

1.4

672.44

511.45

mg/l

0.74

180

1187

Diabetes, varying definitions

1486

7638

1.17

7.05

1.3

1.4

598.34

525.82

mg/l

1.89

1406

7300

Diabetes mellitus

1495

7682

1.16

7.00

1.3

1.4

596.47

524.89

mg/l

1.87

1415

7341

Missing teeth due to accident, extraction or parodontitis

151

952

1.61

6.98

1.3

529.07

558.13

mg/l

0.20

142

894

Vasomotor and allergic rhinitis

529

4085

1.28

6.97

1.3

1.4

436.28

493.00

mg/l

2.03

507

3909

Decubitus ulcer and pressure area

347

2.02

6.89

1.7

1.3

684.50

550.17

mg/l

0.40

325

Haemorrhage in early pregnancy

390

2870

1.34

6.87

1.2

1.3

415.25

475.26

mg/l

2.37

377

2732

Corneal ulcer

244

1707

1.44

6.85

1.2

1.3

617.06

517.23

mg/l

0.98

232

1620

Disorders of gallbladder, biliary tract and pancreas

1351

7461

1.17

6.82

1.4

1.3

560.83

538.66

mg/l

0.28

1288

7112

Obesity, other/unspecified

452

3484

1.31

6.82

1.3

453.96

484.71

mg/l

0.95

435

3332

Superficial injury of shoulder and upper arm

150

950

1.60

6.81

1.3

1.4

644.29

520.08

mg/l

0.49

144

900

Viral hepatitis

115

682

1.71

6.80

1.3

1.4

542.20

507.72

mg/l

0.21

109

647

Paroxysmal tachycardia

283

1713

1.41

6.79

1.3

1.4

501.45

496.09

mg/l

0.07

268

1616

Use of disulfiram, acamprosate or naltrexone

131

804

1.65

6.79

1.3

638.52

532.92

mg/l

0.48

124

762

Chondropathies

216

1482

1.47

6.75

1.4

533.93

499.39

mg/l

0.38

207

1406

Early onset COPD, excluding more controls

227

1574

1.45

6.65

1.3

522.57

565.09

mg/l

0.61

210

1510

Intracranial nontraumatic haemorrhage of fetus and newborn

6.86

6.65

4.4

8.4

651.33

341.64

mg/l

0.64

Lesion of radial nerve

278

2.13

6.63

1.3

1.2

510.08

504.39

mg/l

0.04

258

Other diseases of anus and rectum

340

2526

1.35

6.60

1.3

1.4

572.14

544.66

mg/l

0.18

319

2397

Fracture of shoulder and upper arm

429

3299

1.31

6.56

1.5

1.4

502.28

516.31

mg/l

0.27

405

3131

Medical abortion

880

3958

1.21

6.51

1.3

464.50

478.36

mg/l

0.22

839

3767

Type 2 diabetes

1388

7099

1.16

6.51

1.3

606.95

534.98

mg/l

1.66

1310

6778

Crushed, pushed or stepped on by crowd or human stampede

112

670

1.70

6.43

1.3

1.7

464.50

492.23

mg/l

0.35

107

635

Cardiodefibrillation

217

3084

0.70

6.41

1.4

1.3

570.12

590.14

mg/l

0.21

207

2925

Dental pulpitis 3, only avohilmo

198

977

1.50

6.41

1.4

1.8

346.79

383.14

mg/l

1.04

186

935

Deviated nasal septum

418

3215

1.31

6.40

1.3

632.82

554.56

mg/l

0.55

395

3068

Glucagon-like peptide-1 (GLP-1) analogues

639

4248

1.24

6.36

1.3

632.76

549.29

mg/l

1.06

598

4036

Eating disorders

164

1077

1.54

6.35

1.2

1.4

397.08

455.14

mg/l

1.22

154

1024

Orchitis and epididymitis

107

634

1.71

6.34

1.4

1.5

608.26

563.09

mg/l

0.41

102

595

Acute laryngitis and tracheitis

174

1141

1.52

6.30

1.9

1.4

456.93

469.93

mg/l

0.12

165

1094

Endometriosis of pelvic peritoneum

227

1573

1.44

6.28

1.3

415.99

514.63

mg/l

2.17

210

1511

Other peripheral vascular diseases

108

645

1.70

6.25

1.3

432.30

534.57

mg/l

1.80

103

608

Methotrexate

185

1251

1.49

6.24

1.2

1.3

674.34

509.33

mg/l

0.55

173

1183

Hereditary hypogammaglobulinemia

6.24

6.22

1.1

1.2

386.18

432.32

mg/l

0.36

Eosinophilic disease (BM)

3.05

6.19

1.2

1.4

487.19

512.18

mg/l

0.14

Pedestrian injured in transport accident

565

1.74

6.16

1.2

1.4

454.89

524.63

mg/l

1.64

532

Nonsuppurative otitis media

338

2191

1.34

6.14

1.7

1.4

588.13

461.52

mg/l

0.86

326

2076

Heart failure and coronary heart disease

170

1877

0.67

6.12

1.3

747.20

562.13

mg/l

0.61

160

1769

Cholecystectomy

888

6589

1.20

6.09

1.3

596.74

536.94

mg/l

0.61

846

6268

Diabetes medication

1468

7761

1.15

6.09

1.3

1.4

602.99

526.22

mg/l

2.02

1385

7418

Superficial injury of forearm

139

890

1.58

6.09

1.3

1.6

559.91

492.84

mg/l

0.25

132

842

Diseases of external ear

412

3189

1.30

6.08

1.3

1.4

557.21

513.39

mg/l

0.37

384

3044

Congenital iodine-deficiency syndrome/hypothyroidism

202

2.28

6.08

1.3

1.6

428.38

502.67

mg/l

0.95

189

Colonic or urogenital fistula

337

2538

1.34

6.08

1.3

588.81

518.31

mg/l

0.53

317

2412

Type 1 diabetes

348

2629

1.33

6.08

1.4

1.5

565.27

483.85

mg/l

1.78

330

2513

Other diseases of pleura

496

3478

1.27

6.02

1.5

1.4

602.49

565.44

mg/l

0.25

471

3296

Rheumatoid arthritis

386

2692

1.31

6.01

1.3

706.50

524.77

mg/l

0.85

364

2561

Toxic effects of substances chiefly nonmedicinal as to source

161

1069

1.52

5.98

1.3

1.5

428.03

512.27

mg/l

2.72

153

1011

Procreative management

463

3072

1.28

5.91

1.5

507.78

495.91

mg/l

0.11

437

2925

Other skin changes

191

1316

1.46

5.89

1.3

520.79

530.28

mg/l

0.11

178

1246

Persistent delusional disorders

101

603

1.70

5.88

1.2

1.3

450.97

530.97

mg/l

2.10

570

Correction of physiology of bite - demanding therapy visit

103

619

1.69

5.86

1.3

411.38

483.15

mg/l

1.32

592

Rash and other nonspecific skin eruption

124

782

1.60

5.81

1.7

1.4

430.52

532.73

mg/l

3.54

117

741

Atopic dermatitis, strict definition with reimbursement

435

3307

1.28

5.80

1.4

1.5

447.09

457.04

mg/l

0.14

417

3164

Abnormal serum enzyme levels

337

2523

1.33

5.79

1.3

535.78

587.13

mg/l

1.01

315

2398

Other specified/unspecified inflammatory spondylopathies

363

1.90

5.78

1.3

494.00

504.48

mg/l

0.06

350

Carrier of infectious disease

169

2.37

5.75

1.4

1.5

456.53

416.17

mg/l

0.35

160

Other diseases of intestine

141

918

1.55

5.74

1.4

1.3

741.39

549.70

mg/l

0.49

134

863

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1307

7387

1.16

5.68

1.3

583.37

541.71

mg/l

0.55

1253

7040

Disorder of lipoprotein metabolism, unspecified

144

946

1.54

5.63

1.2

1.3

604.73

547.53

mg/l

0.55

139

899

Wegener granulomatosis

111

2.70

5.56

1.4

1.3

518.14

473.73

mg/l

0.31

103

Otitis media, unspecified

172

1081

1.48

5.55

1.9

1.6

617.42

449.11

mg/l

0.51

160

1021

Presbyopia

523

1.73

5.53

1.3

1.2

508.06

536.88

mg/l

0.30

495

Papulosquamous disorders

480

3834

1.26

5.53

1.3

493.38

541.49

mg/l

1.51

452

3649

Localized swelling, mass and lump of skin and subcutaneous tissue

363

2802

1.30

5.52

1.7

1.4

487.18

528.83

mg/l

0.96

348

2663

Schizophrenia

219

1569

1.41

5.49

1.2

1.3

536.77

510.52

mg/l

0.26

207

1495

Cholecystitis

153

1024

1.51

5.48

1.2

559.01

560.76

mg/l

0.01

142

960

Excessive attrition of teeth

561

2453

1.25

5.48

1.3

448.59

503.77

mg/l

2.40

535

2337

Eating disorder

136

889

1.55

5.45

1.2

1.5

357.87

435.75

mg/l

2.03

129

847

Fracture of lower leg, including ankle

697

5771

1.21

5.45

1.3

1.4

536.25

539.93

mg/l

0.05

669

5491

Phlebitis and thrombophlebitis (not including DVT)

264

1952

1.36

5.44

1.3

498.11

530.76

mg/l

0.56

251

1855

Nonalcoholic fatty liver disease

124

798

1.57

5.37

1.3

1.4

680.13

519.17

mg/l

0.80

118

755

Chronic periodontitis

177

1226

1.46

5.36

1.4

1.3

631.51

548.23

mg/l

0.54

166

1162

Glaucoma

615

4436

1.22

5.35

1.3

555.95

553.68

mg/l

0.03

587

4197

Noninflammatory disorders of female genital tract

626

2571

1.23

5.34

1.3

444.74

491.14

mg/l

0.89

589

2463

Later onset COPD

132

1562

0.66

5.28

1.2

1.3

531.57

595.38

mg/l

0.88

123

1464

Other/unspecified enthesopathies, not elsewhere classified

102

629

1.64

5.27

1.3

501.68

542.15

mg/l

0.37

593

Inflammatory bowel disease

419

3315

1.27

5.27

1.3

1.4

503.68

508.80

mg/l

0.07

401

3152

Chronic kidney disease

292

2193

1.33

5.25

1.3

1.4

569.90

553.48

mg/l

0.20

280

2070

Melanocytic naevi

362

2815

1.29

5.24

1.4

1.3

516.15

491.78

mg/l

0.33

338

2670

Ganglion

256

1896

1.36

5.23

1.3

530.08

504.65

mg/l

0.26

251

1801

Burns and corrosions

187

1316

1.43

5.22

1.3

1.5

741.73

508.68

mg/l

0.36

177

1250

Complications of internal orthopaedic prosthetic devices, implants and grafts

231

1684

1.38

5.22

1.3

666.66

553.29

mg/l

0.90

216

1578

Moderate visual impairment, monocular

4.51

5.21

1.7

1.3

502.15

444.68

mg/l

0.27

Gout, FINNGEN

290

2191

1.33

5.18

1.5

1.3

660.36

570.16

mg/l

1.42

278

2068

Disorder of the sleep-wake schedule

134

2.46

5.13

1.5

1.9

408.97

454.48

mg/l

0.33

128

Other and unspecified mononeuropathies of upper limb

218

2.11

5.09

1.8

1.2

547.62

494.37

mg/l

0.28

203

Nail disorders

111

706

1.59

5.08

1.4

789.35

517.08

mg/l

0.55

104

669

Respiratory insufficiency

459

1.73

5.07

1.5

1.3

467.50

527.06

mg/l

1.12

433

Amyloidosis, other/unspecified

111

2.60

5.03

1.4

1.2

779.29

489.97

mg/l

1.64

101

Chronic laryngitis and laryngotracheitis

166

1151

1.45

5.03

1.3

488.95

517.64

mg/l

0.46

159

1093

Vitreous haemorrhage

120

780

1.56

5.00

1.3

551.78

538.93

mg/l

0.14

112

733

Polyarthrosis

216

1504

1.39

4.99

1.3

587.83

511.02

mg/l

0.39

206

1419

Redundant prepuce, phimosis and paraphimosis

241

1776

1.36

4.96

1.2

1.5

661.24

558.41

mg/l

0.44

227

1701

Other disorders of penis

116

750

1.56

4.95

1.3

1.8

482.72

535.28

mg/l

0.73

108

711

Myopia

172

1205

1.44

4.95

1.3

1.5

442.02

496.49

mg/l

1.21

163

1150

Benign neoplasm of other and ill-defined parts of digestive system

196

1405

1.41

4.94

1.3

465.26

530.22

mg/l

1.51

188

1323

Event of undetermined intent

541

1.67

4.92

1.4

502.12

501.00

mg/l

0.01

505

Gastroduodenal ulcer

261

1956

1.34

4.87

1.3

547.80

584.37

mg/l

0.47

239

1864

Presence of other functional implants

649

3824

1.21

4.87

1.3

548.69

560.81

mg/l

0.20

612

3626

Other diseases of oesophagus

108

691

1.58

4.82

1.3

487.59

557.20

mg/l

0.78

100

648

Disorders of multiple cranial nerves

17.30

4.81

1.3

1.2

469.86

592.20

mg/l

—

Heart failure and antihypertensive medication

292

1464

1.32

4.80

1.5

1.3

544.11

560.30

mg/l

0.17

282

1381

Gastric ulcer

182

1296

1.41

4.77

1.4

1.3

498.90

567.43

mg/l

1.30

171

1230

Moderate visual impairment, binocular

177

2.19

4.76

1.6

1.3

469.85

477.04

mg/l

0.05

168

Pruritus

131

878

1.51

4.75

1.4

620.46

518.37

mg/l

0.89

124

833

Other embolism and thrombosis

150

1033

1.46

4.74

1.3

573.49

530.45

mg/l

0.28

145

975

Presence of other devices

236

1756

1.35

4.70

1.4

1.3

594.72

553.99

mg/l

0.37

221

1661

Dermatophytosis

153

1061

1.46

4.67

1.4

525.84

537.17

mg/l

0.08

147

999

Myocardial infarction, strict

365

3358

0.79

4.64

1.3

626.28

582.36

mg/l

0.34

342

3188

Injury of eye and orbit

180

1288

1.41

4.62

1.3

1.4

502.74

521.87

mg/l

0.31

173

1229

Open wound of ankle and foot

131

884

1.50

4.61

1.3

1.5

542.57

513.21

mg/l

0.29

124

835

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

111

725

1.55

4.56

1.2

1.4

466.06

476.83

mg/l

0.11

103

695

Diabetic retinopathy

359

1781

1.28

4.55

1.3

590.89

604.92

mg/l

0.16

340

1687

Scleritis

105

2.57

4.55

1.2

363.73

402.96

mg/l

0.51

100

Disorders of breast

616

4779

1.20

4.53

1.3

451.68

512.03

mg/l

2.20

589

4555

Achilles tendinitis

119

790

1.52

4.53

1.2

1.3

530.55

508.52

mg/l

0.19

112

750

Open wound of lower leg

172

1226

1.41

4.52

1.3

1.4

521.56

518.40

mg/l

0.02

167

1151

Other maltreatment syndromes

278

1.91

4.51

1.2

1.4

480.94

483.89

mg/l

0.02

266

Other local infections of skin and subcutaneous tissue

124

832

1.51

4.50

2.2

1.5

511.01

539.65

mg/l

0.18

118

786

Moyamoya

10.63

4.50

1.3

1.4

494.00

359.22

mg/l

—

Haemophagocytic lymphohistiocytosis

10.44

4.48

1.5

1.6

419.50

538.00

mg/l

—

Other and unspecified injuries of lower leg

634

1.58

4.46

1.2

1.4

796.40

514.95

mg/l

0.61

601

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

461

3299

1.23

4.45

1.5

1.3

603.20

545.88

mg/l

1.02

442

3122

Sulfasalazine

350

2771

1.27

4.45

1.2

1.3

675.53

516.51

mg/l

0.70

331

2644

Dementia due to Parkinson's disease

118

2.42

4.44

1.3

502.65

549.94

mg/l

0.32

111

Benign neoplasm: Adrenal gland

573

1.61

4.41

1.3

1.2

550.67

494.17

mg/l

0.61

535

Cholelithiasis, broad definition with cholecystitis

1126

6764

1.14

4.41

1.3

575.57

537.99

mg/l

0.44

1070

6442

Mixed conductive and sensorineural hearing loss

137

942

1.47

4.40

1.3

490.20

535.53

mg/l

0.69

129

891

Coronary artery bypass grafting

168

1778

0.72

4.40

1.2

1.3

598.44

571.46

mg/l

0.35

161

1682

Effects of foreign body entering through natural orifice

311

2432

1.29

4.39

1.4

1.5

543.79

515.95

mg/l

0.29

295

2315

Diseases of peritoneum

119

796

1.51

4.39

1.4

1.3

481.07

533.18

mg/l

0.79

109

754

Coxarthrosis

577

3255

1.21

4.37

1.3

680.62

550.55

mg/l

1.46

537

3096

Atopic dermatitis, strict definition

418

3317

1.24

4.37

1.4

1.5

442.50

460.81

mg/l

0.27

402

3170

Melanocytic naevi of trunk

146

1018

1.45

4.37

1.2

506.70

472.28

mg/l

0.31

134

953

Other disorders of skin and subcutaneous tissue, not elsewhere classified

160

1134

1.42

4.36

1.2

1.3

503.23

527.01

mg/l

0.32

152

1069

Biguanides

1270

6913

1.13

4.36

1.3

609.96

534.83

mg/l

1.74

1194

6602

Glaucoma suspect

380

3047

1.25

4.34

1.3

514.08

538.49

mg/l

0.48

363

2880

Traumatic cerebral oedema

12.28

4.33

1.6

1.3

480.71

320.67

mg/l

—

Other (not insulin) diabetes medications

1289

6872

1.13

4.33

1.3

610.22

532.49

mg/l

1.81

1214

6562

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1311

7093

1.13

4.29

1.3

1.4

613.53

537.84

mg/l

1.69

1244

6766

Atrial fibrillation and flutter

367

1903

1.26

4.28

1.3

1.2

536.97

516.72

mg/l

0.29

343

1808

Eosinophilia

108

2.47

4.28

1.2

1.8

487.19

426.26

mg/l

0.48

100

Other inflammation of eyelid

153

1080

1.43

4.28

1.7

1.3

461.65

516.23

mg/l

1.42

147

1024

Artrosis, including avohilmo

1198

5788

1.14

4.25

1.3

529.38

540.04

mg/l

0.22

1141

5524

Other Crohn's disease

634

1.56

4.25

1.3

1.4

485.04

499.67

mg/l

0.12

597

Diseases of salivary glands

232

1753

1.33

4.25

1.3

443.37

540.16

mg/l

3.55

221

1668

Parodontitis and operation codes

1110

7587

1.14

4.24

1.3

561.33

547.33

mg/l

0.14

1061

7230

Diabetic nephropathy, excluding more controls

150

879

1.44

4.22

1.4

1.3

741.59

564.83

mg/l

0.66

142

832

Cushing syndrome

2.62

4.21

1.2

1.3

423.09

480.86

mg/l

0.48

Otitis externa

271

2096

1.30

4.20

1.2

1.4

503.88

506.30

mg/l

0.02

253

1991

Hypertrophic disorders of skin

487

1.64

4.20

1.5

1.4

408.30

490.60

mg/l

1.48

462

Degenerative macular diseases

124

845

1.48

4.19

1.3

1.2

540.97

548.85

mg/l

0.08

119

797

Other diseases of stomach and duodenum

473

1.65

4.14

1.5

1.3

466.11

560.48

mg/l

1.09

442

Other and unspecified local infections of skin and subcutaneous tissue

117

791

1.49

4.13

2.2

1.5

513.30

532.86

mg/l

0.11

111

745

Parodontitis or operation codes

1176

7662

1.13

4.08

1.3

558.38

545.84

mg/l

0.13

1122

7301

Adenomyosis (Endometriosis of uterus)

164

1183

1.40

4.07

1.4

1.3

437.25

524.90

mg/l

2.02

154

1137

Recurring oral aphthae, including avohilmo

169

1226

1.39

4.06

2.4

1.4

491.64

511.26

mg/l

0.13

162

1156

Perforation of tympanic membrane

127

876

1.46

4.06

1.4

532.60

509.61

mg/l

0.14

120

824

Retinal vascular occlusion

119

810

1.48

4.05

1.4

1.2

550.16

551.92

mg/l

0.01

108

760

Molar incisor enamel hypoplasia, with caries

2.72

4.05

13.9

2.7

653.57

323.72

mg/l

0.36

Burkitt lymphoma, excluding all cancers (controls excluding all cancers)

11.26

4.04

4.3

1.3

222.43

544.87

mg/l

—

273

1.84

4.01

1.3

1.2

427.80

528.32

mg/l

1.24

257

Thyrotoxicosis, other and/or unspecified

231

1762

1.32

3.98

1.5

1.3

629.19

509.54

mg/l

0.56

217

1675

Coxarthrosis [arthrosis of hip](FG)

615

3760

1.19

3.97

1.3

680.88

559.30

mg/l

1.42

573

3573

Glomerular disorders in diseases classified elsewhere

134

938

1.44

3.96

1.3

1.4

552.28

543.11

mg/l

0.06

128

885

Melanocytic naevi

362

2921

1.25

3.96

1.4

1.3

516.15

497.94

mg/l

0.24

338

2778

Infectious mononucleosis

124

856

1.46

3.96

1.4

1.5

432.32

448.45

mg/l

0.14

116

810

Benign neoplasm of other and ill-defined parts of digestive system

196

1462

1.35

3.96

1.3

465.26

533.07

mg/l

2.65

188

1381

Parodontitis

1173

7664

1.13

3.95

1.3

558.81

545.78

mg/l

0.13

1119

7304

Rheumatoid arthritis, including avohilmo

437

3597

1.22

3.95

1.3

678.38

527.72

mg/l

0.78

413

3408

Fracture of forearm

669

5354

1.17

3.93

1.3

1.4

523.99

520.90

mg/l

0.03

629

5095

Hypoplasia of dental enamel, including avohilmo

2.54

3.91

12.4

4.2

244.22

329.51

mg/l

1.21

Any prescribed medicine buy

6.42

3.88

2.5

1.6

288.20

573.33

mg/l

—

Retinal vascular disorders

120

826

1.46

3.88

1.4

1.2

549.57

549.44

mg/l

0.00

109

774

Chronic periodontitis, including avohilmo

1167

7662

1.13

3.88

1.3

560.06

545.78

mg/l

0.15

1113

7302

Disorders of parathyroid gland

206

1533

1.33

3.86

1.3

565.32

558.39

mg/l

0.04

192

1446

Status post-ami

340

0.38

3.84

1.1

1.3

438.31

597.49

mg/l

2.02

315

Female genital prolapse

374

1740

1.25

3.84

1.2

1.3

460.66

543.46

mg/l

1.89

351

1670

Burns and corrosions of external body surface, specified by site

143

1020

1.41

3.83

1.3

1.6

447.84

507.94

mg/l

1.27

134

962

Cholelithiasis

1071

6632

1.14

3.83

1.3

581.84

536.16

mg/l

0.53

1020

6312

Preparation and fitting of bite rail to mouth

177

1308

1.36

3.82

1.2

1.4

560.86

509.38

mg/l

0.19

166

1246

Preterm labour and delivery

331

2658

1.25

3.80

1.3

464.34

508.93

mg/l

0.66

319

2539

Type 2 diabetes, definitions combined

1262

6713

1.12

3.78

1.3

607.20

532.81

mg/l

1.67

1190

6409

Haemorrhoids and perianal venous thrombosis

309

2462

1.26

3.77

1.3

494.58

544.46

mg/l

1.03

294

2332

Benign neoplasm: Adrenal gland

597

1.54

3.76

1.3

550.67

549.60

mg/l

0.01

568

Specific developmental disorder of motor function

165

2.08

3.75

2.4

4.7

274.44

343.75

mg/l

0.97

159

Dental caries 2

1082

7532

1.13

3.74

1.6

1.3

469.80

520.51

mg/l

1.41

1051

7176

Encephalocele

9.25

3.74

2.1

1.6

1111.43

325.00

mg/l

—

Recurrent dislocation and subluxation of joint

615

1.53

3.69

1.3

1.4

447.67

482.32

mg/l

0.52

589

Melanocytic naevi of trunk

146

1053

1.40

3.68

1.2

1.3

506.70

513.01

mg/l

0.05

134

995

Dipeptidyl peptidase 4 (DPP-4) inhibitors

125

878

1.44

3.66

1.2

617.55

534.05

mg/l

1.00

119

827

Type 1 diabetes, wide definition, subgroup 1

277

2189

1.27

3.64

1.3

1.5

563.57

488.84

mg/l

1.58

263

2093

Congenital malformations of the circulatory system

192

1402

1.34

3.64

1.7

1.9

428.67

493.94

mg/l

2.10

182

1337

Palmar fascial fibromatosis [Dupuytren]

149

1080

1.39

3.63

1.2

1.3

584.50

576.06

mg/l

0.05

141

1017

Bulimia nervosa (incl. atypical)

314

1.75

3.63

1.2

1.4

403.63

400.42

mg/l

0.02

292

Other abnormalities of plasma proteins

2.45

3.61

1.6

1.3

689.55

467.29

mg/l

0.47

Dental caries 2 and operation codes

1061

7480

1.13

3.59

1.6

1.3

468.02

520.91

mg/l

1.47

1032

7128

Erosion of teeth, including avohilmo

260

1975

1.28

3.59

1.6

1.3

430.65

494.81

mg/l

2.41

251

1884

Other and unspecified disorders of vitreous body

444

3683

1.20

3.55

1.3

611.13

561.08

mg/l

0.25

428

3487

Other diseases of arteries and capillaries

102

694

1.48

3.54

1.3

566.57

554.12

mg/l

0.08

651

Allergic urticaria

108

744

1.47

3.53

1.8

1.7

447.14

505.59

mg/l

0.76

701

Type 2 diabetes, strict (exclude DM1)

1264

6758

1.12

3.52

1.3

607.16

532.72

mg/l

1.68

1192

6452

Cardiac murmurs and other cardiac sounds

121

842

1.43

3.51

1.9

1.7

421.29

500.30

mg/l

1.48

115

795

Injury of other and unspecified intrathoracic organs

487

1.58

3.50

1.4

1.3

579.39

549.42

mg/l

0.14

458

Bitten or struck by other mammals

142

1030

1.39

3.49

1.2

1.4

464.44

482.21

mg/l

0.10

136

981

Other disorders of the genitourinary system

138

996

1.40

3.48

1.3

604.34

519.94

mg/l

0.57

128

943

Diabetic retinopathy, strict definition

183

1211

1.34

3.45

1.2

1.3

575.95

603.31

mg/l

0.21

173

1147

Salpingitis and oophoritis

212

1635

1.30

3.44

1.5

1.3

485.96

513.02

mg/l

0.33

200

1564

Sequelae of injuries of upper limb

123

873

1.42

3.43

1.3

1.4

494.06

539.72

mg/l

0.53

117

831

Other predominantly sexually transmitted diseases, not elsewhere classified

233

1820

1.29

3.43

1.3

546.54

466.76

mg/l

0.71

225

1733

Overexertion and strenuous or repetitive movements

128

915

1.41

3.43

1.4

1.3

513.80

520.97

mg/l

0.06

123

866

Burkitt lymphoma, helper endpoint

8.13

3.43

4.3

2.5

222.43

496.36

mg/l

—

Burkitt lymphoma

8.13

3.43

4.3

2.5

222.43

496.36

mg/l

—

Open wound of forearm

111

774

1.45

3.41

1.2

1.4

496.30

526.22

mg/l

0.26

105

731

Pregnancy with abortive outcome

874

4008

1.14

3.39

1.3

501.30

476.58

mg/l

0.29

829

3814

Chronic hepatitis, not elsewhere classified

261

1.79

3.38

1.4

1.3

575.70

513.98

mg/l

0.18

247

Diseases of arteries, arterioles and capillaries

741

4812

1.15

3.38

1.3

613.13

555.49

mg/l

0.54

702

4572

Anorexia (incl.atypical)

548

1.53

3.36

1.2

1.4

431.42

464.70

mg/l

0.32

521

Endometriosis ASRM stages 1,2

232

1819

1.28

3.33

1.3

422.10

463.46

mg/l

0.96

215

1736

Seborrhoeic dermatitis

109

762

1.44

3.32

1.6

1.4

561.07

526.89

mg/l

0.32

101

720

Diabetes, insulin treatment (Kela reimbursement)

1352

7467

1.11

3.28

1.3

1.4

610.72

539.12

mg/l

1.63

1283

7112

Unspecified nephritic syndrome

163

2.00

3.28

1.3

1.2

458.22

454.29

mg/l

0.03

151

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

153

1135

1.36

3.28

1.3

536.67

552.43

mg/l

0.11

145

1071

Crohn's disease NAS

585

1.50

3.25

1.4

1.5

505.94

496.23

mg/l

0.06

552

Convalescence

394

1.62

3.24

1.3

909.98

494.41

mg/l

0.46

374

Infections of genitourinary tract in pregnancy

127

917

1.40

3.24

1.3

407.20

467.14

mg/l

1.78

122

866

Rhabdomyosarcoma

9.00

3.21

1.2

3.1

211.67

465.75

mg/l

—

Other and unspecified epidermal thickening

207

1.87

3.21

1.7

1.5

498.16

475.51

mg/l

0.17

195

Abnormal results of function studies

100

693

1.46

3.21

1.3

1.5

435.12

528.99

mg/l

3.01

664

Female infertility, cervigal, vaginal, other or unspecified origin

371

2050

1.22

3.19

1.3

454.53

500.64

mg/l

0.55

353

1965

Otitis externa, unspecified

136

996

1.38

3.18

1.2

1.4

465.54

511.18

mg/l

1.08

129

943

Motor disorders

179

1.95

3.18

2.4

4.7

274.44

407.48

mg/l

1.48

174

Other disorders of breast

152

1133

1.35

3.18

1.3

409.49

486.71

mg/l

2.39

145

1078

Other contact dermatitis

686

1.46

3.18

1.2

1.3

449.98

507.53

mg/l

1.09

657

Arthropod-borne viral fevers and viral haemorrhagic fevers

113

803

1.42

3.17

1.5

1.3

531.76

534.91

mg/l

0.02

108

759

Type 2 diabetes, definitions combined, including avohilmo

1268

6768

1.11

3.16

1.3

607.24

530.78

mg/l

1.76

1200

6462

5-aminosalicylic acid

257

2054

1.26

3.16

1.3

517.46

506.55

mg/l

0.12

246

1957

Other histiocytosis syndromes

8.45

3.16

1.2

1.3

732.67

302.75

mg/l

—

Coeliac disease

153

1143

1.35

3.15

1.4

1.5

503.12

506.06

mg/l

0.02

147

1080

Other specified and unspecified retinal disorders

260

1.76

3.14

2.5

1.3

425.97

484.98

mg/l

0.86

243

Rosacea

134

982

1.38

3.13

1.4

1.2

455.24

512.01

mg/l

1.30

127

931

ILD, hospital admission 2, with pulmonary infections

598

1.48

3.12

1.2

1.3

828.48

567.54

mg/l

0.38

570

L04AC Interleukin inhibitors

438

1.57

3.12

1.2

1.3

996.43

503.26

mg/l

0.40

410

Spontaneous rupture of synovium and tendon

582

1.49

3.11

1.3

876.65

533.84

mg/l

0.54

548

Torticollis

112

2.19

3.10

1.3

1.4

569.08

472.58

mg/l

0.28

107

Ulcer of lower limb, not elsewhere classified

133

975

1.37

3.09

1.3

825.31

550.10

mg/l

0.73

124

915

Viral conjunctivitis

167

1.95

3.08

1.3

1.6

402.63

461.62

mg/l

0.83

157

Thyrotoxicosis

284

2303

1.24

3.08

1.4

1.3

618.56

514.04

mg/l

0.62

268

2195

Benign neoplasm: Sigmoid colon

180

1382

1.31

3.07

1.4

1.3

506.35

544.40

mg/l

0.46

164

1300

Other noninflammatory disorders of vagina

650

1.46

3.06

1.8

1.3

588.76

506.92

mg/l

0.35

632

Benign neoplasm: Rectum, anus and anal canal

196

1523

1.29

3.05

1.3

519.79

558.57

mg/l

0.48

181

1437

Glucosamine medication

514

3508

1.17

3.04

1.3

593.94

566.57

mg/l

0.23

490

3315

Alcoholic liver disease

110

784

1.41

3.04

1.2

1.3

548.25

560.07

mg/l

0.06

104

739

Intentional self-harm by other and unspecified firearm discharge

10.78

3.03

2.6

1.2

377.20

416.40

mg/l

—

Injury of muscle and tendon at wrist and hand level

160

1212

1.33

3.02

1.3

518.79

521.97

mg/l

0.03

149

1156

L02BA Anti-estrogens

101

1417

0.71

3.01

1.3

549.38

499.32

mg/l

0.50

1355

Thyroiditis

596

1.47

2.99

1.5

1.3

728.77

512.71

mg/l

0.37

568

Galactorrhea

2.34

2.99

1.4

1.3

306.20

372.81

mg/l

1.46

Pregnancy examination and test

231

1139

1.27

2.97

1.3

1.2

419.33

402.76

mg/l

0.27

225

1079

Unspecified kidney failure

639

1.45

2.94

1.5

1.3

825.77

548.72

mg/l

0.46

599

Sub-endpoint used in defining T1D endpoints

351

2873

1.21

2.94

1.4

1.5

576.81

511.12

mg/l

1.21

333

2733

Ovarian dysfunction

103

732

1.42

2.92

1.2

1.3

394.03

450.76

mg/l

0.96

690

Benign lipomatous neoplasm

321

2654

1.21

2.90

1.3

535.35

523.39

mg/l

0.14

305

2509

Type 1 diabetes, wide definition

282

2302

1.23

2.87

1.3

1.5

559.63

484.61

mg/l

1.64

268

2198

Other abnormal findings of blood chemistry

337

1.62

2.85

1.6

1.3

858.89

497.44

mg/l

0.35

316

Bacterial, viral and other infectious agents

111

803

1.39

2.85

1.3

1.5

468.90

522.13

mg/l

0.83

101

763

Complications predominantly related to the puerperium

331

2752

1.21

2.84

1.3

422.52

465.90

mg/l

1.32

319

2625

IBD patients in KELA-register

293

2408

1.22

2.83

1.4

507.33

509.91

mg/l

0.03

284

2294

Toxic effect of organic solvents

4.10

2.82

1.3

485.56

634.35

mg/l

—

Abscess of anal and rectal regions

103

737

1.41

2.82

1.4

604.29

531.88

mg/l

0.52

698

Bronchitis, not specified as acute or chronic

100

712

1.42

2.81

1.2

1.4

452.78

525.68

mg/l

1.33

672

Allergic rhinitis

415

3490

1.18

2.80

1.3

1.5

417.62

473.91

mg/l

2.05

399

3327

Other and unspecified iridocyclitis

339

1.61

2.79

1.3

1.4

419.02

483.23

mg/l

1.41

321

Acne

138

1036

1.34

2.79

1.5

441.58

434.44

mg/l

0.07

131

977

Drug-induced hypoglycaemia without coma

104

2.16

2.78

1.1

1.4

451.14

451.90

mg/l

0.00

Other bursopathies

131

978

1.35

2.75

1.3

523.94

531.74

mg/l

0.07

124

925

Other coagulation defects

599

1.45

2.74

1.4

472.91

488.66

mg/l

0.15

569

COPD, hospital admissions 1, only main diagnosis

228

2409

0.80

2.74

1.2

1.3

507.67

573.65

mg/l

1.52

213

2275

Lichen planus

140

1058

1.33

2.72

1.4

1.3

531.39

537.79

mg/l

0.07

132

996

Acute peritonitis

469

1.51

2.72

1.4

1.3

471.75

527.30

mg/l

0.89

444

Autoimmune hyperthyroidism

437

1.52

2.71

1.5

1.3

472.79

504.07

mg/l

0.29

415

Hypertrophy of breast in women and men

233

1881

1.25

2.69

1.5

1.3

463.85

496.14

mg/l

0.52

220

1786

Schizoid personality disorder

126

2.02

2.69

1.0

1.2

650.24

470.49

mg/l

0.58

119

Diaper [napkin] dermatitis

5.15

2.69

1.3

5.9

375.57

681.87

mg/l

—

Other inherited muscular atrophy

5.10

2.68

7.9

1.3

325.71

385.00

mg/l

—

Hallux valgus (acquired)

380

2320

1.19

2.67

1.3

673.02

528.35

mg/l

0.83

361

2205

Hallux rigidus

144

1096

1.32

2.67

1.3

652.83

504.01

mg/l

1.15

136

1039

Myocardial infarction

427

3584

0.85

2.67

1.3

599.88

578.92

mg/l

0.17

402

3406

Foreign body entering into or through eye or natural orifice

101

729

1.40

2.65

1.5

1.6

509.89

525.62

mg/l

0.15

684

Diabetic nephropathy

151

1143

1.31

2.65

1.4

1.3

738.83

609.75

mg/l

0.43

143

1080

Benign neoplasm: Rectum

173

1351

1.29

2.65

1.3

527.18

547.60

mg/l

0.21

159

1272

Acne vulgaris

112

823

1.37

2.64

1.5

452.49

440.03

mg/l

0.10

106

778

Allergic contact dermatitis

160

1239

1.30

2.62

1.3

1.4

495.37

491.80

mg/l

0.03

154

1175

Blepharochalasis

285

2356

1.21

2.62

1.3

535.14

548.33

mg/l

0.12

274

2216

Hyperparathyroidism

169

1302

1.29

2.62

1.3

548.96

557.31

mg/l

0.04

158

1225

Unspecified severe protein-energy malnutrition

5.94

2.61

3.7

1.1

310.00

560.64

mg/l

—

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

383

2946

0.85

2.60

1.3

549.17

516.66

mg/l

0.45

365

2797

Malignant neoplasm of other connective and soft tissue

156

1.89

2.60

1.0

1.3

644.28

481.61

mg/l

1.05

148

Malignant melanoma, excluding all cancers (controls excluding all cancers)

169

1320

1.29

2.59

1.3

1.2

552.07

540.22

mg/l

0.11

157

1243

Psoriatic and enteropathic arthropathies

133

1006

1.33

2.59

1.2

1.3

488.40

508.69

mg/l

0.25

126

951

Hypertrichosis

178

1.83

2.59

1.2

1.3

408.78

426.24

mg/l

0.10

167

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

383

2945

0.85

2.59

1.3

549.17

516.65

mg/l

0.45

365

2796

Gonarthrosis,primary

1068

6082

1.11

2.57

1.3

580.33

570.31

mg/l

0.12

1014

5799

Other inflammatory liver diseases

533

1.46

2.56

1.3

1.4

470.01

512.57

mg/l

0.73

504

Benign neoplasm: Rectum, anus and anal canal

196

1562

1.26

2.55

1.3

519.79

543.94

mg/l

0.37

181

1473

Abnormal findings in nipple discharge synovial fluid wound secretions

115

2.04

2.54

1.3

402.43

446.67

mg/l

0.32

109

Asthma mixed form (mode), excluding more controls

379

1.54

2.54

1.3

1.4

485.36

501.78

mg/l

0.09

357

Benign neoplasm: Colon, unspecified

233

1885

1.24

2.53

1.2

1.3

680.06

553.19

mg/l

0.52

222

1772

Malignant neoplasm of bronchus and lung

1177

0.72

2.52

1.3

1.2

842.57

588.36

mg/l

0.41

1093

Female infertility, associated with anovulation

103

753

1.38

2.52

1.3

489.93

428.45

mg/l

0.22

731

Other diseases of lip and oral mucosa

174

1370

1.28

2.52

1.6

1.3

515.17

544.04

mg/l

0.28

160

1301

Asthma mixed form (mode)

380

1.54

2.51

1.3

1.4

485.36

504.72

mg/l

0.11

359

Insulin, fast-acting (human)

177

1397

1.27

2.51

1.2

1.4

542.51

493.80

mg/l

0.56

167

1332

Other congenital malformations of brain

2.67

2.50

1.5

4.3

426.23

429.94

mg/l

0.01

Other and unspecified vascular occlusions

619

1.42

2.49

1.4

1.2

508.35

562.83

mg/l

0.68

579

Hypertrophy of (infrapatellar) fat pad

2.44

2.49

1.7

1.5

383.73

436.47

mg/l

0.33

Lesion of femoral nerve

2.63

2.48

1.1

1.2

472.00

461.48

mg/l

0.07

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

144

1109

1.31

2.48

1.3

1.2

538.72

524.11

mg/l

0.15

134

1038

Disease of hard tissues of teeth, NOS

2.34

2.44

1.2

1.3

467.69

498.83

mg/l

0.19

Inflammatory bowel disease, strict (require KELA)

293

2449

1.20

2.43

1.4

1.3

507.33

505.08

mg/l

0.02

284

2330

Hernia of abdominal wall

507

4427

1.15

2.43

1.4

1.3

495.53

560.83

mg/l

2.29

489

4221

Acute pancreatitis

208

1680

1.24

2.43

1.9

1.3

499.72

548.37

mg/l

0.54

197

1594

Female infertility

403

2127

1.17

2.42

1.3

458.22

505.25

mg/l

0.60

383

2039

Gout, idiopatic and unspecified

226

1845

1.23

2.39

1.3

665.48

563.98

mg/l

1.46

218

1745

Mental and behavioural disorders due to tobacco

727

1.37

2.38

1.3

559.56

524.48

mg/l

0.19

692

Non-small cell lung cancer, squamous, helper endpoint

265

0.41

2.38

1.6

1.2

665.55

589.68

mg/l

0.24

247

Non-small cell lung cancer, squamous

265

0.41

2.38

1.6

1.2

665.55

589.68

mg/l

0.24

247

Spontaneous abortion

573

3426

1.14

2.38

1.3

505.45

478.99

mg/l

0.22

550

3268

Smoking dependency

728

1.37

2.36

1.3

559.56

518.51

mg/l

0.23

690

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

264

0.41

2.36

1.6

1.2

665.55

618.02

mg/l

0.11

242

Benign neoplasm: Sigmoid colon

180

1436

1.26

2.36

1.4

1.2

506.35

546.60

mg/l

0.64

164

1354

Seronegative rheumatoid arthritis

121

917

1.33

2.36

1.2

1.3

638.14

505.88

mg/l

1.01

113

868

Dysplasia of cervi uteri

300

1945

1.20

2.35

1.2

1.3

529.34

504.85

mg/l

0.14

286

1867

Contraceptive management

560

3460

1.14

2.35

1.3

466.87

510.82

mg/l

1.21

536

3305

Other disorders of conjunctiva

143

1110

1.30

2.34

1.2

1.3

730.32

527.10

mg/l

0.55

137

1043

Benign neoplasm of other and unspecified sites

245

1.65

2.33

1.2

609.80

493.13

mg/l

0.41

232

Hirsutism in women

155

1.84

2.33

1.2

1.4

423.11

391.99

mg/l

0.19

145

Follicular cysts of skin and subcutaneous tissue

207

1681

1.24

2.32

1.4

1.3

585.31

521.73

mg/l

0.29

199

1596

Personal history of other diseases and conditions

147

1142

1.29

2.32

1.7

1.6

485.38

451.76

mg/l

0.20

142

1098

Lupus erythematosus

185

1.76

2.31

1.4

1.2

420.50

477.43

mg/l

0.61

173

Acute pancreatitis (for exclusion)

208

1691

1.24

2.31

1.9

1.3

499.72

533.32

mg/l

0.36

197

1603

Medicines for HER+ breast cancer

276

3206

0.84

2.30

1.3

573.55

533.82

mg/l

0.33

262

3051

Other and unspecified psoriasis

537

1.43

2.30

1.3

502.09

523.05

mg/l

0.21

502

ILD, hospital admissions 3, with pneumonia sepsis

520

1.43

2.30

1.2

1.3

896.42

545.76

mg/l

0.44

487

Benign lipomatous neoplasm

321

2720

1.18

2.30

1.3

535.35

534.94

mg/l

0.00

305

2589

Other abnormal products of conception

415

2382

1.16

2.30

1.2

1.3

444.27

456.61

mg/l

0.16

399

2271

Chronic inflammatory disorders of orbit

4.11

2.30

1.4

1.2

407.43

402.22

mg/l

—

Calcific tendinitis

2.61

2.29

1.2

495.08

431.07

mg/l

0.29

Perineal laceration during delivery

144

1637

0.78

2.29

1.2

1.3

458.29

400.52

mg/l

0.77

136

1557

Human immunodeficiency virus [HIV] disease

149

1.84

2.27

1.1

1.3

500.48

507.54

mg/l

0.04

142

Ulcerative colitis

293

2467

1.19

2.27

1.2

1.4

501.13

516.69

mg/l

0.21

280

2346

Benign neoplasm: Colon, unspecified

233

1922

1.22

2.25

1.2

1.3

680.06

571.22

mg/l

0.43

222

1818

Other and unspecified abdominal hernia

287

1.59

2.24

1.1

1.4

493.60

500.69

mg/l

0.04

269

Enteritis due to Yersinia enterocolitica

2.88

2.24

1.6

1.8

469.30

443.58

mg/l

—

Chronic pancreatitis

131

1013

1.30

2.23

1.2

1.3

540.56

545.37

mg/l

0.04

125

960

Prolonged pregnancy

127

1494

0.77

2.22

1.2

1.3

358.51

418.38

mg/l

2.76

119

1429

Hordeolum and other deep inflammation of eyelid

442

1.46

2.21

2.2

1.4

523.46

494.44

mg/l

0.24

422

Malignant neoplasm of rectosigmoid junction, excluding all cancers (controls excluding all cancers)

213

0.42

2.20

1.2

1.3

643.44

508.22

mg/l

—

202

Malignant neoplasm of breast

433

3588

0.87

2.20

1.3

546.88

537.17

mg/l

0.11

412

3422

Ischemic heart diseases

939

5340

1.10

2.20

1.3

558.76

573.55

mg/l

0.15

893

5089

Bicipital tendinitis

353

1.52

2.18

1.3

1.2

488.34

541.43

mg/l

0.50

333

Combinations of oral blood glucose lowering drugs

299

2535

1.18

2.16

1.3

776.84

560.38

mg/l

1.24

289

2417

Wide developmental disorders, excluding more controls

217

1.66

2.16

1.4

2.6

354.14

428.17

mg/l

0.67

206

Psoriasis

320

2730

1.18

2.14

1.2

1.3

476.36

520.03

mg/l

1.34

299

2602

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

598

3628

1.13

2.14

1.3

595.90

550.91

mg/l

0.74

563

3440

Postmenopausal bleeding

301

1394

1.19

2.14

1.4

1.3

485.08

574.99

mg/l

1.52

284

1335

Hypothyroidism, autoimmune, DX-based

3.03

2.11

1.2

1.9

381.78

340.29

mg/l

—

Lichen simplex chronicus and prurigo

488

1.43

2.11

1.6

1.2

662.00

511.61

mg/l

0.64

464

2.18

2.11

1.4

1.2

512.75

494.62

mg/l

0.07

Drug-induced obesity

2.13

2.11

1.1

1.7

503.18

420.22

mg/l

0.34

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

127

1356

0.78

2.10

1.2

1.3

752.68

551.34

mg/l

0.46

120

1272

Need for immunization against certain single viral diseases

4.31

2.09

1.5

2.3

472.00

306.60

mg/l

—

Disorder of visual pathways, unspecified

4.30

2.09

1.3

3.4

2317.83

314.73

mg/l

—

Dental caries 2, only avohilmo

1033

7463

1.09

2.09

1.4

457.24

520.71

mg/l

2.20

1002

7113

Blood alcohol or alcohol intoxication level

191

1.70

2.09

1.3

718.31

490.72

mg/l

0.35

180

Drug-induced osteoporosis with pathological fracture

110

1.95

2.08

2.4

1.2

1743.43

523.01

mg/l

0.50

103

Flat foot [pes planus] (acquired)

100

753

1.34

2.08

1.2

1.5

477.05

490.27

mg/l

0.15

715

Benign neoplasm: Other/unspecified site

110

1.94

2.08

1.4

1.2

690.29

484.56

mg/l

0.38

103

Adalimumab

110

841

1.32

2.07

1.4

1.5

513.96

505.29

mg/l

0.05

102

798

Valvular operations

1167

0.74

2.06

1.1

1.5

718.40

528.62

mg/l

1.35

1103

Iron deficiency

169

1.74

2.06

1.4

1.9

397.29

422.11

mg/l

0.18

160

Benign neoplasm: Rectum

173

1399

1.24

2.06

1.3

1.2

527.18

549.43

mg/l

0.30

159

1318

Benign neoplasm of other and unspecified sites

255

1.59

2.03

1.2

1.3

609.80

478.71

mg/l

0.48

240

DVT of lower extremities

186

1520

1.23

2.01

1.3

524.41

540.55

mg/l

0.18

178

1441

Other overlap syndromes

148

1.79

2.01

1.9

1.2

620.27

463.12

mg/l

0.69

139

Acute nasopharyngitis (common cold)

139

1094

1.27

2.00

1.7

1.3

475.21

536.24

mg/l

1.44

132

1055

Pedal cyclist injured in transport accident

261

2206

1.19

1.99

1.3

1.4

587.47

500.84

mg/l

0.49

253

2091

Assault by other and unspecified firearm discharge

4.04

1.99

2.2

1.6

421.67

527.81

mg/l

—

Benign neoplasm: Caecum

742

1.33

1.98

1.3

1.2

773.92

516.23

mg/l

0.45

687

Biological medication for rheuma

190

1560

1.22

1.98

1.3

1.4

685.13

495.85

mg/l

0.44

175

1488

Peritonsillar abscess

253

2134

1.19

1.97

1.3

515.06

495.87

mg/l

0.08

241

2043

Malignant neoplasm of breast, HER-positive

260

3023

0.85

1.97

1.3

540.56

539.08

mg/l

0.01

246

2875

Umbilical hernia

295

2522

1.17

1.96

1.4

1.3

482.30

534.62

mg/l

1.50

289

2404

Ulcerative colitis, NAS

163

1320

1.24

1.94

1.3

1.4

466.20

502.16

mg/l

0.52

154

1256

Other (seronegative) rheumatoid arthritis, wide

196

1618

1.22

1.94

1.3

606.38

529.57

mg/l

0.80

183

1537

Seropositive rheumatoid arthritis

259

2189

1.18

1.92

1.3

781.74

518.09

mg/l

0.84

245

2075

Benign neoplasm: Transverse colon

747

1.32

1.91

1.3

1.2

476.22

500.59

mg/l

0.38

693

Disorders of puberty

121

1.85

1.90

1.2

3.0

490.14

446.96

mg/l

0.13

113

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

268

2280

1.18

1.90

1.4

1.3

553.64

541.25

mg/l

0.15

253

2179

Dronedarone medication

239

0.45

1.90

1.1

1.3

739.55

545.38

mg/l

0.46

225

Other disorders of kidney and ureter

129

1020

1.27

1.90

1.3

1.4

665.13

542.45

mg/l

0.86

122

961

Other and unspecified rosacea

722

1.33

1.89

1.4

1.3

464.46

516.18

mg/l

1.11

682

Other otitis externa (chronic)

533

1.38

1.89

1.2

1.5

471.68

510.90

mg/l

0.32

503

Malignant neoplasm of breast, HER2-negative

421

3516

0.88

1.89

1.3

550.80

532.14

mg/l

0.24

400

3352

Kidney transplant status

466

1.41

1.88

1.5

1.7

567.14

522.96

mg/l

0.38

441

Toxic liver disease

100

1.93

1.87

1.6

1.4

521.74

441.61

mg/l

0.61

Other obstructive and reflux uropathy

342

1.48

1.86

1.2

1.5

448.11

485.84

mg/l

0.29

324

Benign neoplasm: Ascending colon

123

970

1.27

1.86

1.3

1.2

783.58

525.44

mg/l

0.59

115

907

Contact with heat and hot substances

459

1.41

1.85

1.3

1.6

474.19

501.27

mg/l

0.22

428

Deep endometriosis

110

856

1.29

1.85

1.2

1.3

381.12

488.52

mg/l

3.61

105

816

Hypertrophy of breast

197

1636

1.21

1.85

1.4

1.3

434.46

485.58

mg/l

0.89

185

1558

Nasal polyp

200

1663

1.21

1.85

1.3

551.97

531.92

mg/l

0.18

188

1585

Pregnancy hypertension

525

4225

1.12

1.85

1.3

462.76

487.75

mg/l

0.40

507

4032

Other endophthalmitis

2.65

1.83

1.2

1.8

461.78

448.03

mg/l

—

Colour vision deficiencies

3.13

1.82

1.1

1.3

383.29

487.13

mg/l

—

Thyrotoxicosis with diffuse goitre

153

1241

1.24

1.82

1.5

1.3

471.65

486.93

mg/l

0.21

143

1178

Benign neoplasm: Skin, unspecified

339

0.55

1.82

1.3

1.2

616.84

511.90

mg/l

0.17

318

Pedal cyclist injured in noncollision transport accidents

130

1036

1.26

1.81

1.3

1.5

580.10

521.46

mg/l

0.28

125

980

Benign neoplasm: Other/unspecified site

116

1.84

1.81

1.4

1.3

690.29

493.15

mg/l

0.36

107

Fall on and from ladder

590

1.35

1.79

1.2

1.3

519.58

556.57

mg/l

0.44

550

FESS (DNB20)

143

1154

1.25

1.79

1.3

575.47

522.49

mg/l

0.39

135

1095

Psoriatic arthropathies

108

843

1.29

1.78

1.3

1.4

485.92

503.61

mg/l

0.18

102

797

Vitamin B12 deficiency anaemia

764

1.30

1.78

1.3

476.60

559.86

mg/l

1.80

718

Benign neoplasm: Other and unspecified parts of mouth

256

1.54

1.78

1.4

1.3

599.54

490.68

mg/l

0.64

243

3.49

1.77

1.0

1.2

307.67

331.28

mg/l

—

Pedestrian injured in other and unspecified transport accidents

2.01

1.77

1.1

1.2

515.25

454.53

mg/l

0.29

Burn and corrosion of shoulder and upper limb, except wrist and hand

147

1.72

1.76

1.5

1.6

472.04

455.41

mg/l

0.07

142

Chronic periodontitis, complicated

100

775

1.30

1.75

1.5

1.3

665.59

546.42

mg/l

0.47

731

Pilonidal cyst

105

819

1.29

1.75

1.4

626.83

503.54

mg/l

0.87

100

781

Lichen sclerosus et atrophicus

100

775

1.30

1.75

1.4

1.3

608.07

514.56

mg/l

0.47

737

Atrophic disorders of skin

151

1229

1.23

1.75

1.5

1.3

549.04

525.77

mg/l

0.14

144

1167

Ventral hernia

235

1997

1.18

1.72

1.4

1.3

502.60

537.18

mg/l

0.53

226

1893

Fracture of femur

219

1687

1.19

1.72

1.4

1.3

607.38

562.14

mg/l

0.29

205

1593

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

715

5314

1.10

1.72

1.3

487.26

503.54

mg/l

0.22

682

5070

Benign neoplasm: Skin, unspecified

333

0.57

1.72

1.3

1.2

616.84

482.83

mg/l

0.23

312

Intestinal adhesions without obstruction

631

1.32

1.68

1.2

1.4

527.08

562.60

mg/l

0.30

592

2.08

1.67

1.2

390.36

427.95

mg/l

0.31

Malignant melanoma

139

1128

1.24

1.67

1.3

552.23

543.61

mg/l

0.09

130

1060

Diabetes mellitus in pregnancy

422

2424

1.13

1.66

1.3

467.02

431.40

mg/l

0.48

410

2313

Helminthiases

127

1.76

1.66

1.3

1.7

682.64

425.42

mg/l

1.40

120

Benign neoplasm: Other and unspecified parts of mouth

261

1.51

1.65

1.4

1.3

599.54

504.87

mg/l

0.52

249

Other/unspecified rheumatoid arthritis

120

960

1.26

1.64

1.3

519.90

533.21

mg/l

0.15

113

903

Benign neoplasm: Ascending colon

123

987

1.25

1.64

1.3

1.2

783.58

551.32

mg/l

0.52

115

927

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system

3.77

1.64

3.2

1.4

781.00

496.79

mg/l

—

Correction of physiology of bite - very demanding therapy visit

237

1.54

1.64

1.2

1.4

371.89

468.65

mg/l

1.95

222

Persons encountering health services in circumstances related to reproduction

769

4771

1.09

1.64

1.5

1.4

497.12

536.76

mg/l

0.73

731

4554

Impacted cerumen

739

1.29

1.64

1.5

1.6

778.24

539.36

mg/l

0.58

695

Perioral dermatitis

174

1.63

1.4

440.00

415.16

mg/l

0.12

161

Atrial fibrillation and flutter with reimbursement

264

1454

1.17

1.61

1.3

1.2

575.57

532.36

mg/l

0.55

244

1372

Other and unspecified heterotropia

2.82

1.61

1.1

2.4

314.71

459.23

mg/l

—

Hydronephrosis

108

856

1.27

1.61

1.4

1.3

471.73

530.11

mg/l

0.83

101

811

Seborrhoeic keratosis

208

1767

1.18

1.57

1.4

1.3

572.35

561.20

mg/l

0.09

200

1670

Other disorders of amniotic fluid and membranes

169

1399

1.20

1.54

1.2

1.3

391.89

427.55

mg/l

0.99

164

1339

Other disorders of veins

427

3816

1.12

1.54

1.2

1.3

558.48

514.79

mg/l

0.52

410

3629

Benign neoplasm: Caecum

773

1.28

1.54

1.3

773.92

559.01

mg/l

0.36

722

Infective dermatitis

119

961

1.24

1.53

1.3

771.06

524.25

mg/l

0.64

113

907

Malignant neoplasm of skin

611

4186

1.10

1.52

1.3

588.83

555.33

mg/l

0.59

576

3962

Malignant neoplasm of prostate

295

2132

0.87

1.52

1.3

602.30

609.68

mg/l

0.08

273

2028

Lichen ruber planus, wide definition including periferal and oral lichen planus

213

1819

1.18

1.52

1.3

506.71

551.28

mg/l

0.77

201

1727

Urticaria due to cold and heat

1.99

1.51

1.1

1.3

454.64

390.57

mg/l

0.58

Early onset COPD

227

1950

1.17

1.50

1.3

522.57

558.71

mg/l

0.63

210

1847

Ethmoidectomy

146

1207

1.22

1.50

1.3

1.4

571.88

518.54

mg/l

0.40

138

1147

Endometriosis diagnosis and infertility diagnosis occurring together

130

1063

1.23

1.50

1.4

1.2

446.16

450.67

mg/l

0.04

121

1018

Ischaemic heart disease, wide definition

907

5255

1.08

1.49

1.3

563.60

576.43

mg/l

0.13

862

5007

Gout, strict definition

148

1226

1.21

1.49

1.3

705.12

556.23

mg/l

1.81

143

1154

Lichen planus, including avohilmo

183

1547

1.19

1.48

1.4

1.3

521.64

537.94

mg/l

0.21

173

1464

Burns and corrosions confined to eye and internal organs

219

1.52

1.47

1.2

1.4

2003.58

486.47

mg/l

0.46

208

Molar incisor enamel hypoplasia

304

1.43

1.46

7.8

2.8

483.73

385.13

mg/l

0.21

294

Trigger finger

138

1138

1.22

1.46

1.3

531.49

515.23

mg/l

0.19

132

1081

Gestational diabetes (for exclusion)

475

3028

1.11

1.46

1.3

464.13

427.98

mg/l

0.56

462

2888

Single delivery by forceps and vacuum extractor

144

1058

0.83

1.45

1.3

433.19

445.00

mg/l

0.10

139

1009

Primary open-angle glaucoma, strict

222

1906

1.17

1.45

1.4

1.3

566.81

mg/l

0.00

214

1789

Asymptomatic human immunodeficiency virus [HIV] infection status

2.36

1.45

1.1

1.3

561.89

453.72

mg/l

—

Benign neoplasm: Transverse colon

780

1.26

1.45

1.3

476.22

558.97

mg/l

1.93

729

COPD, early/later onset

356

3376

0.89

1.43

1.3

524.79

574.04

mg/l

1.31

330

3204

Chronic myeloproliferative disease

1.85

1.43

1.2

618.31

544.30

mg/l

0.14

Other and unspecified injuries of abdomen, lower back and pelvis

103

1.77

1.42

1.4

441.67

413.91

mg/l

0.18

Superficial injury of ankle and foot

142

1179

1.21

1.42

1.6

1.5

529.82

483.11

mg/l

0.32

137

1118

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

196

1620

1.18

1.41

1.4

1.8

443.05

488.51

mg/l

1.11

185

1543

Benign neoplasm of ovary

174

1472

1.19

1.41

1.3

475.48

527.60

mg/l

0.77

163

1406

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

1.88

1.41

1.4

1.2

415.40

490.19

mg/l

0.48

Endometriosis of ovary

194

1652

1.18

1.41

1.3

480.74

529.18

mg/l

0.56

180

1589

Puerperal sepsis

142

1180

1.21

1.41

1.3

443.50

509.39

mg/l

1.23

136

1122

Malignant melanoma of skin

108

873

1.24

1.40

1.4

1.3

537.06

551.14

mg/l

0.14

103

822

L02BG Aromatase inhibitors

222

2565

0.86

1.40

1.2

1.3

567.54

550.04

mg/l

0.10

211

2435

Iron deficiency anaemia secondary to blood loss (chronic)

147

1226

1.20

1.40

1.5

1.3

523.49

535.80

mg/l

0.10

140

1156

Disorders of puberty, all

150

1.62

1.39

1.4

3.0

471.54

436.06

mg/l

0.12

141

Cerebral atherosclerosis

2.09

1.38

1.3

1.2

463.00

536.56

mg/l

0.37

Necrotizing fasciitis

3.00

1.37

1.0

1.3

498.40

368.65

mg/l

—

Chronic hepatitis NAS

1.78

1.36

1.2

743.18

418.42

mg/l

0.40

Postpartum care and examination

188

1020

1.18

1.36

1.2

453.31

394.73

mg/l

0.48

181

967

119

976

1.23

1.36

1.2

1.3

412.73

430.83

mg/l

0.20

113

933

Mucosal proctocolitis

145

1213

1.20

1.35

1.1

1.4

477.84

503.59

mg/l

0.32

140

1154

Phakomatoses, not elsewhere classified

1.81

1.35

1.2

2.5

480.00

415.99

mg/l

0.43

Disorder of thyroid, unspecified

1.81

1.34

1.4

1.3

394.69

529.18

mg/l

1.38

Other abnormal uterine and vaginal bleeding

252

1568

1.15

1.34

1.5

1.3

508.50

528.56

mg/l

0.20

230

1504

Endometriosis ASRM stages 3,4

261

2290

1.14

1.33

1.3

458.84

493.45

mg/l

0.56

243

2185

Dental caries 3 and operation codes, only avohilmo

450

2038

1.11

1.33

1.5

1.6

500.06

519.22

mg/l

0.23

423

1961

Foreign body in respiratory tract

428

1.34

1.32

2.2

1.7

423.79

505.02

mg/l

1.11

402

Disorders of continuity of bone

101

817

1.24

1.32

1.5

1.4

430.25

518.51

mg/l

2.24

776

Gestational [pregnancy-induced] hypertension

313

2775

1.13

1.32

1.2

1.3

440.18

448.64

mg/l

0.10

298

2650

Degeneration of macula and posterior pole

419

3116

1.11

1.31

1.3

548.52

566.20

mg/l

0.29

399

2933

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

568

4552

1.09

1.31

1.3

455.94

491.53

mg/l

0.71

550

4338

Benign neoplasm of ovary

174

1484

1.18

1.31

1.3

475.48

508.52

mg/l

0.42

163

1400

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

2.89

1.30

2.0

1.3

368.20

397.67

mg/l

—

Major coronary heart disease event excluding revascularizations

602

4523

0.92

1.30

1.3

573.76

571.44

mg/l

0.02

572

4299

Anoxic brain damage

1.91

1.29

1.5

1.2

430.38

474.08

mg/l

0.22

Other disorders of thyroid

1.74

1.29

1.6

1.3

442.47

465.62

mg/l

0.13

Atherosclerosis, excluding cerebral and coronary sclerosis

300

2700

0.89

1.29

1.3

669.17

563.18

mg/l

0.60

289

2551

Haemangioma, any site

686

1.26

1.28

1.2

472.77

486.33

mg/l

0.12

642

Viral warts

108

884

1.23

1.27

1.3

1.5

641.13

499.73

mg/l

0.36

102

838

Pre-eclampsia or eclampsia

255

2245

1.14

1.26

1.3

457.59

478.99

mg/l

0.24

247

2134

COPD, hospital admissions

355

3344

0.90

1.26

1.3

525.91

574.64

mg/l

1.27

329

3172

AV-block

158

1218

1.18

1.25

1.2

1.4

513.74

536.55

mg/l

0.37

152

1149

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

264

2425

0.88

1.25

1.3

538.47

528.07

mg/l

0.10

250

2298

Tumor necrosis factor alpha inhibitors

167

1427

1.17

1.24

1.3

1.4

719.63

494.06

mg/l

0.47

154

1363

Other benign neoplasms of skin

377

3334

1.11

1.24

1.2

1.3

533.43

519.45

mg/l

0.19

357

3154

Other menopausal disorders

317

1625

1.13

1.24

1.3

468.74

550.49

mg/l

1.23

300

1559

Coronary revascularization (ANGIO or CABG)

403

3108

0.90

1.23

1.3

599.88

583.49

mg/l

0.12

381

2952

Malignant neoplasm of testis

108

1.69

1.23

1.1

1.3

568.00

549.00

mg/l

0.11

103

Benign neoplasm: Descending colon

486

1.30

1.23

1.2

599.60

503.24

mg/l

0.56

450

Anorexia

116

1.66

1.23

4.1

1.6

498.21

411.16

mg/l

0.41

109

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

289

0.62

1.22

1.3

416.33

555.57

mg/l

2.12

267

Ectropion of eyelid

196

1.49

1.22

1.4

1.3

704.55

530.51

mg/l

0.70

184

Conotruncal defects

145

0.48

1.22

1.0

4.0

430.86

424.80

mg/l

—

138

Suggestive for eosinophilic asthma

763

1.24

1.21

1.2

1.3

595.60

522.62

mg/l

0.42

721

Human immunodeficiency virus [HIV] disease resulting in other conditions

140

1.59

1.21

1.1

1.3

536.50

499.23

mg/l

0.22

133

Barrett oesophagus

357

1.35

1.21

1.2

1.3

539.60

560.60

mg/l

0.12

330

Chondromalacia

230

1.45

1.20

1.3

602.00

503.95

mg/l

0.27

215

Polycystic ovarian syndrome, broad definition

136

1146

1.19

1.20

1.2

1.3

468.33

416.84

mg/l

0.25

129

1092

malignant neoplasm of male genital organs

313

2225

0.89

1.20

1.2

1.3

603.96

607.71

mg/l

0.04

291

2115

Entropion and trichiasis of eyelid

532

1.28

1.20

1.2

1.3

639.95

545.39

mg/l

0.51

496

Exposure to other and unspecified man-made environmental factors

117

1.64

1.19

1.1

1.2

497.00

433.22

mg/l

0.38

111

Need for immunization against single bacterial diseases

0.00

1.19

0.0

3.8

—

379.68

—

Nontoxic multinodular goitre

188

1628

1.16

1.19

1.3

1.4

485.26

521.42

mg/l

0.59

180

1534

Foreign body in ear

141

1.58

1.18

1.7

2.0

788.45

435.78

mg/l

0.67

134

Pre-eclampsia

238

2097

1.14

1.18

1.3

461.16

464.86

mg/l

0.03

231

1998

Paget disease

0.00

1.17

0.0

1.2

—

556.48

—

Use of levodopa decarbox-comt-inhibitor

216

1.45

1.14

1.6

1.2

480.81

551.50

mg/l

0.51

201

Lumbosacral root disorders, not elsewhere classified

1.77

1.14

1.9

1.2

354.57

464.08

mg/l

1.23

Exposure to other and unspecified animate mechanical forces

233

1.43

1.14

1.1

1.5

646.97

423.94

mg/l

0.39

219

Other benign neoplasms of skin

377

3422

1.10

1.12

1.2

1.3

533.43

534.94

mg/l

0.02

357

3241

Labyrinthitis

2.44

1.10

1.6

1.2

310.20

394.48

mg/l

—

Nontoxic goitre/thyroid nodule

297

2666

1.12

1.10

1.3

492.87

525.90

mg/l

0.67

283

2519

Other and unspecified disorders of orbit

2.24

1.09

1.4

1.2

559.86

431.09

mg/l

—

Malignant neoplasm of oesophagus

163

0.55

1.09

1.0

1.2

435.67

531.38

mg/l

—

151

Female infertility, tubal origin

425

1.30

1.09

1.2

1.3

485.06

461.90

mg/l

0.15

414

Congenital deformities of hip

177

1.49

1.09

1.7

2.8

360.12

415.60

mg/l

0.36

169

Use of ropinirole

287

1.37

1.08

1.3

541.28

542.38

mg/l

0.01

270

Malignant neoplasm of respiratory system and intrathoracic organs

126

1365

0.85

1.07

1.4

1.2

794.67

570.09

mg/l

0.54

121

1272

Ankyloglossia

169

1.49

1.07

2.4

3.5

451.12

392.62

mg/l

0.21

163

Hypoplasia of dental enamel, prenatal

2.01

1.06

6.8

4.9

1202.22

373.29

mg/l

—

Foreign body on external eye

162

1404

1.16

1.05

1.3

1.4

535.55

528.90

mg/l

0.07

152

1333

Contact with other sharp object(s)

597

1.25

1.05

1.3

1.4

448.07

507.99

mg/l

1.03

563

Polyp of the female genital tract

366

1932

1.10

1.05

1.2

1.3

580.65

531.59

mg/l

0.20

352

1856

Benign neoplasm of mouth and pharynx

104

869

1.20

1.05

1.3

1.2

585.95

488.79

mg/l

0.81

809

Congenital retinoschisis

2.34

1.04

1.2

2.5

435.60

404.59

mg/l

—

Malignant neoplasm, without specification of site

162

1.49

1.04

1.2

638.67

515.18

mg/l

0.29

152

Short Achilles tendon (acquired)

179

1.46

1.03

1.3

446.19

482.88

mg/l

0.26

170

Emergency coronary revascularization (for ACS)

448

3503

0.92

1.03

1.3

590.01

580.58

mg/l

0.07

425

3329

Other infections specific to the perinatal period

1.95

1.03

2.7

6.5

202.78

454.32

mg/l

—

Disorder of pancreatic internal secretion, other and/or unspecified

1.95

1.03

1.3

666.33

446.52

mg/l

—

Presence of cardiac and vascular implants and grafts

368

3056

0.91

1.03

1.2

1.3

569.69

586.42

mg/l

0.24

350

2903

Burn and corrosion confined to eye and adnexa

188

1.45

1.02

1.2

1.4

2353.33

464.45

mg/l

0.47

178

Eustachian salpingitis and obstruction

753

1.21

1.02

1.2

1.4

511.46

467.12

mg/l

0.39

722

Benign neoplasm: Descending colon

501

1.26

1.02

1.2

1.3

599.60

549.67

mg/l

0.24

468

Malignant neoplasm of liver and intrahepatic bile ducts

189

0.58

1.01

1.4

1.3

413.82

535.91

mg/l

1.13

176

Congenital malformations of the respiratory system

164

1.48

1.00

1.5

3.3

740.83

442.87

mg/l

0.37

158

Toxic effect of carbon monoxide

115

1.58

1.00

1.6

1.2

475.39

473.59

mg/l

0.01

109

Congenital malformations of aortic and mitral valves

356

0.70

1.00

1.4

2.1

423.68

500.67

mg/l

1.17

337

Primary open-angle glaucoma

266

2327

1.12

1.00

1.3

547.98

570.37

mg/l

0.29

256

2186

Basal cell carcinoma, including avohilmo

538

3926

1.08

1.00

1.3

584.46

561.12

mg/l

0.37

504

3715

Oral leukoplakia

131

0.53

1.00

1.1

1.2

444.71

521.64

mg/l

—

123

Congenital malformation syndromes predominantly affecting facial appearance

0.00

0.99

0.0

4.5

—

309.96

—

Malignant neoplasm of vagina, excluding all cancers (controls excluding all cancers)

0.00

0.99

0.0

1.1

—

397.30

—

Supervision of high-risk pregnancy

261

1412

1.12

0.99

1.2

472.56

434.38

mg/l

0.29

246

1344

Striae atrophicae

1.69

0.99

1.4

1.3

494.79

405.80

mg/l

0.37

Idiopathic urticaria

173

1.46

0.98

1.3

1.6

456.52

455.22

mg/l

0.01

163

Basal cell carcinoma

523

3861

1.08

0.98

1.3

588.95

560.10

mg/l

0.47

490

3651

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

204

1807

1.13

0.98

1.3

1.4

499.43

508.45

mg/l

0.09

198

1716

Benign neoplasm: Female genital organ, unspecified

0.00

0.98

0.0

1.3

—

339.92

—

COPD (mode)

279

1994

1.11

0.98

1.2

1.3

515.55

558.99

mg/l

0.84

260

1905

Childhood allergy (age < 16)

199

1448

1.14

0.97

1.6

1.8

415.33

417.47

mg/l

0.02

189

1379

Coxarthrosis, primary

585

4728

1.08

0.97

1.3

663.04

554.59

mg/l

1.25

546

4490

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

1.76

0.97

1.2

1.3

326.25

397.56

mg/l

1.11

Maternal care for other known or suspected fetal problems

305

1769

1.11

0.97

1.2

1.3

421.61

429.48

mg/l

0.08

295

1692

Other respiratory diseases principally affecting the interstitium

147

1275

1.16

0.96

1.3

747.51

564.66

mg/l

0.46

134

1197

Oesophageal obstruction

233

1.38

0.96

1.4

1.3

630.28

551.70

mg/l

0.20

218

Other interventions on the root canals of the tooth

141

1.51

0.96

1.4

1.5

459.29

399.80

mg/l

0.49

133

Bacterial sepsis of newborn

1.81

0.96

5.0

7.0

520.64

454.15

mg/l

0.15

Congenital malformation of biliary tract

2.30

0.95

1.2

5.0

241.17

400.63

mg/l

—

349

2998

1.10

0.95

1.3

644.62

555.45

mg/l

0.71

330

2817

Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)

246

0.65

0.95

1.0

1.2

527.94

523.69

mg/l

0.02

229

Antenatal screening

242

1521

0.89

0.94

1.3

1.2

420.28

427.81

mg/l

0.09

232

1450

Skin changes due to chronic exposure to nonionizing radiation

323

2783

1.10

0.93

1.3

660.83

559.21

mg/l

0.77

304

2614

Maternal care related to the fetus and amniotic cavity and possible delivery problems

570

3124

1.08

0.92

1.3

502.27

466.98

mg/l

0.22

546

2976

Retinal breaks without detachment

152

1327

1.15

0.92

1.3

469.03

541.35

mg/l

2.25

147

1253

Haemangioma and lymphangioma, any site

744

1.20

0.92

1.2

469.69

488.70

mg/l

0.18

696

Later onset COPD, excluding more controls

122

1106

0.86

0.92

1.2

1.3

517.38

528.81

mg/l

0.13

114

1049

Vitiligo

1.65

0.92

1.6

1.5

404.07

416.15

mg/l

0.06

Inflammatory disease of cervix uteri

510

1.24

0.90

1.8

1.3

526.14

500.08

mg/l

0.14

482

In situ neoplasms

350

3210

1.09

0.89

1.2

1.3

518.95

525.40

mg/l

0.07

333

3035

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, excluding all cancers (controls excluding all cancers)

1.63

0.88

1.6

1.3

460.00

468.72

mg/l

0.04

Pre-eclampsia or poor fetal growth

364

3338

1.09

0.88

1.2

1.3

436.19

462.15

mg/l

0.43

351

3185

Procedures for purposes other than remedying health state

186

1.41

0.88

1.6

1.3

422.46

470.68

mg/l

0.47

175

Sulfonylureas

265

2333

0.90

0.87

1.2

1.3

786.81

539.88

mg/l

1.30

249

2208

Benign neoplasm: Skin of ear and external auricular canal

281

1.32

0.87

1.4

1.3

697.71

487.60

mg/l

0.79

261

Haemangioma, any site

722

1.20

0.87

1.2

1.5

472.77

518.12

mg/l

0.49

685

Artificial joint operation, meniscal resection

1074

6803

1.05

0.86

1.3

574.70

561.00

mg/l

0.17

1015

6496

Hypoplasia of dental enamel , including avohilmo

287

1.32

0.86

8.9

2.8

295.11

387.33

mg/l

1.55

279

Use of rasagiline

187

1.40

0.86

1.5

1.2

474.12

549.36

mg/l

0.81

174

Benign neoplasm of mouth and pharynx

104

889

1.17

0.85

1.3

585.95

523.61

mg/l

0.44

838

Autism spe, excluding more controls

145

1.46

0.85

1.2

2.1

316.86

467.30

mg/l

1.99

136

Corns and callosities

532

1.23

0.85

1.7

1.3

931.19

542.17

mg/l

0.43

502

Maternal care for known or suspected abnormality of pelvic organs

303

1907

1.10

0.85

1.3

406.50

452.84

mg/l

1.00

297

1825

Dislocation, sprain and strain of joints and ligaments of elbow

578

1.22

0.84

1.7

1.8

500.60

483.34

mg/l

0.10

552

Placenta praevia

434

0.76

0.84

1.2

1.3

465.48

452.89

mg/l

0.05

411

Other surgical follow-up care

222

1.36

0.84

1.2

1.6

660.50

459.45

mg/l

0.30

211

LSIL lesion of the cervix uteri, vagina or vulva

160

1416

1.13

0.82

1.4

1.2

478.34

466.93

mg/l

0.07

152

1361

Chronic tubulo-interstitial nephritis

267

1.32

0.81

1.3

1.2

484.34

493.86

mg/l

0.07

255

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

482

3091

1.07

0.81

1.3

588.17

540.56

mg/l

0.85

451

2920

Fetus and newborn affected by complications of placenta, cord and membranes

0.00

0.81

0.0

4.3

—

330.60

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

505

3725

1.07

0.80

1.2

1.3

599.93

559.77

mg/l

0.62

475

3519

Congenital malformations of heart and great arteries

147

1255

1.14

0.80

1.4

2.0

398.85

496.99

mg/l

4.10

137

1194

Dyshidrosis [pompholyx]

114

1.51

0.80

1.5

1.2

431.71

407.87

mg/l

0.20

109

Psoriasis vulgaris

195

1751

1.12

0.79

1.2

1.3

473.67

519.90

mg/l

1.10

180

1659

Ulcerative colitis (strict definition, require KELA)

186

1666

1.12

0.79

1.2

1.4

499.40

501.59

mg/l

0.02

181

1582

Alcohol abuse counselling and surveillance

123

1.48

0.78

1.2

446.06

500.23

mg/l

0.55

117

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

170

1596

0.89

0.77

1.4

1.3

747.70

558.96

mg/l

0.61

161

1500

Actinic keratosis

309

2698

1.09

0.77

1.3

670.16

561.04

mg/l

0.80

291

2535

All dysplastic lesions of the cervix uteri, vagina or vulva

338

3102

1.08

0.77

1.3

522.56

454.09

mg/l

0.60

324

2967

ILD, hospital admissions

123

1076

1.15

0.77

1.2

1.3

740.16

548.15

mg/l

0.40

112

1010

Abnormal findings in secretions and smears from cervix uteri vagina vulva

589

4358

1.06

0.76

1.3

474.45

492.39

mg/l

0.20

565

4169

Benign neoplasm: Skin of ear and external auricular canal

288

1.29

0.76

1.4

1.3

697.71

512.12

mg/l

0.66

268

LSIL lesion of the cervix uteri

128

1125

1.14

0.75

1.2

484.75

460.24

mg/l

0.12

121

1078

Actinomycosis

2.12

0.75

1.8

1.2

661.20

591.50

mg/l

—

Other chronic obstructive pulmonary disease

355

3184

0.93

0.75

1.3

525.28

585.96

mg/l

1.52

329

3023

Dental caries 1 and operation codes, only avohilmo

372

1730

1.08

0.75

1.5

1.7

516.63

512.93

mg/l

0.04

350

1659

Other specific arthropathies, wide

158

1.40

0.75

1.4

1.3

784.41

487.11

mg/l

0.54

151

Evidence of alcohol involvement determined by blood alcohol level

108

1.50

0.74

1.2

468.06

448.98

mg/l

0.14

102

Other congenital malformations of the digestive system

421

1.23

0.74

2.5

2.7

414.15

438.21

mg/l

0.16

404

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

179

1609

1.12

0.73

1.2

1.4

505.95

504.98

mg/l

0.01

174

1529

Birth asphyxia

1.64

0.73

3.0

5.4

1177.00

398.82

mg/l

—

Sequelae of poliomyelitis

1.63

0.73

1.1

564.89

498.24

mg/l

—

Malignant neoplasm of rectosigmoid junction

108

0.55

0.73

1.3

1.2

314.83

489.73

mg/l

—

100

In situ neoplasms

350

3097

1.08

0.72

1.2

1.3

518.95

511.21

mg/l

0.08

333

2916

Other diseases of gallbladder

308

1.27

0.72

1.4

1.2

437.21

545.02

mg/l

1.80

291

Heart failure and bmi 25plus

267

2006

0.92

0.72

1.3

569.89

608.03

mg/l

0.51

253

1893

Other conjunctival vascular disorders and cysts

168

1.38

0.72

1.1

1.3

694.96

497.07

mg/l

0.63

157

Oesophagitis

398

1.24

0.72

1.3

535.85

557.51

mg/l

0.10

374

Single delivery by caesarean section

196

1255

0.90

0.72

1.5

1.3

423.79

461.70

mg/l

0.41

191

1197

Other and unspecified nonscarring hair loss

1.60

0.72

1.6

1.2

421.67

347.35

mg/l

—

Pollen allergy

233

2104

1.10

0.72

1.3

1.7

403.81

455.00

mg/l

0.98

223

2007

Interstitial lung disease

123

1083

1.14

0.71

1.2

1.3

740.16

547.79

mg/l

0.40

112

1017

Interstitial lung disease endpoints

123

1083

1.14

0.71

1.2

1.3

740.16

547.79

mg/l

0.40

112

1017

Obstructed labour due to maternal pelvic abnormality

155

1385

1.12

0.71

1.2

1.3

514.04

510.51

mg/l

0.02

146

1320

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

127

1121

1.14

0.71

1.2

469.31

497.66

mg/l

0.53

117

1058

Other interstitial pulmonary diseases

123

1084

1.14

0.71

1.2

1.3

740.16

548.46

mg/l

0.40

112

1018

Neurofibromatosis, type 1

1.57

0.70

1.1

1.4

446.67

406.87

mg/l

—

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

181

1925

0.90

0.70

1.3

547.94

510.66

mg/l

0.33

173

1816

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

490

3155

1.07

0.70

1.3

609.24

539.03

mg/l

1.30

461

2982

Complications of cardiac and vascular prosthetic devices, implants and grafts

135

1.42

0.69

1.5

1.4

678.68

500.60

mg/l

0.88

126

Keratoconus

205

1.33

0.67

1.1

1.3

827.74

490.95

mg/l

0.51

194

Bicuspidal aortic valve syndrome

295

0.74

0.67

1.5

1.6

442.73

531.85

mg/l

1.26

278

143

1209

1.12

0.66

1.3

1.2

572.33

585.74

mg/l

0.10

133

1132

Need for immunization against other single viral diseases

145

1.39

0.66

1.4

1.2

805.30

467.08

mg/l

0.71

137

Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)

128

1.42

0.66

1.1

1.2

568.00

541.13

mg/l

0.18

120

Congenital malformations of posterior segment of eye

1.61

0.66

1.7

3.7

397.43

456.09

mg/l

—

Benign neoplasm: Connective and other soft tissue of head, face and neck

120

1.43

0.65

1.1

1.5

481.59

486.31

mg/l

0.02

114

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

248

1617

0.92

0.64

1.3

611.68

583.77

mg/l

0.28

232

1541

Perforation of oesophagus

1.75

0.64

1.4

1.2

569.60

459.28

mg/l

—

Calcific aortic valvular stenosis

186

2000

0.91

0.64

1.3

605.72

569.33

mg/l

0.39

177

1883

Calcific aortic valvular stenosis, operated

186

2000

0.91

0.64

1.3

605.72

569.33

mg/l

0.39

177

1883

Labour and delivery complicated by fetal stress [distress]

264

1908

0.92

0.64

1.3

398.26

416.56

mg/l

0.33

258

1816

Malignant neoplasm of other and unspecified parts of biliary tract, excluding all cancers (controls excluding all cancers)

131

0.61

0.64

1.1

1.3

414.63

525.64

mg/l

—

121

Complications of labour and delivery

782

4160

1.05

0.64

1.3

490.75

493.33

mg/l

0.03

748

3957

Other chronic obstructive pulmonary disease, including avohilmo

464

4093

0.94

0.63

1.2

1.3

548.55

574.29

mg/l

0.28

430

3885

Open wound of hip and thigh

252

1.28

0.63

1.3

1.6

746.44

491.66

mg/l

0.43

238

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

469

3048

1.06

0.63

1.3

592.58

541.06

mg/l

0.92

439

2881

Thyroiditis, unspecified

121

1.42

0.63

1.4

1.5

546.35

480.39

mg/l

0.25

114

Vasomotor rhinitis (mode)

627

1.17

0.62

1.4

1.3

392.45

524.77

mg/l

5.98

595

Maternal care for known or suspected malpresentation of fetus

185

1514

0.91

0.62

1.3

369.59

416.63

mg/l

2.26

180

1448

Arthropathic psoriasis

113

1003

1.13

0.61

1.2

1.3

497.68

530.49

mg/l

0.35

107

947

Cellulitis of external ear

1.49

0.61

1.1

1.6

456.77

393.88

mg/l

0.56

Hypertensive Renal Disease

191

1.31

0.61

1.1

1.3

552.40

568.37

mg/l

0.07

174

Conduction disorders

291

2247

1.08

0.61

1.2

1.4

505.26

540.06

mg/l

0.73

280

2123

Benign neoplasm: Liver

165

1.34

0.61

1.1

1.3

467.82

419.60

mg/l

0.22

153

Operations 2 for CAVS

186

1993

0.91

0.61

1.3

605.72

569.87

mg/l

0.38

177

1876

Calcific aortic valvular stenosis, diagnosis (helper)

186

1993

0.91

0.61

1.3

605.72

569.87

mg/l

0.38

177

1876

Non-ischemic cardiomyopathy

275

2093

1.08

0.60

1.5

1.3

516.82

562.29

mg/l

0.95

265

1975

Primary biliary cholangitis (PBC)

141

0.63

0.60

1.2

1.3

520.89

495.15

mg/l

—

132

Calcific aortic valvular stenosis, including rheumatic fever

187

1998

0.91

0.59

1.3

604.83

569.41

mg/l

0.38

178

1881

Seropositive rheumatoid arthritis, wide

258

2392

1.08

0.59

1.3

781.74

533.30

mg/l

0.78

245

2277

Erectile dysfunction, exclusion

0.00

0.59

0.0

1.2

—

589.30

—

Colitis, primary sclerosing

112

0.62

0.58

1.0

1.4

364.71

407.13

mg/l

—

106

Pacemaker

226

2379

0.92

0.58

1.2

1.3

525.18

554.63

mg/l

0.50

210

2245

Arthropathy in ulcerative colitis

106

1.43

0.58

1.1

1.3

487.40

423.92

mg/l

0.40

Benign neoplasm: Duodenum

184

1.31

0.58

1.6

1.3

538.92

520.81

mg/l

0.12

171

Coronary angioplasty

321

2634

0.93

0.57

1.3

588.98

569.15

mg/l

0.12

305

2500

Graves disease, strict definition

100

886

1.13

0.57

1.4

1.3

454.75

489.13

mg/l

0.40

850

Benign neoplasm: Short bones of lower limb

0.58

0.57

1.4

1.3

329.00

407.76

mg/l

—

Other nonscarring hair loss

1.52

0.57

1.5

1.2

408.27

360.61

mg/l

0.17

Parapsoriasis

141

1.36

0.57

1.1

1.5

567.26

480.68

mg/l

0.28

132

Heart failure, strict

506

3837

0.95

0.56

1.4

1.3

591.83

572.37

mg/l

0.14

487

3631

Exclusion endpoint for clefts

185

1.31

0.56

1.4

3.5

325.92

457.34

mg/l

1.51

180

Malignant neoplasm of cervix uteri, excluding all cancers (controls excluding all cancers)

195

0.71

0.56

1.1

1.3

566.71

440.15

mg/l

0.39

182

Other hammer toe(s) (acquired)

150

1276

1.10

0.56

1.3

632.42

512.34

mg/l

0.35

139

1198

Carcinoma in situ, bladder

229

0.74

0.56

1.3

1.2

791.29

549.30

mg/l

0.56

210

Other specified/unspecified spondylopathies

150

1.34

0.56

1.3

1.2

447.95

534.34

mg/l

0.95

143

Traumatic ischaemia of muscle

1.46

0.56

1.5

1.2

462.77

476.42

mg/l

0.05

Injury of muscle and tendon at lower leg level

144

1306

1.10

0.55

1.3

728.15

533.62

mg/l

0.53

139

1236

Primary gonarthrosis, bilateral

492

4086

1.05

0.55

1.3

567.69

575.09

mg/l

0.10

468

3880

Systemic disorders of connective tissue in diseases classified elsewhere

1.60

0.55

1.0

1.7

342.67

482.55

mg/l

—

Other specified transport accidents

1.60

0.55

1.7

1.3

253.17

426.18

mg/l

—

Chronic nephritic syndrome

312

1.22

0.54

1.6

1.2

653.87

521.42

mg/l

0.39

287

Anomalies of dental arch relationship, including avohilmo

224

1862

1.08

0.54

2.4

1.5

444.66

458.42

mg/l

0.15

213

1774

Haemangioma and lymphangioma, any site

786

1.14

0.54

1.2

1.5

469.69

524.89

mg/l

0.67

747

Cutis laxa senilis

1.49

0.54

1.1

1.2

401.11

480.75

mg/l

—

Primary coxarthrosis, bilateral

242

2251

1.08

0.53

1.3

720.88

544.67

mg/l

1.28

224

2130

All-cause Heart Failure

498

3773

0.95

0.53

1.4

1.3

593.57

573.48

mg/l

0.14

480

3568

Macular pucker

121

1091

1.11

0.53

1.4

1.3

544.66

544.69

mg/l

0.00

115

1026

Family history of malignant neoplasm

982

0.88

0.53

1.2

1.3

499.43

502.58

mg/l

0.02

936

Androgenic alopecia

1.44

0.53

3.6

1.3

580.78

358.66

mg/l

—

Neuroendocrine tumor and carcinoma of small intestine, excluding all cancers (controls excluding all cancers)

0.62

0.52

1.0

1.2

466.33

464.80

mg/l

—

Inguinal hernia

686

4431

1.04

0.52

1.3

1.4

611.33

569.73

mg/l

0.31

651

4230

Inhalation and ingestion of other objects causing obstruction of respiratory tract

1.51

0.52

1.2

2.0

350.00

421.80

mg/l

—

Duodenal ulcer

742

1.13

0.52

1.2

1.3

672.19

598.62

mg/l

0.38

693

Calcaneal spur

1.41

0.51

1.4

1.2

443.44

456.90

mg/l

—

Other congenital malformations of tongue, mouth and pharynx

152

1.32

0.51

3.7

446.70

436.86

mg/l

0.03

147

Other psoriatic arthropathies

103

923

1.12

0.51

1.3

486.79

529.00

mg/l

0.49

874

Abscess of lung

1.42

0.51

1.7

1421.77

458.60

mg/l

0.55

Carcinoma in situ of other and unspecified sites

247

0.77

0.50

1.3

1.2

754.47

551.11

mg/l

0.51

228

Psoriatic arthropathies, ICD10

106

952

1.12

0.50

1.3

488.34

531.99

mg/l

0.53

100

902

D07AA Corticosteroids, weak (group I)

173

1592

1.09

0.50

1.4

1.8

498.89

469.27

mg/l

0.26

165

1513

Contact with other hot fluids

244

1.24

0.48

1.2

1.8

387.12

498.45

mg/l

1.83

231

Other disorders of prostate

208

1.25

0.48

1.5

1.2

699.23

561.07

mg/l

0.54

189

Amputation of ankle bones

137

1.32

0.47

1.4

1.2

524.17

506.91

mg/l

0.08

129

HSIL lesion of the vulva

146

1.31

0.47

1.5

1.2

843.47

456.99

mg/l

0.47

135

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

100

1046

0.90

0.47

1.2

801.16

557.35

mg/l

0.44

974

Hypersensitivity pneumonitis due to organic dust

111

1.36

0.47

1.5

1.2

384.13

457.49

mg/l

0.87

103

Other/unspecified seropositive rheumatoid arthritis

252

2363

1.07

0.46

1.3

788.26

533.44

mg/l

0.78

240

2249

Ectopic pregnancy

185

1716

1.08

0.46

1.3

435.64

487.80

mg/l

1.08

177

1640

Benign neoplasm: Connective and other soft tissue of head, face and neck

129

1.33

0.46

1.1

1.3

481.59

452.87

mg/l

0.13

123

Hepatocellular carcinoma

118

0.67

0.46

1.4

1.3

424.88

538.48

mg/l

—

110

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

248

2327

1.07

0.45

1.3

790.25

534.52

mg/l

0.77

236

2214

Unstable angina pectoris

316

2770

0.94

0.45

1.3

641.81

578.69

mg/l

0.33

302

2626

Infections of breast associated with childbirth

329

1.19

0.45

1.3

382.28

459.80

mg/l

1.40

312

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

265

1722

0.94

0.45

1.2

1.3

609.22

580.43

mg/l

0.32

249

1638

Tooth eruption problems

163

1492

1.08

0.44

2.2

1.6

398.07

434.42

mg/l

0.49

154

1420

Melanocytic naevi of eyelid, including canthus

1.46

0.44

1.1

1.3

540.60

431.27

mg/l

—

Idiopathic gout

648

1.13

0.44

1.2

1.3

852.29

554.47

mg/l

1.85

606

All dysplastic lesions of the cervix uteri

291

2742

1.06

0.44

1.2

1.3

523.34

442.87

mg/l

0.62

278

2624

Premature rupture of membranes

227

1781

0.94

0.44

1.2

1.3

451.36

428.74

mg/l

0.26

215

1700

ILD, hospital admissions 1, main diag only

106

962

1.10

0.44

1.2

1.3

774.43

549.75

mg/l

0.41

898

Benign neoplasm: Liver

175

1.26

0.43

1.1

1.4

467.82

436.75

mg/l

0.13

163

Peripheral artery disease

349

2958

0.95

0.43

1.3

737.73

565.14

mg/l

0.93

333

2797

Rheumatic valve diseases

129

0.69

0.43

1.3

316.56

464.10

mg/l

—

124

COPD related to multimorbidity

306

2722

0.95

0.43

1.3

533.45

583.45

mg/l

1.09

282

2582

Bronchiectasis

574

1.14

0.43

1.4

1.3

462.58

529.12

mg/l

0.70

541

Major anomalies of jaw size

230

1.22

0.43

1.3

1.8

376.04

450.11

mg/l

1.47

215

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

127

1165

1.09

0.42

1.2

1.3

469.31

533.47

mg/l

1.65

117

1101

Noonan syndrome

0.00

0.42

0.0

4.4

—

268.69

—

Folliculitis decalvans

0.00

0.42

0.0

1.1

—

780.20

—

Carcinoma in situ, bladder

217

0.78

0.41

1.3

1.2

791.29

509.24

mg/l

0.68

198

Traumatic amputation of ankle and foot

0.00

0.41

0.0

1.3

—

620.94

—

Congenital malformations of genital organs

105

951

1.10

0.41

1.5

1.8

415.28

449.42

mg/l

0.36

912

Benign neoplasm: Skin of eyelid, including canthus

130

1198

1.09

0.40

1.2

1.3

552.76

519.54

mg/l

0.31

123

1122

Non-small cell lung cancer

100

1097

0.91

0.40

1.2

801.16

587.04

mg/l

0.37

1024

Malignant neoplasm of vulva, excluding all cancers (controls excluding all cancers)

1.35

0.40

1.7

1.2

1199.38

467.66

mg/l

0.62

Liposarcoma, excluding all cancers (controls excluding all cancers)

1.42

0.39

1.3

812.10

512.35

mg/l

—

COPD

382

3298

0.95

0.39

1.3

524.62

584.89

mg/l

1.58

355

3135

Benign neoplasm: Duodenum

196

1.23

0.39

1.6

1.2

538.92

512.65

mg/l

0.19

186

Coronary atherosclerosis

687

4582

0.97

0.38

1.3

551.18

578.60

mg/l

0.38

646

4355

Inguinal or femoral hernia, bilateral

780

1.10

0.38

1.2

1.3

598.10

533.16

mg/l

0.43

729

Venous complications and haemorrhoids in the puerperium

1.34

0.38

1.5

1.3

508.15

422.76

mg/l

0.34

Wide developmental disorders

308

1.17

0.37

1.4

2.9

354.14

436.26

mg/l

0.72

296

Inguinal hernia, bilateral

771

1.10

0.37

1.2

1.3

600.94

534.21

mg/l

0.43

721

Family history of other conditions

112

0.71

0.37

1.3

1.7

424.00

398.95

mg/l

—

106

Laparoscopic left hemicolectomy

112

0.71

0.37

1.1

1.2

528.50

511.85

mg/l

—

104

Leiomyoma of uterus

553

3000

1.04

0.37

1.3

522.97

488.00

mg/l

0.42

529

2859

Other disorders of iris and ciliary body

170

1.24

0.37

1.2

1.3

511.52

466.03

mg/l

0.28

159

Contact with lifting and transmission devices, not elsewhere classified

143

1.27

0.37

1.6

1.3

586.39

518.04

mg/l

0.23

134

Acute nephritic syndrome

152

1.26

0.37

1.4

453.32

468.82

mg/l

0.09

144

Parodontitis or/and operation codes

819

4723

1.03

0.37

1.3

557.91

526.84

mg/l

0.25

787

4494

Adjustment and management of implanted device

134

1243

1.08

0.36

1.1

1.3

514.70

553.44

mg/l

0.49

128

1174

Injury of muscle and tendon at hip and thigh level

840

1.10

0.36

1.4

1.3

611.71

547.21

mg/l

0.40

793

Multiple delivery

818

0.90

0.36

1.3

471.11

493.75

mg/l

0.16

779

Deep bite

121

979

1.08

0.35

2.2

1.8

395.83

470.02

mg/l

1.89

113

937

Corneal degeneration

108

1.30

0.35

1.1

1.5

662.93

467.84

mg/l

0.53

Aortic aneurysm

164

1719

0.94

0.35

1.4

1.3

528.91

564.01

mg/l

0.57

157

1619

Idiopathic thrombocytopenic purpura

227

1.19

0.34

1.7

1.4

615.96

459.08

mg/l

0.67

215

Medical treatment for female infertility

218

2297

0.95

0.34

1.3

449.78

425.17

mg/l

0.17

202

2207

Cystic kidney disease

254

0.82

0.34

1.2

1.6

586.19

510.24

mg/l

0.29

240

Abnormal spermatozoa

846

0.91

0.34

1.2

595.07

566.26

mg/l

0.26

798

Coxarthrosis, primary, with hip surgery

380

3751

0.96

0.34

1.3

669.67

548.75

mg/l

1.12

356

3551

Carcinoma in situ of other and unspecified sites

232

0.82

0.34

1.3

754.47

516.69

mg/l

0.63

212

Male infertility

387

1.14

0.33

1.3

1.4

1322.66

533.38

mg/l

0.48

369

Angina pectoris

626

4094

1.03

0.33

1.3

582.44

579.77

mg/l

0.02

592

3888

Neuroendocrine tumor and carcinoma of small intestine

0.68

0.33

1.0

1.2

466.33

485.44

mg/l

—

Follicular adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

0.66

0.33

1.2

588.67

427.72

mg/l

—

Benign neoplasm: Tongue

209

0.81

0.32

1.3

576.47

518.40

mg/l

0.20

195

Pneumothorax

540

1.11

0.32

1.3

730.15

549.47

mg/l

0.32

503

Malignant neoplasm of breast, HER-negative

161

1710

0.94

0.32

1.3

567.18

518.85

mg/l

0.41

154

1619

Carbimazole or st.post thyroidectomy, condition for graves disease

204

1932

1.06

0.32

1.4

1.3

473.78

498.22

mg/l

0.43

194

1836

Mental and behavioural disorders associated with the puerperium

1.31

0.32

1.2

1.3

326.25

362.06

mg/l

0.65

Benign neoplasm: Peripheral nerves and autonomic nervous system

110

1.28

0.32

1.1

1.3

566.00

448.60

mg/l

1.06

102

Olecranon bursitis

408

1.13

0.31

1.2

1.3

513.02

554.62

mg/l

0.42

384

Benign neoplasm: Tongue

208

0.81

0.31

1.3

576.47

480.14

mg/l

0.37

196

HSIL lesion of the cervix uteri, vagina or vulva

217

2062

1.05

0.31

1.2

1.3

559.71

455.89

mg/l

0.63

209

1973

Malignant neoplasm of other and ill-defined digestive organs, excluding all cancers (controls excluding all cancers)

0.73

0.31

1.1

1.2

611.71

486.57

mg/l

—

Varicose veins

659

4839

1.03

0.30

1.3

611.54

553.01

mg/l

0.40

629

4603

Benign neoplasm: other/unspecified salivary gland

194

1.19

0.29

1.1

1.3

440.83

500.64

mg/l

0.82

185

Other, unspecified and serous retinal detachments

222

1.18

0.29

1.3

1.4

438.50

544.87

mg/l

1.10

207

Pathological resorption of teeth

222

1.18

0.29

1.2

1.4

515.42

574.65

mg/l

0.30

205

Other disorders of breast and lactation associated with childbirth

148

1.22

0.29

1.2

1.4

365.78

382.86

mg/l

0.16

141

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

185

1.19

0.29

1.4

1.2

473.50

533.42

mg/l

0.29

173

Other and unspecified corneal deformities and disorders

251

1.16

0.28

1.7

1.3

533.66

494.74

mg/l

0.24

237

Benign neoplasm: other/unspecified salivary gland

195

1.18

0.28

1.1

1.2

440.83

499.30

mg/l

0.79

185

Unspecified lump in breast

147

1389

1.06

0.27

1.2

1.3

446.98

514.73

mg/l

1.74

142

1324

Adhesive middle ear disease

122

1.24

0.27

1.0

1.5

479.47

402.13

mg/l

0.53

116

Traction detachment of retina

1.22

0.27

1.5

1.2

577.38

444.74

mg/l

—

Serous carcinoma of ovary, excluding all cancers (controls excluding all cancers)

268

0.86

0.27

1.0

1.2

481.17

473.66

mg/l

0.04

250

Malignant neoplasm of vulva

1.20

0.26

1.5

1.1

1383.25

458.37

mg/l

—

Malignant neoplasm of other and unspecified parts of biliary tract

0.69

0.26

1.2

1.3

422.00

541.12

mg/l

—

Malignant neoplasm of small intestine

141

1.21

0.26

1.6

1.2

531.41

518.25

mg/l

0.06

132

Benign neoplasm: Short bones of lower limb

0.67

0.26

1.4

1.2

329.00

444.79

mg/l

—

Multiple gestation

914

0.93

0.26

1.6

1.3

512.46

434.11

mg/l

0.75

875

Valvular heart disease excluding rheumatic fever

473

3559

0.97

0.25

1.4

577.89

555.29

mg/l

0.37

452

3382

Thyrotoxicosis with toxic multinodular goitre

446

0.89

0.25

1.3

1.2

676.35

522.69

mg/l

1.01

421

Pyogenic granuloma

123

1.22

0.25

1.1

1.4

516.33

427.06

mg/l

0.26

115

Femoral hernia

320

1.13

0.25

1.1

1.2

588.94

503.24

mg/l

0.23

299

Mental and behavioural disorders of puerperium, not classified elsewhere

1.26

0.24

1.2

1.3

326.25

360.06

mg/l

0.62

Obstructed labour due to malposition and malpresentation of fetus

239

2344

0.96

0.24

1.2

1.3

458.86

445.27

mg/l

0.12

228

2229

Abrasion of teeth

289

2047

1.04

0.24

1.3

439.96

528.47

mg/l

4.60

272

1953

Impacted maxillary molar

538

0.91

0.24

1.3

1.5

382.80

405.66

mg/l

0.32

505

Other and unspecified acute skin changes due to ultraviolet radiation

180

0.83

0.24

2.2

1.2

479.20

498.86

mg/l

0.08

169

Congenital malformations of ovaries, fallopian tubes and broad ligaments

532

1.09

0.24

1.3

453.42

451.57

mg/l

0.01

508

Other noninflammatory disorders of uterus, except cervix

209

1365

1.05

0.24

1.3

498.29

547.00

mg/l

0.64

199

1313

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

193

1846

1.05

0.24

1.4

1.3

690.59

551.71

mg/l

1.62

187

1746

Precocious puberty

1.36

0.23

1.2

3.2

751.80

337.00

mg/l

—

Maternal care for known or suspected fetal abnormality and damage

174

1477

1.05

0.23

1.3

465.63

426.19

mg/l

0.23

167

1413

Non-rheumatic valve diseases

468

3511

0.97

0.23

1.4

570.55

554.98

mg/l

0.24

447

3335

Lung cancer and mesothelioma

131

1182

0.95

0.23

1.2

1.3

774.23

528.06

mg/l

0.63

124

1124

Chronic respiratory disease originating in the perinatal period

1.26

0.23

3.8

5.4

445.80

374.02

mg/l

—

Personal history of allergy to drugs, medicaments and biological substances

1.26

0.22

1.1

1.2

352.55

423.99

mg/l

0.87

Twin gestation

887

0.93

0.22

1.6

1.3

513.35

429.71

mg/l

0.80

849

Malignant neoplasm of other and ill-defined sites, excluding all cancers (controls excluding all cancers)

0.74

0.22

5.3

1.3

342.29

508.45

mg/l

—

Postpartum haemorrhage due to retained placenta

115

1215

0.95

0.22

1.3

535.59

452.15

mg/l

0.59

110

1170

Nephrotic syndrome

257

1.13

0.22

1.7

1.9

757.90

468.65

mg/l

0.62

242

Digeorge syndrome

0.00

0.22

0.0

8.7

—

234.90

—

Oral lichen ruber planus, including avohilmo

487

1.09

0.22

1.3

1.2

427.17

518.08

mg/l

2.14

464

Vibratory urticaria

0.00

0.22

0.0

1.2

—

611.00

—

Ascorbic acid deficiency

0.00

0.22

0.0

3.0

—

261.40

—

Induced delusional disorder

0.00

0.22

0.0

1.3

—

395.91

—

Benign neoplasm: Lacrimal gland and duct

0.00

0.21

0.0

1.1

—

326.55

—

Disorders of copper metabolism

0.00

0.21

0.0

3.9

—

329.00

—

Congenital glaucoma

0.00

0.21

0.0

1.1

—

322.50

—

Juvenile dermatomyositis

0.00

0.21

0.0

2.9

—

326.73

—

Lichen striatus

0.00

0.21

0.0

1.2

—

484.00

—

Hypotony of eye

0.00

0.21

0.0

1.2

—

572.00

—

Transepidermal elimination disorders

0.00

0.21

0.0

1.1

—

320.20

—

Intentional self-harm by jumping or lying before moving object

0.00

0.21

0.0

1.1

—

472.80

—

Thyrotoxicosis from ectopic thyroid tissue

0.00

0.21

0.0

1.2

—

400.17

—

Iodine-deficiency-related goitre

0.00

0.21

0.0

1.1

—

328.83

—

Polydactyly

0.00

0.21

0.0

5.3

—

293.17

—

Secondary lactase deficiency

0.00

0.21

0.0

1.3

—

480.83

—

Alport

0.00

0.21

0.0

4.4

—

344.17

—

Other and unspecified haemorrhagic conditions

103

0.77

0.21

1.0

1.4

645.75

416.69

mg/l

—

Operations for atrial fibrillation

104

0.77

0.21

1.0

1.2

498.50

528.13

mg/l

—

Colorectal neuroendocrine tumor and carcinoma, excluding all cancers (controls excluding all cancers)

105

0.76

0.21

1.5

1.3

419.87

424.16

mg/l

—

Haemolytic disease of fetus and newborn

0.00

0.21

0.0

8.6

—

224.00

—

Hirsprung

0.00

0.21

0.0

4.5

—

630.85

—

Other recurrent vertebral subluxation

0.00

0.21

0.0

1.2

—

404.69

—

Whooping cough

1.17

0.21

1.6

1.2

413.00

455.60

mg/l

—

Disorders of sexual preference

0.00

0.21

0.0

1.3

—

606.92

—

Benign neoplasm: Peripheral nerves and autonomic nervous system

117

1.20

0.20

1.1

1.2

566.00

419.49

mg/l

1.59

107

Other congenital malformations of eye

0.00

0.20

0.0

3.4

—

282.14

—

Benign neoplasm: Uterine tubes and ligaments

1.21

0.20

1.2

386.33

474.07

mg/l

—

Benign neoplasm: Skin of eyelid, including canthus

130

1241

1.05

0.19

1.2

1.3

552.76

538.48

mg/l

0.12

123

1168

Rheumatic fever incl heart disease

186

0.86

0.19

1.3

1.2

376.06

475.92

mg/l

0.68

175

Cervical root disorders

1.16

0.19

5.2

1.2

572.33

459.15

mg/l

—

Delivery

467

2411

1.03

0.19

1.3

537.81

482.38

mg/l

0.57

438

2288

Other disorders originating in the perinatal period

128

1.18

0.18

3.3

4.6

319.87

340.84

mg/l

0.11

128

Arterial embolism and thrombosis of lower extremity artery

227

0.88

0.18

1.3

471.55

532.42

mg/l

0.34

211

malignant neoplasm of female genital organs

107

1123

0.95

0.18

1.2

1.3

569.37

554.01

mg/l

0.06

102

1067

Other specified/unspecified nutritional deficiencies

1.17

0.18

1.0

1.3

535.14

430.95

mg/l

—

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

141

1444

0.96

0.18

1.2

1.3

568.23

516.69

mg/l

0.32

136

1353

Other injuries of spine and trunk, level unspecified

1.15

0.17

1.1

1.6

757.57

449.64

mg/l

—

Seropositive rheumatoid arthritis, strict definition

137

1314

1.04

0.17

1.2

1.3

932.48

522.74

mg/l

0.65

129

1238

COPD-related respiratory insufficiency

806

1.06

0.17

1.2

1.3

523.76

605.19

mg/l

0.76

756

Benign leiomyoma with endometriosis

139

1336

1.04

0.16

1.3

485.01

515.33

mg/l

0.34

129

1277

Benign leiomyoma with endometriosis

139

1336

1.04

0.16

1.3

485.01

512.99

mg/l

0.28

129

1261

Carcinoma in situ of vulva

1.15

0.16

1.5

1.2

560.88

384.27

mg/l

—

Benign neoplasm: Parathyroid gland

1.15

0.16

1.3

1.2

457.25

538.37

mg/l

—

Congenital malformations of breast

139

1.15

0.16

1.1

1.3

339.25

413.79

mg/l

0.97

131

288

1.10

0.16

2.2

4.0

382.94

408.00

mg/l

0.11

283

Benign neoplasm: Appendix

0.78

0.15

1.8

1.2

423.83

464.58

mg/l

—

Gastrointestinal stromal tumor and sarcoma, excluding all cancers (controls excluding all cancers)

0.77

0.15

1.0

1.2

611.00

493.22

mg/l

—

Small cell lung cancer, excluding all cancers (controls excluding all cancers)

140

0.86

0.15

1.3

661.92

497.95

mg/l

0.84

131

Abscess of external ear

102

1.18

0.15

1.3

1.5

773.42

402.51

mg/l

0.67

Pregnancy, childbirth and the puerperium

322

1644

1.03

0.15

1.3

466.41

453.65

mg/l

0.16

301

1553

Benign neoplasm: Scapula and long bones of upper limb

0.79

0.14

1.0

1.3

488.43

393.46

mg/l

—

Malignant neoplasm of larynx

0.79

0.14

1.3

765.86

538.22

mg/l

—

Mandibular prognathia AND surgery (LeFortI or BSSO or LeFortI AND BSSO), including avohilmo

0.77

0.14

1.0

2.7

437.86

446.81

mg/l

—

Intrahepatic Cholestasis of Pregnancy (ICP)

674

1.05

0.14

1.1

1.3

419.97

436.49

mg/l

0.12

648

Delivery, wide proxy

378

1968

1.02

0.14

1.3

491.85

461.30

mg/l

0.45

352

1866

Filling of root of tooth

254

0.90

0.14

1.3

1.4

548.91

506.89

mg/l

0.21

239

Benign neoplasm: Skin of lip

0.83

0.14

1.4

1.3

378.25

453.22

mg/l

—

Colorectal neuroendocrine tumor and carcinoma

0.80

0.13

1.5

1.3

419.88

439.23

mg/l

—

Benign neoplasm: Vulva

170

0.88

0.13

1.0

1.3

439.07

440.19

mg/l

0.01

161

Heart failure,strict

486

3567

0.98

0.13

1.4

1.3

539.93

570.71

mg/l

0.66

467

3383

Autism

218

1.10

0.13

1.2

2.4

309.67

425.40

mg/l

1.85

206

Oral leukoplakia and related diseases, including avohilmo

715

1.05

0.13

1.3

1.2

534.14

531.85

mg/l

0.01

675

191

1740

0.97

0.13

1.3

587.94

574.80

mg/l

0.11

180

1629

Dental caries 2 and operation codes, only avohilmo

924

5664

1.01

0.13

1.4

462.41

524.22

mg/l

1.90

899

5382

HSIL lesion of the vagina

117

0.85

0.13

1.4

1.3

1387.40

429.39

mg/l

—

107

Respiratory and cardiovascular disorders specific to the perinatal period

264

1.08

0.13

5.2

3.9

708.13

394.95

mg/l

0.78

259

Pleural effusion

114

1099

1.04

0.13

1.4

1.3

529.39

576.57

mg/l

0.47

109

1024

Other assisted single delivery

161

1.12

0.13

1.2

1.4

341.17

421.37

mg/l

1.33

155

Toxic effect of alcohol

161

1.12

0.13

1.4

1.3

459.17

503.43

mg/l

0.23

151

Major coronary heart disease event

717

4847

0.99

0.13

1.3

562.12

573.18

mg/l

0.14

679

4607

Retinoschisis and retinal cysts

171

1.11

0.12

1.1

1.4

575.84

519.83

mg/l

0.43

158

Colectomy operation

130

1343

0.97

0.12

1.2

1.3

552.69

544.08

mg/l

0.05

123

1264

Congenital malformations of eye, ear, face and neck

639

1.05

0.12

1.3

2.1

387.42

463.99

mg/l

2.16

606

Ulcerative ileocolitis

344

0.93

0.12

1.1

1.3

486.06

518.69

mg/l

0.12

324

Serous carcinoma of ovary

251

0.91

0.12

1.0

1.3

481.17

513.05

mg/l

0.19

239

Benign neoplasm: Vulva

168

0.89

0.11

1.0

1.3

439.07

487.27

mg/l

0.42

158

Assault by sharp object

124

1.13

0.11

1.2

1.3

434.57

509.79

mg/l

0.60

117

Maternal care for known or suspected disproportion

404

0.94

0.11

1.4

1.3

565.26

442.30

mg/l

0.39

387

Other and unspecified disease of Bartholin gland

219

0.91

0.11

1.2

1.3

408.10

494.59

mg/l

0.79

208

Benign neoplasm: Kidney

260

0.92

0.11

1.2

1.3

408.63

521.10

mg/l

2.16

248

Impacted teeth

201

1913

0.98

0.10

1.5

1.4

429.92

438.95

mg/l

0.07

192

1819

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

750

1.04

0.10

1.4

1.2

691.78

534.93

mg/l

1.00

695

Carcinoma in situ of skin of lower limb, including hip

115

1.13

0.10

1.3

1.2

480.54

510.48

mg/l

0.18

107

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

820

1.04

0.10

1.1

1.3

440.17

452.93

mg/l

0.10

786

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

212

1.09

0.10

1.5

1.2

569.74

505.67

mg/l

0.28

197

Mixed hyperlipidaemia

300

1.07

0.10

1.3

1.2

586.00

549.67

mg/l

0.20

281

Embedded teeth, including avohilmo

949

1.03

0.10

1.6

1.5

461.22

453.01

mg/l

0.05

900

Maxillary prognathism

1.11

0.10

1.0

2.2

272.80

362.76

mg/l

—

Benign neoplasm: Vagina

114

0.87

0.09

1.3

1.2

553.60

432.44

mg/l

—

103

Acute appendicitis, with complications

176

1798

0.98

0.09

1.3

588.22

528.89

mg/l

0.60

169

1707

Mandibular prognathia

134

0.89

0.09

1.1

2.4

401.50

456.28

mg/l

0.34

127

Cholangitis (primary sclerosing, PSC), with reimbursement 202

146

1.10

0.08

1.3

2.0

413.69

428.31

mg/l

0.09

137

HSIL lesion of the cervix uteri

195

1914

1.02

0.08

1.2

1.3

524.01

454.95

mg/l

0.36

187

1834

Malignant neoplasm of other and unspecified parts of tongue

1.14

0.08

1.2

457.90

483.59

mg/l

—

Benign neoplasm: Pharynx, unspecified

1.08

0.08

1.4

1.3

645.71

409.62

mg/l

—

Cardiomyopathy, other and unspecified

662

0.97

0.07

1.4

1.3

655.16

536.53

mg/l

1.06

629

Benign neoplasm: Parathyroid gland

1.05

0.07

1.3

1.2

457.25

476.39

mg/l

—

Sequelae of tuberculosis

0.87

0.07

2.1

1.2

347.71

514.07

mg/l

—

Inguinal of femoral hernia, unilateral

196

1.07

0.07

1.0

1.2

608.52

480.04

mg/l

0.20

182

Femoral hernia, unilateral

196

1.07

0.07

1.0

1.2

608.52

480.04

mg/l

0.20

182

Inguinal hernia, unilateral

196

1.07

0.07

1.0

1.2

608.52

480.04

mg/l

0.20

182

Long labour

273

2351

1.01

0.07

1.3

473.55

441.08

mg/l

0.30

264

2234

Secondary malignant neoplasm of other and unspecified sites

1.06

0.07

2.2

1.2

482.22

512.92

mg/l

—

Hyphaema and other vascular disorders of iris and ciliary body

118

1.10

0.07

1.2

1.3

518.54

432.46

mg/l

0.61

109

Malignant neoplasm of other and unspecified female genital organs

104

0.86

0.06

1.0

1.2

540.67

523.56

mg/l

—

Other diseases caused by chlamydiae

104

0.86

0.06

1.3

367.67

469.53

mg/l

—

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

104

0.86

0.06

1.1

1.3

379.00

405.09

mg/l

—

Single spontaneous delivery

447

2402

0.99

0.06

1.2

1.3

541.88

482.83

mg/l

0.59

420

2279

Benign neoplasm of other and unspecified female genital organs

355

0.96

0.06

1.1

1.3

459.18

503.78

mg/l

0.36

338

Inflammation of lacrimal passages (acute and unspecified)

121

0.91

0.06

3.0

1.3

548.18

457.97

mg/l

0.25

115

Poor fetal growth

131

1287

1.02

0.05

1.2

1.3

440.66

431.14

mg/l

0.05

125

1230

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

182

0.93

0.05

1.2

452.41

489.63

mg/l

0.30

170

Postpartum haemorrhage

278

2445

0.99

0.05

1.2

1.3

462.27

441.42

mg/l

0.25

267

2323

COPD, hospital admissions 3, with asthma pneumonia sepsis

199

1713

0.99

0.05

1.3

515.54

571.13

mg/l

1.01

180

1610

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

181

0.94

0.05

1.2

452.41

467.92

mg/l

0.12

170

Postpartum hemorraghe, all women as controls

278

2743

1.01

0.04

1.2

1.3

462.27

429.95

mg/l

0.46

267

2621

Benign neoplasm of other and unspecified female genital organs

352

0.97

0.04

1.1

1.2

459.18

465.79

mg/l

0.04

327

Pure hyperglyceridaemia

170

1.06

0.04

1.4

546.61

495.67

mg/l

0.25

161

Gonarthrosis, primary, with knee surgery

517

4247

0.99

0.04

1.3

584.31

575.36

mg/l

0.07

480

4038

Localized scleroderma [morphea]

109

0.92

0.04

1.5

1.2

479.10

486.07

mg/l

—

100

Malignant neoplasm of cervix uteri

109

0.92

0.04

1.2

1.3

486.90

402.28

mg/l

—

101

261

1.04

0.03

1.7

4.2

401.18

399.54

mg/l

0.01

256

Other acute skin changes due to ultraviolet radiation

260

1.04

0.03

1.9

1.3

444.30

506.17

mg/l

0.56

245

Postpartum hemorraghe, parous women as controls

278

2416

1.01

0.03

1.2

1.3

462.27

433.24

mg/l

0.40

267

2311

Left hemicolectomy

161

1.06

0.03

1.1

1.2

434.94

501.74

mg/l

0.62

147

Leiomyoma of uterus

696

3942

1.00

0.03

1.3

550.86

508.31

mg/l

0.49

668

3764

Migraine without aura, drug-induced

102

1.08

0.03

1.5

1.3

696.18

419.91

mg/l

0.57

Postmenopausal atrophic vaginitis

240

1434

1.01

0.02

1.3

466.18

569.74

mg/l

1.98

233

1374

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

699

1.02

0.02

1.1

1.3

419.97

453.06

mg/l

0.28

668

Macular hole

391

1.02

0.02

1.4

1.2

442.40

554.93

mg/l

1.91

364

Embedded and impacted teeth

301

2570

1.00

0.02

1.5

1.4

436.10

448.94

mg/l

0.13

288

2453

Benign neoplasm: Vagina

107

0.93

0.02

1.3

1.2

553.60

420.47

mg/l

—

Supervision of normal pregnancy

255

1465

0.99

0.02

1.3

1.2

390.64

426.69

mg/l

0.91

244

1396

Orthopaedic devices associated with adverse incidents

123

1.06

0.01

1.3

1.2

454.23

511.55

mg/l

0.49

115

Carcinoma in situ of skin of lower limb, including hip

123

1.06

0.01

1.3

480.54

533.99

mg/l

0.38

115

COPD, hospital admission 2, with asthma infections

251

2151

1.00

0.01

1.3

506.74

570.99

mg/l

1.47

227

2031

Non-allergic asthma

781

1.01

0.01

1.3

1.9

426.78

527.39

mg/l

1.89

742

Malignant neoplasm of other and unspecified female genital organs, excluding all cancers (controls excluding all cancers)

207

0.97

0.01

1.1

1.2

554.20

470.53

mg/l

0.35

195

Crossbite

647

0.99

0.01

3.2

2.2

309.67

446.73

mg/l

6.53

618

Benign neoplasm of thyroid gland

273

1.03

0.01

1.2

1.4

489.21

500.84

mg/l

0.08

260

Myocardial infarction, without ST-elevation

316

2906

1.00

0.01

1.2

1.3

690.20

558.84

mg/l

0.65

290

2755

Benign neoplasm of urinary organs

337

1.01

0.00

1.2

1.3

462.26

516.77

mg/l

0.56

317

Carcinoma in situ of other and unspecified genital organs

147

1.02

0.00

1.3

434.00

468.51

mg/l

0.20

135

Benign neoplasm of thyroid gland

276

1.01

0.00

1.2

1.3

489.21

485.38

mg/l

0.03

261

Gender identity disorders

102

0.98

0.00

1.2

1.4

435.80

484.80

mg/l

—

Cholangitis (primary sclerosing, PSC)

426

1.01

0.00

1.2

1.6

485.58

498.05

mg/l

0.10

403

Small cell lung cancer, helper endpoint

118

1.02

0.00

1.3

1.2

661.92

520.73

mg/l

0.66

110

Small cell lung cancer

118

1.02

0.00

1.2

661.92

520.73

mg/l

0.66

110

Malignant neoplasm of larynx, excluding all cancers (controls excluding all cancers)

132

0.98

0.00

1.8

1.2

950.77

511.91

mg/l

1.56

125

Maxillary retrognathism

158

1.01

0.00

1.1

2.4

451.63

435.10

mg/l

0.05

148

Autism spe

212

0.99

0.00

1.2

2.6

316.86

452.57

mg/l

1.67

202

Benign neoplasm: Kidney

238

1.01

0.00

1.2

1.3

408.62

475.99

mg/l

1.11

225

Abnormal findings on diagnostic imaging of breast

1.01

0.00

1.7

1.2

453.20

460.42

mg/l

—

Allergic contact dermatitis due to drugs in contact with skin

169

1.01

0.00

1.2

1.3

598.24

478.74

mg/l

0.41

155

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

849

1.00

0.00

1.1

1.3

440.17

468.30

mg/l

0.25

811

Other specified congenital malformation syndromes affecting multiple systems

151

0.99

0.00

1.1

4.0

279.33

403.42

mg/l

1.67

146

Premature separation of placenta [abruptio placentae]

195

1.03

0.00

1.3

1.4

481.85

466.79

mg/l

0.05

186

Cholera

315

1.02

0.00

1.3

1.2

632.34

521.87

mg/l

0.65

305

Benign neoplasm of urinary organs

335

1.01

0.00

1.2

1.3

462.26

508.67

mg/l

0.46

316

Labyrinthine dysfunction

0.00

0.0

1.2

—

476.56

—

Trichomoniasis

0.88

0.00

1.2

1.1

512.00

484.24

mg/l

—

Inflammation of lacrimal passages (chronic)

0.91

0.00

1.7

1.3

564.89

501.44

mg/l

—

Leiomyosarcoma, excluding all cancers (controls excluding all cancers)

0.94

0.00

1.0

1.3

540.29

487.61

mg/l

—

Lipid storage disorder, other/unspecified

0.00

0.0

1.4

—

304.00

—

Benign neoplasm: Appendix

0.94

0.00

1.8

1.2

423.83

497.53

mg/l

—

Malignant neoplasm of anus and anal canal, excluding all cancers (controls excluding all cancers)

0.92

0.00

1.1

1.2

490.50

479.10

mg/l

—

Actinic reticuloid

0.00

0.0

1.0

—

362.00

—

Crushing injuries involving multiple body regions

0.00

0.0

1.4

—

438.40

—

Intracranial laceration and haemorrhage due to birth injury

0.00

0.0

1.2

—

401.00

—

Ankylosis of teeth

0.00

0.0

1.2

—

351.17

—

Periodic paralysis

0.00

0.0

4.2

—

347.17

—

Secondary sideroblastic anaemia due to drugs and toxins

0.00

0.0

1.2

—

499.67

—

Miliaria rubra

0.00

0.0

1.6

—

648.00

—

Diseases caused by chlamydiae

0.93

0.00

1.3

367.67

454.91

mg/l

—

Benign neoplasm: Scapula and long bones of upper limb

0.90

0.00

1.0

1.3

488.43

445.08

mg/l

—

Selective deficiency of immunoglobulin M [IgM]

0.00

0.0

4.6

—

367.40

—

Disorders of fructose metabolism

0.00

0.0

1.4

—

458.00

—

Legal intervention

0.00

0.0

1.0

—

698.17

—

Disorders of tyrosine metabolism

0.00

0.0

1.1

—

361.63

—

Carcinoma in situ of respiratory system, other/unspecified

0.00

0.0

1.4

—

828.40

—

Immunodeficiency with increased immunoglobulin M [IgM]

0.00

0.0

1.3

—

392.83

—

Explosion and rupture of other specified pressurized devices

0.00

0.0

1.1

—

562.44

—

Benign neoplasm: Mesothelial tissue of other sites/unspecified

0.00

0.0

1.2

—

286.20

—

Congenital malformations of anterior segment of eye

0.99

0.00

1.1

2.0

429.00

420.44

mg/l

—

Rifle, shotgun and larger firearm discharge

0.00

0.0

1.0

—

627.56

—

Other birth injuries

0.00

0.0

1.0

—

281.43

—

Drowning and submersion in swimming-pool or bath

0.00

0.0

1.5

—

953.83

—

Slow fetal growth and fetal malnutrition

0.96

0.00

1.0

6.5

294.29

418.21

mg/l

—

Traumatic amputation of forearm

0.00

0.0

1.2

—

349.17

—

Toxic effect of metals

0.00

0.0

1.3

—

370.00

—

Benign neoplasm of other and unspecified intrathoracic organs

0.96

0.00

1.4

1.3

637.86

440.56

mg/l

—

Carcinoma in situ of oesophagus

0.00

0.0

1.1

—

732.25

—

Cleft palate

0.96

0.00

1.0

1.6

492.00

362.29

mg/l

—

Use of cabergoline

0.92

0.00

2.6

1.3

410.13

397.17

mg/l

—

Benign neoplasm: Uterine tubes and ligaments

0.98

0.00

1.2

386.33

474.26

mg/l

—

Malignant neoplasm of pyriform sinus, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.4

—

693.00

—

Carcinoma in situ of oesophagus

0.00

0.0

1.2

—

672.22

—

Carcinoma in situ of bronchus and lung

0.00

0.0

1.2

—

371.50

—

Carcinoma in situ of other and unspecified genital organs

150

1.00

0.00

1.3

434.00

485.01

mg/l

0.30

138

Carcinoma in situ of respiratory system, other/unspecified

0.00

0.0

1.4

—

828.40

—

Acquired keratosis follicularis

0.00

0.0

1.1

—

302.00

—

Nanophthalmos, microphthalmos and macrophthalmos

0.00

0.0

6.7

—

233.83

—

Staphylococcal scalded skin syndrome

0.00

0.0

2.5

—

252.25

—

Macular pucker, drug-induced

0.00

0.0

1.1

—

423.13

—

Other deformity of hallux (acquired)

1.00

0.00

2.0

1.3

373.00

442.93

mg/l

—

Cicatricial pemphigoid

0.00

0.0

1.3

—

355.44

—

Chondrolysis

0.00

0.0

1.0

—

401.00

—

Ischaemic infarction of muscle

0.00

0.0

1.2

—

681.60

—

Iliac crest spur

0.00

0.0

1.5

—

402.83

—

Fetus and newborn affected by maternal complications of pregnancy

0.91

0.00

2.3

5.8

261.75

391.14

mg/l

—

Androgen resistance syndrome

0.00

0.0

3.4

—

491.44

—

Common variable immunodeficiency with predominant abnormalities of T-cell numbers and function

0.00

0.0

1.2

—

306.17

—

Crushing injury and traumatic amputation of part of abdomen, lower back and pelvis

0.00

0.0

1.1

—

423.25

—

Trachoma

0.00

0.0

1.2

—

531.60

—

Histoplasmosis

0.00

0.0

1.0

—

383.29

—

Crushing injury of thorax and traumatic amputation of part of thorax

0.00

0.0

1.2

—

793.20

—

Myelofibrosis

0.00

0.0

1.0

—

392.20

—

Benign neoplasm: Lacrimal gland and duct

0.00

0.0

1.1

—

327.75

—

Injury of blood vessels at ankle and foot level

0.00

0.0

1.3

—

582.89

—

Cardiovascular disorders originating in the perinatal period

1.00

0.00

2.0

5.8

1223.00

457.42

mg/l

—

Fat embolism (traumatic)

0.00

0.0

1.2

—

515.20

—

Ascariasis

0.00

0.0

1.3

—

376.00

—

Toxic effect of other inorganic substances

0.00

0.0

1.0

—

553.00

—

Legal intervention and operations of war

0.00

0.0

1.0

—

648.71

—

Intentional self-harm by crashing of motor vehicle

0.00

-0.00

0.0

1.3

—

616.00

—

Birth injury to scalp

0.00

-0.00

0.0

4.6

—

267.13

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Protein [Mass/volume] in Cerebral spinal fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS